studies in Natural Products Chemistry Volume 20 Structure and Chemistry (Part F) (Including Cumulative Index Volumes 1-20)
Studies in Natural Products Chemistry edited by Atta-ur-Rahman
Vol. 1 Stereoselective Synthesis (Part A) Vol. 2 Structure Elucidation (Part A) Vol. 3 Stereoselective Synthesis (Part B) Vol. 4 Stereoselective Synthesis (Part C) Vol. 5 Structure Elucidation (Part B) Vol. 6 Stereoselective Synthesis (Part D) Vol. 7 Structure and Chennistry (Part A) Vol. 8 Stereoselective Synthesis (Part E) Vol. 9 Structure and Chemistry (Part B) Vol.10 Stereoselective Synthesis (Part F) Vol.11 Stereoselective Synthesis (Part G) Vol.12 Stereoselective Synthesis (Part H) Vol.13 Bioactive Natural Products (Part A) Vol.14 Stereoselective Synthesis (Part I) Vol.15 Structure and Chemistry (Part C) Vol.16 Stereoselective Synthesis (Part J) Vol.17 Structure and Chemistry (Part D) Vol.18 Stereoselective Synthesis (Part K) Vol.19 Structure and Chemistry (Part E) Vol.20 Structure and Chemistry (Part F)
Studies in Natural Products Chemistry Volume 20 Structure and Chemistry (Part F) (IncludingCumulative Index Volumes 1-20)
Edited by
Atta-ur-Rahman
H.E.J. Research Institute of Chemistry, University of Karachi, Karachi 75270, Pakistan
1998
ELSEVIER
-
Amsterdam - Lausanne - New York Oxford - Shannon - Singapore - Tokyo
ELSEVIER SCIENCE B.V. Sara Burgerhartstraat 25 P.O. Box 211, 1000 AE Amsterdam, The Netherlands
© 1998 Elsevier Science B.V. All rights reserved. This work and the individual contributions contained in it are protected under copyright by Elsevier Science B.V., and the following terms and conditions apply to its use: Photocopying Single photocopies of single chapters may be made for personal use as allowed by national copyright laws. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. Permissions may be sought directly from Elsevier Science Rights & Permissions Department, PO Box 800, Oxford 0X5 IDX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail:
[email protected]. You may also contact Rights & Permissions directly through Elsevier's home page (http://www.elsevier.nl), selecting first 'Customer Support', then 'General Information', then 'Permissions Query Form'. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London WIP OLP, UK; phone: (+44) 171 436 5931; fax: (+44) 171 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents for internal circulation within their institutions. Permission of the publisher is required for resale or distribution of such material outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this work, including any chapter or part of a chapter. Contact the publisher at the address indicated. Except as outlined above, no part of this work may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.
First edition 1998 Library of Congress Cataloging in Publication Data A catalog record from the Library of Congress has been applied for. ISBN: 0-444-50105-3 ® The paper used in this pubUcation meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper). Printed in The Netherlands.
FOREWORD
Natural Product Chemistry continues to grow at an increasing pace and this growth is reflected in the present volume of Studies in Natural Product Chemistry which is the 20^^ of this series. The first 20 volumes were largely devoted to structure and synthesis of various classes of natural products, irrespective of their bioactlvity. Subsequent volumes of this series will however be devoted to the chemistry of bioactive natural products and will therefore represent a departure from the earlier volumes. The present volume contains contributions from a number of eminent scientists and covers Interesting reviews on terpenes, alkaloids and other types of natural products reported from terrestrial and marine sources. It is hoped that this volume will be received with the same enthusiasm and Interest as the previous volumes of this series. Comprehensive Indexes covering all the 20 volumes, have been prepared and they include a Cumulative General Subject Index along with more focused Cumulative Indices on Organic Synthesis, Pharmacological Activity and Biological Source. This comprehensive indexing of the volumes should make the entire series much more valuable and user-friendly. I would like to express my thanks to Dr. Farzana Akhtar, Dr. Farhana Noor-e-AIn, Mr. Zaheer-ul-Haq, and Miss Rehana Shah for their assistance in the preparation of the Index. I am also grateful to Mr. Waseem Ahmad for typing and to Mr. Mahmood Alam for secretarial assistance.
Atta-ur-Rahman
Ph.D. (Cantab), Sc.D. (Cantab)
July 31. 1998
This Page Intentionally Left Blank
PREFACE Volume 20 of this well known series entitled: "Studies in Natural Products Chemistry", continues the high standard of the previous volumes. The 17 Chapters represent a broad spectrum of topics which serve as an excellent overview of the vast array of natural products research continuing on a worldwide basis. The areas covered do not duplicate to any significant extent material covered in previous volumes and indeed present to the interested reader, information which is useful and pertinent to those involved in the highly diverse avenues of natural products. Each of the chapters is well written and brings fonA/ard in review fashion, a particular area of natural products chemistry. The manner of presentation in the majority of chapters allows the linkage of synthetic and structural chemistry with biological applications and relevance. As the area of natural products research continues to expand into these interdisciplinary avenues, the information provided by the authors is particularly useful not only to the specialist but to the scientist wishing to develop a general knowledge of the specific field covered within the Chapter. This Volume, as the previous volumes in this series, is highly recommended as a useful summary of important information which spans the diverse area of biological activity, medicinally Important terpenes, alkaloids, steroidal lactones, carotenoids, natural colourants, peptides and the use of enzymes in the products of chiral synthons.
James P. Kutney
This Page Intentionally Left Blank
CONTENTS Foreword
V
Preface
vii
Contributors
xi
Terpenes and their Biological Relevance G.G. HABERMEHL AND W. FLIEGNER
3
Crinitol, an Acyclic Diterpene Diol from Marine Algae I. KUBO AND L.R. SMITH
25
Stereoselective Synthesis of Methylcyclopentanoid Monoterpenes A. BIANCO
41
Chemical Constituents of Taxus Species V.S. PARMAR AND A. JHA
79
Withanolides, Biologically Active Natural Steroidal Lactones : A Review A.S.R. ANJANEYULU, D. S. RAO, P.W. LEQUESNE
135
Natural Products by Oxidative Phenolic Coupling Phytochemistry, Biosynthesis and Synthesis 263 G.M. KESERU AND M. NOGRADI
Narcissus Alkaloids J. BASTIDA, F. VlLADOMAT AND C. CODINA
323
Total Synthesis of Naphthylisoquinoline Alkaloids M.A. RIZZACASA
407
DNA - Damaging Natural Products with Potential Anticancer Activity A.A. LESILE GUNATILAKA AND DAVID G.I. KINGSTON
457
In Vitro Models of Human Disease States J.M. PEZZUTO, C.K. ANGERHOFER AND H. MEHDI
507
Synthesis of Carotenoids H. PFANDER, M. LANZ AND B. TRABER
561
Structure Elucidation of Phenylpropanoid Wood Extractives S. OZAWA, T. SASAYA AND S. NlSHIBE
613
Chemical and Biological Investigations of Salvia Species Growing in Turkey A. ULUBELEN AND G. TOPCU
659
The Chemistry of Some Natural Colourants J.H.P. TYMAN
719
Bioactive Natural and Synthetic Acronycine Derivatives Modified at the Pyran Ring S. MICHEL AND F. TILLEQUIN
789
Chiral Synthons by Selective Redox Reactions Catalysed by Hitherto Unknown Enzymes Present in Resting Microbial Cells H. SIMON AND H. GUNTHER
817
Microcystins and Nodularins Hepatotoxic Cyclic Peptides of Cyanobacterial Origin L. MORODER AND S. RUDOLPH-BOHNER
887
Subject Index
921
CONTRIBUTORS A.S.R. Angerhofer
Professor of Organic Chemistry, School of Chemistry, Andhra University, Visakhapatnam-530 003, India
Cindy Kay Angerhofer
Program for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy and Department of Surgical Oncology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, U.S.A.
A.S.R. Anjaneyulu
School of Chemistry, Andhra University, Visakhapatnan 530 003, India
Jaume Bastida
Department of Natural Products, Faculty of Pharmacy, University of Barcelona, Avda., Diagonal 643-08028 Barcelona, Catalonia, Spain
Armandodoriano Bianco
Centro di Studio CNR per la Chimica delle Sostanze Organiche, Naturali Dipartimento di Chimica-Universita La Sapienza-Roma, Italy
Carles Codina
Department of Natural Products, Faculty of Pharmacy, University of Barcelona, Avda., Diagonal 643-08028 Barcelona, Catalonia, Spain
W. Fliegner
Chemisches Institut der Tieraztichen, Hochschule Hannover, Lehrgebiet fur Organische Chemie, Bischofsholer Damm 15, HausNr. 123, 30173 Hannover, Germany
Abeysinghe Arachchige Leslie Gunatilaka
Bioresources Research Facility, The University of Arizona, Tucson Arizona, 250 East Valencia Road, Tucson, Arizona 85706, USA
Helmut Giinther
Institut fur Organische Chemie und Biochemie, Universitat Munchen, D-8 5 747 Garching, Germany
G.G. Habermehl
Chemisches Institut der Tieraztichen, Hochschule Hannover, Lehrgebiet fur Organische Chemie, Bischofsholer Damm 15, HausNr. 123, 30173 Hannover, Germany
Amitabh Jha
Department of Chemistry, University of Delhi, Delhi-110 007, India
G.M. Keserti
Research Group for Alkaloid, Chemistry of the Hungarian, Academy of Sciences, P.O. Box 91, H-1521 Budapest, Hungary
Gyorgy Miklos Keserii
Department of Chemical Information Technology, Technical University of Budapest, POB 91, H-1521 Budapest, Hungary
Technische
David George Ian Kingston
Bioresources Research Facility, The University of Arizona, Tucson Arizona, 250 East Valencia Road, Tucson, Arizona 85706, USA
Isao Kubo
Department of Environmental Science, Policy and Management, University of California, 201 Wellman Hall, Berkely California 94720-3112, U.S.A.
Marc Lanz
Department fiir Chemie und Biochemie, University of Berne Freiestr. 3, CH-3012 Berne, Switzerland
P.W. LeQuesne
Department of Chemistry, North Eastern University, Boston, MA 02115, USA
Haider Mehdi
Program for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy and Department of Surgical Oncology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, U.S.A.
Sylvie Michel
Universite Rene Descartes-Paris V, Faculte De Pharmacie, Laboratoire de Pharmacognosie, U.R.A. au C.N.R.S.N. 1310 4, Avenue de I'Observatoire, 75270 Paris Cedex 06, France
Luis Moroder
Max-Plank-Institut far Biochemie, Am Klopferspitz 18a, D-82152, Martinsried, Germany
Sansei Nishibe
Faculty of Pharmaceutical Sciences, Health Sciences, University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-02, Japan
Mihaly Nogradi
Research Group for Alkaloid, Chemistry of the Hungarian, Academy of Sciences, P.O. Box 91, H-1521 Budapest, Hungary
Shuji Ozawa
Department of Forest Science, Faculty of Agriculture, Hokkaido University, Sapporo 060, Japan
Virinder Singh Parmar
Department of Chemistry, University of Delhi, Delhi-110 007, India
John Michael Pezzuto
Program for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy and Department of Surgical Oncology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, U.S.A.
Hanspeter Pfander
Department fiir Chemie und Biochemie, University of Berne Freiestr. 3, CH-3012 Berne, Switzerland
D. Satyanarayana Rao
School of Chemistry, Andhra University, Visakhapatnan 530 003, India
Mark A. Rizzacasa
School of Chemistry, The University of Melbourne, Parkville, Victoria 3052, Australia
Sabine Rudolph-Bohner
Max-Plank-Institut fur Biochemie, Am Klopferspitz 18a, D-82152, Martinsried, Germany
Takashi Sasaya
Department of Forest Science, Faculty of Agriculture, Hokkaido University, Sapporo 060, Japan
Helmut Simon
Institut fur Organische Chemie und Biochemie, Universitat Munchen, D-85747 Garching, Germany
Leverett R. Smith
Department of Environmental Science, Policy and Management, University of California, 201 Wellman Hall, Berkely California 94720-3112, U.S.A.
Francois Tillequin
Universite Rene Descartes-Paris V, Faculte De Pharmacie, Laboratoire de Pharmacognosie, U.R.A. au C.N.R.S.N. 1310 4, Avenue de I'Observatoire, 75270 Paris Cedex 06, France
Giilacti Topcu
Department of Chemistry, Tubitak, Marmara Research Center, P.O. Box 21, 41470, Gebze-Kocaeli, Turkey
Bruno Traber
Department fur Chemie und Biochemie, University of Berne Freiestr. 3, CH-3012 Berne, Sv^itzerland
John Henry Paul Tyman
Department of Chemistry, Brunei University West London, Uxbridge, Middlesex UB8 3PH, U.K.
Ayhan Ulubelen
Department of Chemistry, Faculty of Pharmacy, University of Istanbul, 34452 Istanbul, Turkey
Francese Viladomat
Department of Natural Products, Faculty of Pharmacy, University of Barcelona, Avda., Diagonal 643-08028 Barcelona, Catalonia, Spain
Technische
This Page Intentionally Left Blank
Structure and Chemistry
This Page Intentionally Left Blank
Atta-ur-Rahman (Ed.) Studies in Natural Products Chemistry, Vol. 20 © 1998 Elsevier Science B.V. All rights reserved.
Terpenes and their Biological Relevance G.G. Habermehl and W. Fliegner 1.
INTRODUCTION Terpenes are a large group of natural products, occurring mainly in higher
evolved plants as secondary metabolites. The occurrence in higher evoluted plants only may be understood as a consequence of phylogenesis. Under the pressure of selection from herbivorous animals, the synthesis of substances with repellent properties has been necessary in order to make possible a coexistence of different plant and animal species. The first chemical deterrence mechanisms were of an unspecific kind. The synthesis proceeded via the shikimic acid pathway which was already completely developed in gymnosperms. One example of this is the synthesis of lignin. Lignin is one of the most abundand contents of wood, varying between 18 and 30 %. Although its main property is the formation of the stroma, it possesses some antifungal and insectizide properties. By the shikimic acid pathway phenols and tannins are formed, too, to prevent an attack from microorganisms and animals. During the following evolution this pathway has been left stepwise, until in the angiosperms the acetate-mevalonate pathway dominated. This pathway in angiosperms has opened an immense chemical source to specifically acting poisons and repellents, many of them being terpenes. This invention was followed by intense evolutionary interactions between plants and animals, yielding that high diversity of angiosperms, and at the same time, animal species since about 100 million years ago. About 65 million years ago this development of plants was perfect, and the angiosperms predominant. This evolution of poisonous substances in plants coincides with the extinction of the dinosaurs. If one looks closer to this event, one may observe that there has been no complete extinction; many of the saurians survived in one way or another. For example, our birds come from flying saurians; the close connection between the birds and the reptiles of today can be seen in their closely related physiology, leading to the zoological classification of "Sauropsidae", enclosing both, reptiles and birds. And if you have a look at the saurians of today, nearly all of them are carnivorous. All these facts may lead to the conclusion that the herbivorous saurians only became extinct. This is supported by the fact that the dinosaurs did not disappear within a short period of time, as one should accept if this was due to a cosmic event, or a big vulcanic eruption, but within a million of years or so. All these observations fit together, if one accepts that the complete change in
the plant kingdom, together with the newly developed substances led to the end of the dinosaurs. The new physiology with the new acetate-mevalonate pathway gave the opportunity to the plants to produce a tremendous amount of substances acting as protecting agents. 2.
TERPENES AND THEIR ACTIVITIES 2.1 Terpenes as Repellents In a few cases only, the topical situation (spines, thorns) is of protective
value against herbivores. The most potent and effective chemical repellents against these animals are those producing pain or discomfort because of a bad taste or smell. Typical examples are the irritating diterpene-esters from Euphorbiaceae or from Thymelaeaceae (1), or the toxic bitter principles from the Cucurbitaceae, e.g. the Cucurbitacines (2). There are also numerous terpenes acting as contact allergens with serious skin irritations, like the sesquiterpenelactones from Asteraceae (3). Sometimes substances may be effective even after consumption, provided that the animal can recognize the connection between feed and result. In many cases this is not true and, therefore, not a protection. It is well known that cattle or horses like to eat outside the fence, even if they are on a good meadow, either for curiosity or instinct of play. Good examples are here andromedotoxin from Rhododendron
and Andromeda
species, or the
terpene-alkaloids from Aconitum, belonging to the most potent plant toxins. 2.2 Resistance Formation Microorganisms are able to establish resistances because of their great genetic flexibility, the short generation times, and intraspecific as well as interspecific gen exchange. A generally known example of this capability is the resistance against therapeutically used antibiotics. But insects, too, are able to adapt to chemical repellents, even using such substances for their own defense, as is well known from ants and beetles.In such cases a substance which should protect its producer (allomone) becomes a substance useful for the attacker (kairomone), (4, 9). 2.3 Underground Competition Not only animals but also plants are competing in the struggle for the best conditions of life, and they use chemical defense mechanisms, too. Some plants are able to set free germicides directly from the roots. Another mechanism is to exsude from the surface of the leaves such substances which come into the earth by the rain (5). Typical examples are Salvia
leucophylla
and
Artemisia
californica. These shrubs suppress the growth of any plants within a radius of 1 meter completely, by excretion of 1.8-cineol and campher; these substances
inhibit the growth up to a distance of 9 meters (6). 2.4 Terpenes as Signal Substances Terpenes are also used as signal substances, especially with ants but also with other insects. Farnesol is used as male attractrant (7), Citral, geraniol, nerolic acid, and geranic acid are used to transmit information on feed sources (8). These substances, mostly monoterpenes, and sesquiterpenes are produced by plants and taken up by the insects who store them in special glands from which they are released according to their needs. These mechanisms have been developed in a most sophisticated way by ants, butterflies, and beetles (9). Using mixtures of terpenes in different concentrations, they have established a real "chemical language". 2.5 Activities within the Plants. Some terpenes act as plant hormones, e.g. as growth regulators. Such regulators are the brassinolides, steroids with a seven-membered lacton ring B as well as two vicinal diol functions in ring A, and in the side chain (10). The brassinosteroids show in submicromolar concentrations a complex physiologic activity spectrum, e.g. a raise in resistance against stress factors like heat, cold, drought or phytopathogenic infection. The biochemistry of these effects has been studied in detail (11).
3.
TERPENES AS PLANT POISONS AND REPELLENTS. 3.1 General aspects Among all the activities of terpenes from plants, their toxicity is most
important for several reasons. One aspects is their role in ecology as protection of the plants, the other is the economic aspect and also the health aspect, as terpenes are involved in quite a number of envenomations. Envenomations in humans are not rare; mostly children are involved who eat or suck berries or leaves. However, in an increasing number, also adults are involved. On the "green wave" they collect herbs and roots by themselves, considering them "more healthy" than the commercial ones, but confounding them with dangerous species. In the same way therapeutics from plants are estimated harmless for being "natural remedies", and envenomation occurs, frequently due to an overdose.But in most of the cases animals are involved, not only grazing animals but also small animals at home. In the following section the most important plants with terpenes as toxins will be presented together with their chemistry and the symptoms of poisoning.
3.2 Family: Apicaceae Sium latifoliurriy Water parsnip. The plant is abundand in Central Europe but occurs also in the rest of the continent, and also in parts of Africa. The fruit contains (6-7%) of a mixture of limonen (80 %), perillaaldehyde (6%),oc-, and B-pinene, 6-bisabolon, and c?<.-curcumene. Poisoning has been observed in cattle and in sheep with gastroenteritis which led to sudden death. In humans having eaten roots, vomiting, diarrhea, bradycardia as well as muscle paralysis have been observed (14). 3.3 Family: Aquifoliaceae Ilex aquifolium, Holly. The family includes 440 species distributed all over the world with centres in China (112 species) and Brasil (75 species). Ilex aquifolium
is the most
abundand species in Central Europe where it may be found in forests, but it is also very popular as ornamental plant in houses and gardens. The poisonous parts are the berries, and to a lesser extent also the leaves; they contain ursolic acid, uvaol, o^-amyrin, and a bisnor-monoterpene, Ilex-lactone (12), as well as 27-p-cumaroxy-ursolic acid (13). The South American
Ilex
paraguariensis
contains also coffein and theobromin, and is therefore used as tea. Symptoms of poisoning have been observed in children after consumption of berries, with vomiting, diarrhea and drowsyness. 3.4 Family: Araliaceae Hedera helixy Ivy Ivy is far distributed in Europe, and in South Africa; it has been introduced to North America. Preferred locations are forests with old trees, bushes, and walls. It is a creeping plant which may go up about 30 meters. It must not be confounded with poison ivy ! The poisonous parts are the leaves, and even more the blue-black pea-size berries. The active terpenes are triterpene saponins, about 2 - 6 % of the weight. The main saponins are oc-hederin which on hydrolysis yields hederagenin, arabinose and rhamnose, and 6-hederin yielding oleanolic acid, arabinose and rhamnose on hydrolysis. Furthermore the sesquiterpenes germacren, 6-elemen, and elixen are found (14). The hederins share with other saponins a strong hemolytic activity (15). Typical symptoms after ingestion are irritation of mucous membranes, vomiting, headache, drowsyness, and irregular pulse. Milk fever like disease has been observed in cattle (16), and poisoning of horses is also described (17). Allergic contact dermatidis in humans has been described extensively (18, 19, 20). The hederosaponins possess antibacterial as well as antifungal activities (20).
Perilla aldehyde
Limonen
Ursolic acid, R=COOH -Amyrin, R=CH3
Ilex lactone
;ooH
Hederagenin, R-j = CH2OH R2= Rhamnose-Arabinose
Germacen
B-Elemen
Oleanolic acid, R-| = CH3
Elixen
3.5 Family: Asteraceae The Asteraceae (Compositae) comprise about 15,000 species, and thus belong to the biggest plant families. They include herbs, shrubs, and trees, and they are divided into two subfamilies: The Asteroideae distributed worldwide, and the Cichorioideae, distributed mainly on the Northern Hemisphere, and characterized by containing a milky juice. Lactuca virosa, Prickleylettuce Prickleylettuce is endemic to the Mediterranean area, but, due to its former use as medicinal plant has been distributed over Europe and Western Asia. It is no more used in medicine due to its toxicity which in humans leads to an increase of the respiration connected with sweating and drowsyness, and eventually exhaustion which explains its former use as narcotic, and as antaphrodisiacum. In animals damage of the heart, and hypotension have been described (14). The toxicity of the main components lactucin, and lactucopicrin is relatively low. The main protection of the plants is due to its bitter taste connected with both of these compounds. Xanthium species, Cocklebur The toxic compounds are atractyloside and carboxyatractyloside (21). The aglycones of these glycosides are of the kauran type (22). These compounds had earlier been isolated from Atractylis gummifera, endemic to the Mediterranean Area (23, 24). The action mechanism of the poisoning is a specific inhibition of the ATP-ADP carrier of the inner mitochondria membranes, thus preventing the transport of the nucleotides to the place of cell respiration within the mitochondria. The result is a deficiency of ADP there, and finally stop of the respiration chain. The toxicity of carboxyatractyloside is 10.7mg/kg body weight (mouse, i.p.) (23). Typical symptoms in animals are faintness, ataxia interrupted by agitation, koma, and finally death. The hematologic examination showed an increase in the neutrophil granulocytes, extreme hypoglycaemia, and a significant rise of the liver enzymes (25). Carboxyatractyloside is a substance inhibiting the growth of other plants; it may be compared in its inhibiting activity with abscissic acid. Wedelia species. Wedelia glauca is a shrub causing losses in cattle in Argentina, Brasil, and Uruguay (26). The toxic substance again is atractyloside (27) and related kauran type acids (26). Wedelia asperrima is responsible for considerable losses in grazing animals, especially of sheep in Australia. The toxin responsible is wedeloside (28) with some unusual features in its structure: The occurrence of an amino sugar is rare in plants; the distribution of the hydroxy groups in the kauran system is quite
Lactucin, R=H Lactucopikrin, R =CO-CH2-C6H4-(p-OH)
HOCH
Atractylosid, R = H Carboxyatractylosid, R = C O O H
PhCH2CH2(:o—J
r-^UO
OOC-^ ^COOH
Wedeiosid
OH
10
unusual. The toxicity is 1 mg/kg body weight (mouse). Death occurs within 24 hours after ingestion of the plant. Experiments showed (28) that this compound has a strong antitumor activity. Helenium species Helenium microcephalum, Smallhead sneezeweed. Helenium microcephalum
is a herbal plant distributed in the South of the
USA, and in North Mexico, where it is responsible for poisoning of cattle, sheep and goats. The toxic substance is helenalin (29, 30). 2.5 g of fresh plant material per kg body weight lead to the death of the animals. The symptoms occur early, after one hour already and include salivation, colic, diarrhea, vomiting and progressive faintness, and finally death, usually within 24 hours. Post mortem findings include changes in liver, heart, brain, kidney, and mucosa (31). Helenium amarumy Bitter sneezeweed. This plant is endemic to the South and the East of North America. Poisoning in animals is rare because of its low toxicity, and its extreme bitter taste which prevents animals from eating. Occasional uptake of small amounts of leaves, however, are sufficient to give the milk of those animals a bitter taste. The bitter principles are tenulin and isotenulin (32).. Milk with 1 ppm tenulin is undrinkable. The toxicity of tenulin is far lower that that of helenalin; in experiments sheep tolerated up to 700 mg tenulin/kg body weight without showing signs of poisoning (33). Hymenoxis odorata, Western Bitterweed. Western Bitterweed is distributed in the Southwest of the USA, and is the main reason for big losses in sheep and goats (34, 35). The responsible compound is the sesquiterpen lacton hymenovin. Sheep are extremely sensitive: 150 - 200 mg will cause death within 24 hours. Most poisonings do not occur acute but are chronic, as may be seen from the fact that sheep develop the first symptoms after being one or two weeks on grassland with Western Bitterweed. The symptoms start with loss of appetite, followed by mucous flux from the nose, and progressive faintness. Post mortem findings included edema of the mucous membranes as well as necroses in liver and kidneys; the gall bladder shows petechial bleedings. Geigeria species, Vermeerbos. Geigeria species are responsible for losses of sheep and goats, occasionally also cattle in South Africa. The poisoning
is known under the
name
"Vermeersiekte" (Vomiting disease). Just to give one example: In 1954 about 50.000 sheep died from this poisoning in the area close to Kimberley (36). As the name of this disease explains, the prominent symptom is heavy vomiting; muscle tremor is followed by immobility. The toxins are vermeerin and geigerin,
11
Isotenulin
Tenulin
xp:^ Helenalin
Vermeerin
Hymenovin
Gejgerin
12 the first one showing again the exocyclic methylene lacton group, and the second the unsaturated five membered ring keton. Structure-activity relationship. The cytotoxicity of these compounds is due to a very reactive centre in the molecule, the exocyclic oC-methylene-/^lacton group which may easily add to sulfhydryl groups of enzymes or other proteins (32, 34, 35). Therefore, cystein applied immediately has been shown to be a useful antidot in hamsters (34). Tenulin, which is less toxic than the other compounds lacks this methyl en el acton group; it possesses an <>c,6-unsaturated keto group in the cyclopentane ring, as is found in many toxins and carcinogens. Allergic Reactions. Sesquiterpene lactones are a special characteristic of the Asteraceae. In a test of more than 80 of such compounds it has been found that the exocyclic methylene lacton system mentioned above is also responsible for sesitization (37, 38, 39), and allergic reactions. Many Asteraceae have been used as teas or tinctures in traditional medicine. The abundant content of poisonous compounds or allergenes has led to less and less application. 3.6 Family: Brasicaceae Iberis amara, Wild Candytuft, Bitter Candytuft This plant, growing up to 40 cm, is endemic to the Mediterranean Area but may also be found cultivated in gardens. The whole plant is toxic especially the seeds. Poisoning by Candytuft is a synergistic effect from many compounds. As in most other Brassicaceae it contains glucosinolates, but also the cucurbitacines E, I, J, and K (40). The symptoms, therefore, depend on the dominating substances. Glucosinolates possess bacteriostatic properties, the cucurbitacines are cytotoxic. The gastrointestinal form of poisoning is connected with loss of appetite, loss of rumination, thirst, salivation, decrease of milk production, colic, and diarrhea or also constipation. The respiratory form is characterized by edema
and
emphysema of the lungs resulting in difficulties in breathing. The nervous form of the poisoning shows loss of orientation, and sometimes loss of vision. Hemoglobinuria is frequent (41). 3.7 Family: Chenopodiaceae Chenopodium ambrosioides, Wormseed, Jerusalem oak, Stinking weed. Chenopodium introduced
to
Chenopodium
abrosioides
Central
is endemic to South America, but it has been
and North
anthelminticum
further varieties, differing
America, to
Europe
and
to
Africa.
is a variety thereof, and there are a number of in their contents of terpenes. The
botanical
classification has still to be revised. Toxic parts include the fresh blooming
13
leaves, the seeds, and especially the seed oil. "Oleum chenopodii" contains about 70 % Ascaridol, and about 22% of Cymol, limonen, isolimonen, and ^-terpinen. Ascaridol is a monoterpene with a peroxy group, which is very rare in natural products (7). From a Japanese variety, compounds like pinocarvon and aritason have been isolated (7, 42). In Argentinian plants up to 40% p-Cymol have been found. Envenomations are described in chicken uptaking the seeds. Symptoms were vomiting, gastritis, and faintness (17). Poisoning in humans has not been observed by the
plant itself
but from
improper
application of
Oleum
Chenopodii in pharmacy. Due to its content of ascaridol it is used against intestinal parasites.Even with proper treatment side effects like nausea, vomiting, trembling of hands and feet, as well as deafness (paralysis of the nervus cochlearis) are not rare. After longer application liver, spleen and kidneys are also affected. 3.8 Family: Cucurbitaceae. Bryonia alba, White bryony Bryonia dioica. Red bryony Ecballium elaterium. Squirting cucumber Citrullus colocynthiSy Bitter apple These four plants are endemic to the Mediterranean Area but have been introduced to other parts of Europe; the bitter apple is also found in the savannahs of Africa. All parts of the plants are poisonous, especially roots and fruits. The compounds responsible are the cucurbitacines, a rather big family of tetracyclic triterpenes, occurring either in free form or as glycosides. They have been studied intensively (2, 43, 44, 45, 46). Envenomations in humans occur either by improper use of preparations in traditional medicine; there is a broad spectrum of indications described, so that one can hardly believe the real effectivity. Children are endangered because of the fruits. 15 berries of bryony are considered to be fatal. A general feature of the cucurbitacines is their cytotoxicity, causing irritations of the skin leading to necroses and ulcera. Most of the internal symptoms follow the same way: Diarrhea, vomiting, headache, and in severe cases convulsions and death. There is no difference of symptoms between animals and humans. Most animals would avoid the plants because of their bitter taste. But in cattle it has been observed that they eat again, after having recovered from the first poisoning. Due to the cytotoxicity of the cucurbitacines they have been investigated as potential antitumor agents. In cell cultures they decreased the protein biosynthesis remarkably, but in vivo the side effects are too severe as that there was any practical use.
14
Ascaridol
Pjnocarvon
Acetylandromedol (Andromedotoxin)
Cucurbitacin I: R=OH Cucurbitacin E: R=OAc
15
Cucurbitacin D (Elatericin A), R = =H Cucurbitacin B, R=OAc
^"3 Cucurbitacin K: RrCH(OH)-(j-OH CH3
Cucurbitacin L
^"3 Cucurbitacin J: R=lj-OH CH,
16
3.9 Family: Cupressaceae, Thuja occidentalis American arbor vitae Thuja orientaliSy Oriental arbor vitae Thuja occidentalis is, as its common name says, endemic to North America Thuja orientalis to China. Both plants, however, are widely spread now worldwide as ornamental plants. There is no difference in the composition of their terpenes. The main component, also responsible for the toxicity is thujon with more than 50 per cent of the essential oil from Thuja. Furthermore fenchone, campher, sabinene, and terpineol-4, tannins and bitter principles are found, too. Envenomation in humans was formely due to its use as abortivum. Thujon is a local irritant. Ingestion causes bleedings of the mucous membranes in the gastrointestinal system resulting in diarrhea and vomitus. In more severe cases the temperature is elevated, liver (atrophy), heart (bleeding into the muscle) and kidney (degeneration) are damaged. Tonic-clonic convulsions and finally paralysis of the Central Nervous System preceed death (47). Today Thuja oil is still used in the so-called "natural medicine" as done by non-medical practitioners. Unfortunately people have the idea that "natural medicine" is especially healthy. Poisoning in animals is rather rare as the taste of the tips of the branches is bitter and burning. Juniperus sabina. Savin Juniperns virginiana, Virgin Cedar Juniperus communis, Common Juniper Juniperus spp. are distributed worldwide. The poisonous compounds in the essential oil are sabinen, sabinol, sabinyl acetate as the main substances, and pinen, myrcen, limonen, Cymol and Thujon as byproducts. Envenomation in humans is by improper use of the essential oil in "natural medicine". Besides acute gastroenteritis, central nervous symptoms may be observed as nausea and vomiting, convulsions and respiratory arrest. Other syptoms are arrhythmia of the heart, damage of kidneys and liver, uterine cramps. Juniperus communis is much less toxic and is used as diureticum, diaphoreticum, nervicum, and emenagogum. It is also used against ectoparasites. The fruits are used as aromatics and for the preparation of liquors. Poisoning of animals has not been observed, because of the bad taste of the plant (48).
17
3.10 Family: Ericaceae Rhododendron
species
Rhododendron
ponticum. Common Rhododendron
Rhododendron
chrysanthum. Yellow Alpine Rose
Rhododendron
luteum
Rhododendron
Alpine Rose
ferrugineum,
Rhododendron
hirsutum, Alpine Rose
Rhododendron
simsii, Azalea
Rhododendron
species are far distributed on the Northern hemisphere and in
Australia. Poisoning has been observed in humans and in animals, the most important substance responsible being andromedotoxin (=Acetylandromedol) (48, 49). Usually the whole plant is toxic, including pollen and nectar which is important as honey may be poisonous from andromedotoxin. Andromedotoxin is synonymous with acetylandromedol, asebotoxin, rhodotoxin, and graynatoxin (50); its LD50 is 0.3 mg/kg body weight (dog, orally), and 2-5 mg/kg in rats (orally) (14). Rhododendron ursolic
acid,
Rhododendron
uvaol,
and
hirsutum,
simiarenol.
endemic
to
ponticum also contains the triterpenes Rhododendron Central
Europe
and
ferrugineum, does
not
possess
andromedotoxin; its toxicity is due to ursolic acid which shows the same symptoms but is much less toxic. Andromedotoxin poisoning leads to a gastroenteritis, connected with burning sensation in the mouth, nausea, vomiting, bradycardia
and
respiratory
distress.
Its
hypotensive
activity
in
low
concentrations is used therapeutically The pharmacology has been studied in detail (51). Poisoning occurs in humans and in animals. The oldest case report in the history of toxicology stems from the Greek author Xenophon: His soldiers during a campaign against Persia had eaten honey and suffered from vomitus and diarrhea; they behaved like drunk, a few of them died. Today we know that this was honey from Rhododendron
ponticum (52, 53). Occasionally, one can
read in newspapers that such poisonings with honey are still occurring in Turkey. Among animals, mainly sheep are affected; goats and cattle use to vomit immediately, and so get rid of the toxic compounds. This mechanism is also a learning effect. Horses are unable to vomit, and therefore are especially endangered; detailed reports on sheep poisoning have been published (54,55). Ledum palustre, Dutch myrte. Ledum palustre contains two not really toxic but pharmacologically active compounds, ledol, and palustrol, responsible for poisoning (56). They cause local
18
Ledol
Palustrol
P h o r b o l : R-, = R 2 = H TPA, ( 1 2 - 0 - T e t r a d e c a n o y l - p h o r b o l - 1 3 - a c e t a t e ) : R-j = C O - ( C H 2 ) i 2 - C ^ H 3 R2 = C O - C H 3
CH2OH Huratoxin: R = CH=CH-CH=CH-(CH2)6-CH3
19 ecstasy, which has been used to prepare "Porstbeer", beer with addition of a small amount of ledol, producing a "good" intoxication. The use of such herbs in brewing beer, therefore has been forbidden in Germany since 1415, by the so-called "Purity Law for Beer". 3.11 Family: Euphorbiaceae Euphorbia species, Spurge. Euphorbia spp. are distributed worldwide with about 680 species. Their outer appearance may vary considerably, from herbs and shrubs in temperate zones to cactus-like, succulent stems with or without leaves in subtropical or tropical areas. All of them have in common that they contain abundandly milky juice, containing the active compounds. Up to now about 80 species have been investigated for such compounds, and practically all of them contain substances with skin irritating activity followed by formation of blisters and necrosis, the mucosa being damaged severely; in eyes they cause conjunctivitis, sometimes followed by blindness. Taken up orally, they cause vomiting, severe diarrhea, and in rare cases mydriasis, delirium and respiratory distress. Chemically, they are diterpene esters of the tigliane, daphnane, and ingenane type. Many of them possess also cytotoxic or co-carcinogenic activity. Envenomations in humans are limited to improper application in traditional medicine. Poisoning of animals occurs accidentally only, because of the burning taste. Animals usually avoid these plants, but grazing animals sometimes cannot avoid the uptake of such plants. In sheep, cattle and horses poisonings have been described with the signs of hemorrhagic gastroenteritis, liver damage, and central nervous disturbances. The most potent substance is TRA, a diester of phorbol. Croton tigliurriy Croton. Croton is endemic to the tropical parts of Asia; it has been imported to Mauritius and to East Africa. Croton oil was a well-known purgative in human as well as in veterinary medicine (57, 58). The active compounds are esters of phorbol, a tetracyclic, tiglian-type diterpen. Croton oil possesses a burning taste and causes vomiting and diarrhea; applied locally it produces skin irritation followed by formation of blisters and edema. Closely related to phorbol is huratoxin (daphnan-type frame) from Hura crepitans^ a tree endemic to the tropical part of America (59). 3.12 Family: Ranunculaceae. Aconitum napelluSy Monkshood, Wolfsbane. Delphinium species, Larkspur. Both plants are toxic. Poisoning in humans has been reported from the roots as well as from the pollen (honey) (60, 61). Among animals, horses are especially sensitive (51), but due to the bad taste the plant usually is avoided.
20 /0CH3
H3CO
^CH3
Aconitin
Ri = C O - C Q H S ; R2 = CO-CH3 ; R3 = C2H5
Aconin
R-| = R2 = H
;
R3 = C2H5
J)CH3
Cf^CH2-f-|
Lycoctonin
Taxicin I
21
\^
H 11
P
QH
OHO 1
li
R-C-NH-ChKH^O-C
Taxol A: R = CgHs Taxol B: R = CH2CH=CHCH3
Daphnetoxin: R-j = CgHs ; R2 = H Mezerein: R-j = CgHs ; R2 = OCO-(CH=CH)2-C6H5 Simplexin: R-j = C9H-19 ; R2 = H
22
The symptoms are more or less identical with those already reported, namely salivation, vomiting, diarrhea, and in severe cases death due to respiratory paralysis. The compounds responsible are aconitin, aconin, lycoctonin and related compounds. 3.13 Family: Taxaceac Taxus species. Common yew, English yew. Taxus species are far distributed in Europe, North Africa, West Asia, and North America (Ground Hemlock). More than 30 compounds have been isolated and investigated chemically, and pharmacologically (62). Poisoning in humans is rare (63, 64) but some fatalities have been reported. Taxus branches, however, are dangerous in animals, especially in horses and pigs. Envenomations in wild living animals are rare. Death occurs very fast from respiratory paralysis (51, 65). Typical compounds are taxicin and the taxols which have been falsely attributed as alkaloids. The taxols have gained interest because of their potential antitumor activity. 3.14 Family: Thymelaceae. Daphne mezereum, Mezereon. Mezereon is endemic to Europe, West Asia, and Canada. Poisoning is due to Daphnetoxin, Mezerein, and Simplexin (66); their toxicity has been determined (51). The structures of the compounds are closely related to huratoxin. The symptoms are identical, but more severe; the kidneys are concerned especially with nephritis, albuminuria, hematuria, and stranguria. Envenomations are observed mainly with children, eating the red berries. In animals poisoning has been reported, but is a rare event because of the burning taste of the plant. This is probably also the reason why poisoning in wild animals is unknown so far. 4.
CONCLUSION. This review does not cover all terpenes isolated from plants nor all plants with terpenes as secondary metabolites. This is , however,a selection in respect to their activities. As may be seen, the toxicity is varying,, but what is common in all, is a bad taste, bitter, burning, and causing irritation of mouth lips and tongue. This clearly shows that these compounds have been developed during the evolution as protection, thus establishing an equilibrium between herbivors and plants. Such protection has been especially important in the "early" times of the angiosperms. So it is worth looking for their biological relevance, and it is also interesting that wild animals obviously have learned to deal with the dangers of their feed. And this may explain, too, why many herbivors became extinct some 60 million years ago, while carnivors did not show this break in evolution.
23
REFERENCES 1 2 3 4 5 6 7 8 9 10 11
12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
F.J. Evans and R.J. Schmidt, Planta med., 38 (1980) 289-316. D. Lavie and E. Glotter,Fortschr. Chem. Org. Naturst., 29 (1971) 307-362. H. Schildknecht, Angew. Chem., 93 (1981) 164-183. R.L. Metcalf, R.A. Metcalf and A.M. Rhodes, Proc. Nat. Acad. Sci. USA, 77 (1980) 3767-3772. J. Bonner, Bot. Rev., 16 (1950) 51-65. C.H. Muller, W.H. Muller and B.L. Haines, Science, 143 (1964) 471-473. H. Metzner, Biochemie der Pflanzen, Enke, Stuttgart, 1973. J.G. MacConnell and R.M. Silverstein, Angew. Chem., 85 (1973) 647-657. G. Habermehl, Gifttiere und ihre Waff en. Springer, Berlin, 1994. M.D. Grove, G.F. Spencer, W.K. Rohwedder, N. Mandava, J.F. Worley, J.D. Warthen, G.L. Steffens, J.L. Flippen-Anderson and J.C. Cook, Nature 281 (1979)216. G. Adam and U. Petzold, Naturwissenschaften 81 (1994) 210 ; G. Adam, A. Porzel, J. Schmidt, B. Schneider and B. Voigt in: Atta-ur-Rahman, S.T. (ed) Studies in Natural Products Chemistry: New developments in brassinosteroid research. Elsevier, Amsterdam, 1995. H. Thomas and H. Budzikiewicz, PfanzenphysioL, 99 (1980) 271-276. H. Budzikiewicz and H. Thomas, Z. Naturforsch., 35b (1980) 230-231. H. Liebenow and K. Liebenow, Giftpflanzen, Enke, Stuttgart, 1981. H. Wagner and H. Reger, Dtsch. Apoth. Ztg., 126 (1986) 2613-2617. E. Wiesner, Ernahrungsschaden d. Idw. Nutztiere, Fischer, Jena, 1970. J.W. Hardin and J.M. Area, Human poisoning from native and cultivated plants, Duke University Press, Durham, NC, 1974. L. Goldmann, R.H. Preston and H.R. Muegel, Arch. Derm., 74 (1956) 311-312. J.C. Mitchell, Contact Dermatitis, 7 (1981) 158-159. R. Jaspersen-Schib, Schweiz. Apoth. Ztg., 114 (1976) 265-267; Dtsch. Apoth. Ztg., 124 (1984) 2326. R.J. Cole, B.P. Stuart, J.A. Lansden and R.H. Cox, J. Agr. Food Chem.,28 (1980) 1330. J.A.S. Lewis, J.K. MacLeod and P.B. Oelrichs, Tetrahedron, 37 (1981) 4305-4311. S. Luciani, N. Martini and R. Santi, Life Sci., 10 (1971) 961-968. B. Danieli, E. Bombardelli, A. Bonati and B. Gabetta, Phytochemistry, 11 (1972) 3501-3504. B.P. Stuart, R.J. Cole and H.S. Grosser, Vet. Pathol.,18 (1981) 368-383. J.C. Oberti, A.B. Pomilio and E.G. Gros, Phytochemistry, 19 (1980) 2051. C D . Schteingart and A.B. Pomilio, J. Nat. Prod., 47 (1984) 1046-1047. P.B. Oelrichs, P.J. Vallely, J.K. MacLeod and LA.S. Lewis, J. Nat. Prod., 43 (1980) 414-416. D.A. Witzel, G.W. Ivie and J.W. Dollahite, Am. J. Vet. Res.,37 (1976) 859-861. W. Herz in: R.F. Keeler, K.R. van Kampen and L.F. James (Eds), Effects of Poisonous Plants on Livestock: Sesquiterpene lactones from livestock poisons. Academic Press, New York, San Francisco, London, 1978. J.W. Dollahite, W.T. Hardy and J.B. Henson, J. Am. Med. Vet. Assoc. 145 (1964) 694. G.W. Ivie, D.A. Witzel and D.D. Rushing, J. Agr. Food Chem. 23 (1975) 845-849. J.W. Dollahite, L.D. Rowe, H.L. Kim and B.J. Camp, Southwest. Vet. 26 (1972) 135. G.W. Ivie, D.A. Witzel, W. Herz, R. Kanan, J.O. Norman, D.D. Rushing, J. H. Johnson, L.D. Rowe and J.A. Veech, J. Agr. Food Chem., 23 (1975) 841-845. J.T. MacGregor, Fd. Cosmet. Toxicol., 15 (1977) 225-227.
24
36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
J.PJ. Joubert, J. S.Afr. Vet. Assoc. 54 (1983) 255-258. F. Bohlmann, Naturwissenschaften 67 (1980) 588-594. J.C. Mitchell and G. Dupuis, Brit. J. Derm., 84 (1971) 139-150. B.M. Hausen, Planta med., 50 (1984) 229-234. R. Gmelin, Arzneimittelforschung 13 (1963) 771. G. Rosenberger, Krankheiten des Rindes, Parey, Berlin, Hamburg, 1978. T. Takemoto and N. Nakajima, J. Pharm. Soc. Japan 77 (1957) 1157. P.R. Enslin, F.J. Joubert and S. Rehm, J. Sci. Food Agr., 7 (1956) 646. D. Lavie, D. Willner and Z. Merenlender, Phytochemistry, 3 (1964) 51. M.R. Cooper and A.W. Johnson: Poisonous plants in Britain and their effects on animals and men: Ministry of Agriculture Fisheries and Food, London, 1984. A.A. Forsyth: British Poisonous Plants: Ministry of Agriculture Fisheries and Food. Bulletin 161, pp.73-74, London, 1979. Hagers Handbuch d. pharm. Praxis (P.H. List and L. Horhammer, Eds), Springer, Berlin, Heidelberg, New York, 1980. K. Hiller and G. Bickerich: Giftpflanzen, Enke, Stuttgart, 1988. F. Zymalowski, P. Pachaly and S. Auf dem Keller, Planta med., 17 (1969) 8-13. H. Schindler, Planta med., 10 (1962) 232-237. H.J. Hapke: Toxikologie fiir Veterinarmediziner, Enke, Stuttgart, 1988. E.G.C. Clarke, D.J. Humphreys and T. King: Nachweis von Andromedotoxin, in E.Kaiser (Ed): Tier- und Pflanzengifte, Goldmann, Miinchen, 1973. A.M. Chambers, Scott. Med. J. 29 (1984) 107-108. R.J. Higgins, D.A.R. Hannam, D.J. Humphreys and J.B.J. Stodulsky, Vet. Rec. 116(1985)294-295. L.A.M.G. van Leengoeld and J.J. van Amerongen, Tijdschr. Diergeneesk., 108 (1983) 41-42. D.H.E. Tattje and R. Bos, Planta med., 41 (1981) 303-307. E. Hecker and R. Schmidt: Phorbolesters, the irritants and cocarcinogenes of Croton tiglium L. in: Fortschr. Chem. Org. Naturst. 31 (1974) 377-467. E. Hecker, Dtsch. Apoth. Ztg. 126 (1986) 2599. G. Fiirstenberg and E. Hecker, Planta med., 22 (1972) 241-266. H.H. Kalbfleisch, Arch. Toxicol.,13 (1943/44) 17-20. Y. Saito, A. Midura, K. Sasaki, M. Satake and M. Uchiyama, Bull. Natl. Inst. Hyg. Sci., 9 (1980) 32-35. R.W. Miller, J. Nat. Prod. 43 (1980) 425-437. S. Ritter, Dtsch. Apoth. Ztg. 125 (1985) 1834-1836. S. Ritter and E.G. Krienke: Vergiftungen im Kindesalter. Enke, Stuttgart, 1986. B. von Dach and R. A. Streuli, Schweiz. med. Wschr. 118 (1988) 1113-1116. H. Schildknecht and R. Maurer, Chemiker Ztg. 94 (1970) 849. H. Schildknecht, Angew. Chem. 93 (1981) 164-183.
Atta-ur-Rahman (Ed.) Studies in Natural Products Chemistry, Vol. 20 © 1998 Elsevier Science B.V. All rights reserved.
25
Crinitol, an Acyclic Diterpene Diol from Marine Algae I. Kubo and L.R. Smith Crinitol, (1), is a diterpene diol whose properties can in some ways be taken as representative of the current challenges in studying and finding uses for secondary plant metabolites. It is readily availability from a natural source and has a relatively uncomplicated structure; despite this, its function in the plant is not fully clarified. As will be discussed below, crinitol shows a modest level of antimicrobial and other biological activity. We can already control many troublesome microorganisms that contaminate food and cosmetics with natural products, including plant secondary metabolites, that are currently available. Nevertheless, discovery H. OH I
I
I
I ^^Q..M
x'^V^'^v--^^^ 9R and 9S Crinitol (1 and 2) of new effective antimicrobial agents continues to be important since microorganisms have developed resistance to many commonly used antimicrobial agents. There is no doubt that plants are still a good source for new antimicrobial agents. However, a typical difficulty with antimicrobial phytochemicals is that they are not usually potent enough to be considered for practical applications. Hence, studies to enhance the total biological activity are needed. In order to proceed with this, understanding the effects on microbial systems on a molecular basis is essential. The moderate activity of crinitol (1) isolated from several marine brown algae is an example of this level of potency, and its chemistry and bioactivity can be taken as a case study of the sort of questions that can arise in current studies of natural products. ISOLATION AND BIOGENESIS Crinitol (1) was first isolated from one of the most studied marine brown algae, Cystoseira crinita Bory (Cystoseiraceae), and its structure was established as 3,7,11,15tetramethylhexadeca-2,6,10,14-tetraene-l,9-diol (1); it was later found in the closely related species Cystoseira baleahca (2). The absolute configuration at C-9 was not determined in the Cystoseira-dQTivQd samples, but was determined as R in crinitol isolated from another brown
26 alga, Sargassum tortile C. Agaedh (Sargassaceae) (3). The Sargassutn identification had been pursued on the basis of assays of insect growth inhibition against the pink bollworm, Pectinophora gossypiella, by an artificial diet feeding assay (4). The larger biosynthetic context of crinitol has been extensively studied in brown algal species, which have yielded a wide variety of related diterpenes (5,6). It has been suggested that in the uncommon cases where plants accumulate geranylgeraniol (3) metabolically, oxidation products of geranylgeraniol "are possibly nothing more than the expression of its catabolism" (6). Such catabolic oxidation products reported have included a number of diols isomeric with crinitol, including 12-(5)-hydroxygeranylgeraniol (12-(5)-3,7,11,15-tetramethylhexadeca-2,6,10,14tetraene-l,12-diol) (4) (7,8); 13-(S)-hydroxygeranylgeraniol (eleganediol, or 13-(5)-3,7,ll,15tetramethylhexadeca-2,6,10,14-tetraene-l,13-diol) (5) (8-12); and bifurcanol (3,7,11,15tetramethylhexadeca-2,6,10,13-tetraene-1,15-diol) (6) (8). In view of the suggested
OH HO H
12-(S)-Hydroxygeranylgeraniol (4)
Geranylgeraniol (3)
OH
Eleganediol (5)
Bifurcanol (6)
^^
16-Hydroxygeranylgeraniol (7)
origin, it perhaps ought to be expected that similar compounds would be present in other plant sources, not just in algae; 16-hydroxygeranylgeraniol (7) has been reported to occur in a Japanese fungus, Boletinus cavipes (13). ABSOLUTE CONFIGURATION AND CONFORMATIONAL CONSIDERATIONS At the time that crinitol was isolated from 5. tortile (3), the absolute configuration at C-9 was not known. To define the absolute configuration of the stereocenter, the circular exciton chirality method (3,14) was applied. Four derivatives (8-11) were made and their CD
27
Ax'0::>^C-^^
xiv'v.^'^^^
(8)
(9) Br
(10)
(11)
spectra were recorded. Among them, only 10 and 11, whose C-9 hydroxy! group was pbromobenzoylated, showed the predicted benzoate Cotton effects. The absolute value (Ae) of both of these benzoate Cotton effects were almost identical; 10, -5.3 (247 nm) and 11 -5.4 (244 nm). These data clearly indicate that the C-1 benzoate chromophore does not interact with the C-9 benzoate chromophore, unlike dibenzoates of cyclic compounds (15). The observed negative Cotton effect is due to only to the interaction between the benzoate ^La transition and the double bond TT-T* transition. If all possible rotomers were equally present the sum of the Cotton effect should cancel. However, it has been shown for a large number of secondary allylic benzoates the rotomer having the carbinyl hydrogen and double bond eclipsed is favored. The presence of a large /yjc of 9.0 Hz between the olefinic and C-9 carbinyl protons in 10 and 11 is consistent with such a preferred conformer, as the size of the coupling is dependent on the dihedral angle. Thus, the absolute configuration of crinitol was determined to be 9R This was the first actual application of the allylic benzoate method (14) to a natural acyclic allylic alcohol. The configurational assignment did not quite end with this first determination, however. In the course of preparing a sample of the "unnatural" 9S crinitol isomer (2) by racemization, derivatization and recycle HPLC (discussed below), crinitol isolated from S. tortile was later found to contain a small amount (13%) of the 95 isomer (16). Mosher's NMR method (16-18) verified the original assignment of configuration for the dominant natural enantiomer. Given the significant presence of both enantiomers in S. tortile, one might conclude that the biosynthesis of crinitol is not highly stereospecific, and crinitol's optical purity will probably vary from source to source.
Before leaving the topic of absolute
configuration determination, we should mention a third method applicable to this type of compound, that of Horeau (19), which was used to determine the configuration of eleganediol (12). Horeau's method is based on the differential reactivity of racemic 2-phenylbutyric anhydride with chiral alcohols.
28 Given the size and flexibility of the crinitol molecule, statements about preferred conformations must be regarded as tentative. However, a clue may lie in an interesting concentration effect, found in the 300 MHz ^H NMR spectrum of natural 9R crinitol (15) as shown in Figure 1. The C-9 hydroxy results in a clearly separated C-9 proton (H9) at 6 4.4, whose coupling provide clues to conformational preferences near the center of the molecule. In particular, the observed splitting goes from a quartet (7=7.4 Hz) at ca. 15% in CHCI3, to a triplet (7=8.4 Hz) in ca. 1% solution. Coupling to the C-10 olefinic proton (HJQ, a doublet at 6 5.15) remains almost constant, but a clear differentiation appears in coupling to the diastereotopic methylene protons on C-8. A predominantly anti H9/H10 orientation throughout would be consistent with recent studies reported by Gung et al. (20). The spectra seem to indicate that there is no particular C-8/C-9 conformational preference at high concentration. On dilution, however, the different couplings that emerge would be more consistent with a predominantly extended C-8/C-9 conformation in which H9 is anti to the pro-5 proton (Hg^) on C-8, and therefore gauche to the pro-i? proton (Hg;^; H85 and Hg;^ appear as a partially visible multiplet around 6 3.2. A "hairpin" conformation around C-8/C-9 might also rationalize the observed couplings, but would appear sterically unreasonable and at variance with reported studies on similar analogs (20). Other concentration-related differences appear, for example in the C-1 methylene proton pattern at ca. 6 4.1, but interpretation is not so straightforward. Crinitol may exert its bioactivity by interaction with membranes, and the C-9 proton could perhaps provide an NMR "probe" of the environment in which the center of the crinitol molecule finds itself in such interactions; one might speculate similarly about the related diols 4-7. ANTIBACTERIAL AND OTHER BIOLOGICAL ACTIVITY Crinitol was isolated from 5. tortile by following a bioassay for growth inhibition of P. gossypiella{3). The only active principle isolated in the methanol extract, a viscous colorless liquid, ([«]£) -5°, cO.43, CH3OH) was identified as crinitol (1, [a]D -3°), previously isolated from C crinita, by comparison of spectral data (1). The effective dose (ED50) for 50% growth inhibition of P. gossypiella was 500 ppm. In our continuing search for new antimicrobial agents from botanical sources, crinitol was later found to exhibit moderate antibacterial activity against several Gram-positive bacteria (21-23) as shown in Table 1. For comparison. Table 1 also includes results from assays of geranylgeraniol (3), famesol (12) and geraniol (13). Crinitol exhibited weak to moderate activity against all the Gram-positive bacteria tested but not the Gram-negative bacteria up to 800 /xg/ml. It did not show any activity against fungi, except T. mentagrophytes. This dermatologically pathogenic fungus was
29
Figure 1. Downfield Portion of the 300 MHz Proton NMR Spectrum of Crinitol, in Chloroform-d.
30
susceptible to crinitol with the minimum inhibitory concentration (MIC) of 25 figlml (23). Interestingly, T. mentagrophytes was relatively susceptible to many long-chain alcohols (23). Among the Gram-positive bacteria tested, P. acnes was the most sensitive bacterium, with an MIC of 25 jwg/ml. By contrast, S. aureus was the least sensitive, with an MIC of 400 jitg/ml. In addition, crinitol was found to be bactericidal against P. acnes. This was determined as follows: 30 III taken from the medium that was incubated for 2 days with the MIC of crinitol was added into 3 ml of the crinitol-free fresh medium and incubated for 2 days. No recovery of this follicular bacterium was observed.
MIC (fig/ml) 1
3
12
13
Bacillus subtilis Brevibacterium ananoniagenes
50 100
>800
12.5 12.5
400 400
Streptococcus mutans
50
>800
12.5
400
Staphylococcus aureus
400
>800
25
800
Propionibacterium acnes
25
>800
>800
>800
6.25 >800
400
Escherichia coli
>800
800
Pseudomonus aeruginosa
>800
>800
>800
>800
Enterobacter aerogenes
>800
>800
>800
Saccharomyces cerevisiae Candida utilis Pityrosporum ovale Penicillium crustsum
>800 >800 >800
>800 >800 >800
>800 >800 >800 >800
400 400 200
>800
—
Trichophyton mentagrophytes
25
—
>800 12.5
200 200
, The rate of activity varied slightly with the seed culture mediaL, the physiological age of the culture, and the type of culture medium. — , Not tested. In addition to crinitol, two structurally related minor acyclic diterpene alcohols, geranylgeraniol (3) and phytol, were also isolated from the active fraction in S. tortile, although neither of them exhibited any activity up to 800 fig/ml as listed in Table 1. In addition, several derivatives of crinitol as well as its two common natural congeners, famesol
31
(12) and geraniol (13) were also assayed. The hydroxy group at C-9 in crinitol seemed to be essential for the antibacterial activity. In fact, the oxidized compound, 9-oxocrinitol, and mono- and diacetyl derivatives, did not exhibit any activity up to 8(X) /ig/ml. Among the three naturally occurring alcohols tested (3,12,13), a sesquiterpene alcohol, famesol (12), exhibited the most potent activity against several Gram-positive bacteria and T. mentagrophytes. In contrast, a diterpene alcohol, geranylgeraniol (3), did not show any activity up to 800 ixglml. Alcohols are among the most versatile of all natural products. Free and esterified alcohols occur widely in nature, e.g. in fruit. The antimicrobial effects of alcohols have been reported. However, studies have been limited to short-chain ( < Cg) alcohols, almost exclusively ethanol. Antimicrobial activity of long-chain ( > C^) alcohols, on the other hand, has been demonstrated only with restricted microorganisms because of their limited solubility in water. To place our results with crinitol in the more general context of antimicrobial activities of alcohols, we investigated a series of simple aliphatic alcohols as a model (23,24). The study was focused towards understanding the role of the hydrophobic portion since all the molecules studied possess the same hydrophilic hydroxyl group. The mechanisms of antibacterial activity of long-chain alcohols are due to a balance between the polar hydrophilic (head) and nonpolar hydrophobic (tail) portions of the molecule. The fluidity of a cell membrane can be disturbed maximally by particular hydrophobic moieties attached to hydroxyl groups. They could enter the molecular structure of the membrane with the polar hydroxyl group oriented into the aqueous phase by hydrogen bonding and nonpolar carbon chain aligned into the lipid phase by dispersion forces. It may not be illogical to suppose that a hydrophobic chain length greater than that for the maximum activity disperses into the lipid layer, resulting in the breaking of the hydrogen bond. Thus, when the balance between hydrophilic and hydrophobic portions of the alcohol was destroyed by the dispersion forces, on the other words when the hydrophobic character, log P, exceeded the maximum value, log PQ, the activity disappeared. The maximum activity depends on the hydrophobic chain length from the hydrophilic hydroxyl group, and also the microorganisms being tested (23,24). This general rule may apply to many other membrane-active antimicrobial agents analogous to crinitol. C-9 CONFIGURATION AND BIOACTIVITY: RACEMIZATION AND RESOLUTION VIA MTPA ESTERS As part of our studies of the antimicrobial activity of crinitol and related compounds (23), it was of interest to test whether the two enantiomers of crinitol exhibit the same or different activities, as a clue to whether the antimicrobial action might be due to some specific interaction beyond the above hypothesized general lipophilic action on cell membranes.
32
However, a source of the non-natural 9S isomer (2) was first required. The ready availability of natural crinitol made a racemization/resolution route, as illustrated in Scheme 1, attractive. Racemization was accomplished by Collins oxidation (16,25) to the dicarbonyl compound (14), followed by lithium aluminum hydride (LAH) reduction to give the racemic mixture (1 -I- 2). Resolution via diastereomeric derivatives seemed plausible. Esterification with enantiomerically pure a-methoxy-a-(trifluoromethyl) phenylacetic acid (MTPA) (17), followed by separation of diastereomers by recycle-HPLC (R-HPLC), had earlier been used to purify enantiomers of ipsenol and ipsdienol (26). A model system, the resolution of ^3-nonen-2-ol, a secondary ally lie alcohol naturally occurring in Rooibos tea (16,27), also worked satisfactorily. Therefore, the route using the te-(MTPA) esters was selected for crinitol. With crinitol, use of MTPA chloride/dimethylaminopyridine (16,28) gave the desired mixed diester (15 + 16) cleanly and in high yield. The mixed diesters were then separated by recycle-HPLC (16). It is of interest that recycle-HPLC of the te-MTPA ester of natural crinitol showed the presence of a small amount (13%) of the 95isomer, as mentioned above. Absolute configurations were checked in the crinitol bis-MTPA esters 15 and 16 by their iH-NMR spectra, using the Mosher method, as extended by Ohtani et al. (16-18). This method presumes a Sj^-periplanar arrangement of the C-H bond at the chiral center, the ester carbonyl bond, and the a-C-trifluoromethyl bond of the ester moiety. In this geometry, the ester's phenyl and methoxy groups, respectively, shield and deshield nearby groups in the alcohol moiety. While the C-9 configurations of the crinitol bis-MTPA esters were already reasonably assignable by comparison with material prepared from the known 9i? natural diol (3), it was nonetheless reassuring that the relative shifts of the clearly identifiable C-8 methylene hydrogens (6 2.37 and 2.17 in 15, vs. 2.42 and 2.21 in 16) were consistent with predictions by the Mosher/Ohtani NMR method. Diastereomeric excesses of the separated MTPA esters 15 and 16 were determined to be >96%, based on NMR measurements. Higher diastereomeric excesses could have been obtained by further chromatography, but the values obtained sufficed for our needs. The "unnatural" 95crinitol was assayed for antimicrobial activity simultaneously with a sample of natural crinitol, against the same battery of Gram-positive microorganisms originally used with the natural material alone (16). Against B. subtilis, B. ammoniagenes, 5. aureus, 5. mutans and P. acnes, the natural and unnatural material showed identical activity, which also matched the results of earlier tests (21) on natural material alone. This indicated that, for these test species at least, the configuration at C-9 is irrelevant to antimicrobial activity. This seems to indicate that antimicrobial activity is not due to interaction with a specific receptor, but rather to the above mentioned more general lipophilic interaction affecting cell membranes (24).
33
Scheme 1
x^>x-v^x^t^^
Collins Oxidation
OH
14 LiAIH/
A > - 0 : v ' 0 ^ > ^ - x ^ ^
+ xW^-vJ^V^^^
MTPA Chloride/DMAP ^ OMTPA
.A>-^\..A>X.^^
OMTPA
15
OMTPA
+
H
OMTPA 16 1. Recycle HPLC 2. NaOH
Separated
1 + 2
34
ENHANCED ANTIMICROBIAL ACTIVITY BY SYNERGISTIC COMBINATION Although crinitol may play an important role in the defense of living plants, and can easily be obtained in relatively large quantities from S. tortile or other sources (3), its antibacterial activity may not be potent enough to be considered for practical use as a single active ingredient. For this reason, the enhancement of the antibacterial activity of crinitol by combining it with other substances was explored (29), although the rationale for selecting "other substances" remains in a preliminary stage. The initial selection of adjuvants to crinitol was based largely on the above mentioned structure-activity relationship study. Thus, the hydroxy group at C-9 in crinitol seems to be essential to its antibacterial activity. The ally lie C-9 hydroxy group is easily oxidized, a possibility which might detoxify crinitol in bacterial systems. Because crinitol possesses two ally lie alcohol groups in its molecule (at C-1 and C-9), we combined it with several antioxidants which have been used as food and cosmetic additives. Thus two natural antioxidants, vitamins C and E, and two synthetic antioxidants, BHA and BHT, were chosen for the experiment. While the synthetic antioxidants exhibited antimicrobial activity against all the test bacteria (30), natural antioxidants did not show any activity up to 800 jug/ml. In combination with crinitol, neither of the natural antioxidants showed any enhancing activity against the bacteria tested. Neither synthetic antioxidant exhibited any synergistic effect against 5. aureus at all. Table 2 shows the MIC of crinitol in combination with the two synthetic antioxidants at the concentration of each 1/2MIC. The activity of crinitol against 5. mutans was significantly increased by both BHA and BHT. The antibacterial activity of crinitol against this cariogenic bacterium was increased 64-fold by BHT; the MIC was lowered from 50 to 0.78 fjLg/ml. Similarly, BHA also synergized crinitol against S. mutans, but not as much as BHT; the MIC was reduced only from 50 to 12.5 /xg/ml. Interestingly, crinitol also enhanced the antibacterial activity of BHT and BHA against S. mutans 16- and 8-fold, respectively. The data were obtained by the broth checkerboard method (31). By way of comparison, we might consider the famesol/anacardic acid synergism against P. acnes. Its antibacterial activity against this follicular bacterium was significantly increased in combination with ViMlC of anacardic acid isolated from the cashew Anacardium occidentale (Anacardiaceae) apple, nut and nut shell oil (32). More specifically, the MIC of famesol was lowered from 6.25 to 0.78 ^g/ml, in combination with 0.39 figlml of anacardic acid. Interestingly, this synergism was found to be vice versa; the MIC of anacardic acid was reduced from 0.78 to 0.2 /xg/ml when it was combined with 3.13 /xg/ml of famesol (33). The mode of action of the combination, however, remains unclear.
35 Table 2. MICs of crinitol alone and in combination with V2MTC of BHA and BHT MIC (Mg/ml) Microorganisms tested 1 + BHA 1 1 + BHT B. subtilis
50
50
12.5
B. ammoniagenes
100
100
50
S. mutans
50
12.5
0.78
S. aureus
400
400
400
P. acnes
25
6.25
6.25
ECOLOGICAL ASPECTS Crinitol was originally reported from C. crinita, "a brown seaweed rather common along the Sicilian coasts" (1); C. baleahca, another species from which crinitol has been reported, also was collected from Sicily for study (2). A wide range of Mediterranean algae have been studied and characterized (5,6); although crinitol itself seems to have been reported from only two species in the region, many related compounds have been described, and there seems to be significant variability in seaweed populations in the region (5,6,8,11,12,34,35). Much less has been reported on congeners of the marine brown alga S. tortile, which is known as "yoremoku" in Japan. This seaweed is commonly found on rocks from below the low-tide level to depths of several meters or more. In order to investigate the biological activity of crinitol, more S. tortile was collected from different geographic locations along coasts of the Pacific Ocean and the Sea of Japan during different seasons. The isolation of crinitol was monitored by an antibacterial activity assay against B. subtilis. As a result of this study, the quantity of crinitol in S. tortile was also analyzed in terms of its geographical and seasonal variation. More specifically, S. tortile was collected from two different geographic location in Japan, one at Kata, Wakayama, which is along the coast of the Pacific Ocean, and the other near Maizuru, Kyoto, which is along the coast of the Sea of Japan. The antibacterial crinitol was isolated as the only active principle based on bioassay-guided fractionation of the CH2CI2 extracts of 5". tortile collected during both spring and fall at Kata. It should be noted that crinitol was not only the antibacterial principle but also it was one of the major compounds (yielding about 1 % of the fresh weight) from 5. tortile collected at Kata. In contrast, it could not be isolated from those S. tortile collected near Maizuru, regardless of the season. Although seasonal variation of crinitol in S. tortile was not observed, the geographical
36 variation was remarkable. This variation could be caused by genotypic and/or by phenotypic factors. These results seem to be interesting from a chemotaxonomic point of view, since species of Sargassum are often difficult to identify. It should, however, be noted that geographical and seasonal variation among marine natural products seems to be common. Morphologically, it is noticeable that S. tortile grows better around Kata (the Pacific Ocean variety) than Maizuru (the Sea of Japan variety); the water temperature around the latter is cooler than the former. Thus, the algae collected from around Kata were larger than those of Maizuru. The observed geographical variation of crinitol in S. tortile may be caused by an environmental difference, if crinitol is hypothesized to be a defense substance. The water temperature around Kata is warmer than Maizuru, and bacteria at the former location may be more active than at the latter. If this hypothesis is true, then the algae growing around Kata may need more antibacterial agent to combat them. Clearly, further study is needed to confirm this. Based on the above findings, we also collected several other species of Sargassum algae along the coast of the Western United States. For example, S, muticum was collected near Trinidad, California. Although its /i-hexane extract exhibited weak antibacterial activity against B. subtilis, its CH2CI2 extract (from which crinitol was isolated from S. tortile) showed no activity. More specifically, crinitol was not identified in S. muticum at all. CONCLUSION Crinitol's natural role in seaweeds remains unclear, but it can be classified as a nonionic surfactant judging from its chemical structure. Its biological activity suggests that it may possibly exert a chemically protective function. The basis of crinitol* s antibacterial activity apparently derives from its properties as a nonionic surfactant that may disrupt cell membranes. The binding of nonionic surfactants can only involve relatively weak head-group interactions, such as hydrogen bonding, so that the predominant interactions will be hydrophobic (36). However, the specific binding site of crinitol still remains to be established. A wider range of bioassays may be appropriate forjudging possibly useful bioactivity; related substances, for example, have shown cytotoxicity in sea urchin egg development (8) and physiological effects on intestinal contractions (37). If crinitol is to find use as an antibacterial agent, this will probably require use of adjuvants to enhance its activity. Combining two or more substances to enhance the total biological activity may not only be a most efficient way to use renewable natural products, but also the microorganisms may take longer to develop their resistance to two or more toxins
37
whose mode of action is diverse. Factors such as potential human toxicity or irritancy (for which there is no current evidence) would also need to be checked. Conceivable uses of crinitol, as with many other natural products, may simply be defined by availability, physical properties, and the relative ease with which possible options might be explored. Acknowledgement This work was supported in part by NOAA, National Sea Grant College Program, Department of Commerce, under grant number NA85AA-D-SG140, project number R/MP-32, through the California Sea Grant Program, and the California State Resources Agency for financial support. The work has involved a number of scientists. We are greatly indebted to the colleagues cited in the references, especially Dr. T. Matsumoto, Dr. N. Ichikawa and Dr. M. Himejima. S. tortile was collected by Dr. N. Ichikawa and identified by Dr. H. Nakahara. We also thank Gretchen Peterson for assisting in the literature search. REFERENCES 1
2 3
4 5 6 7 8
9
E. Fattorusso, S. Magno, L. Mayol, C. Santacroce, D. Sica, V. Amico, G. Oriente, M. Piattelli, and C. Tringali, Oxocrinol and crinitol, novel linear terpenoids from the brown alga Cystoseira crinita, Tetrahedron Lett., (1976) 937-940. V. Amico, P. Neri, M. Piattelli and G. Ruberto, Linear diterpenoids from Cystoseira baleahca, Phytochemistry, 26 (1987), 2637-2639. L Kubo, T. Matsumoto and N. Ichikawa, Absolute configuration of crinitol, an acyclic diterpene insect growth inhibitor from the brown algae Sargassum tortile, Chem Lett., (1985) 249-252. I. Kubo, Screening techniques for plant-insect interactions, in Methods in Plant Biochemistry (K. Hostettmann, ed.), Academic Press, London, 1991, Vol. 6, pp 179193. E. Fattorusso, Recent results in the chemistry of mediterranean algae, in Marine Natural Products Chemistry (D. J. Faulkner and W. H. Fenical, eds.), Nato Conference Series, Plenum Press, New York and London, 1977, pp. 165-178. M. Piattelli, Chemistry and taxonomy of Sicilian Cystoseira species. New. J, Chem., 14 (1990) 777-782. R. Vails, B. Banaigs, C. Francisco, L. Codomier and A. Cave, An acyclic diterpene from the brown alga Bihrcaria bifurcata, Phytochemistry, 25 (1986), 751-752. R. Vails, B. Banaigs, L. Piovetti, A. Archavlis and J. Artaud, Linear diterpene with antimitotic activity from the brown alga Biiurcaria biAircata, Phytochemistry, 34 (1993), 1585-1588. J. F. Biard, J. F. Verbist, R. Floch and Y. Letoumeux, Epoxyeleganolone et eleganediol, deux nouveaux diterpenes de BiAircaria biAircata Ross (cystoseiracees). Tetrahedron Lett., 21 (1980), 1849-1852.
38
10 11 12
13 14
15 16
17 18
19 20 21 22 23 24
25 26
L. Hougaard, U. Anthoni, C. Christophersen and P. H. Nielsen, Eleganolone derived diterpenes from Bifiircaria blAircata, Phytochemistry, 30 (1991), 3049-3051. R. Vails, V. Mesguiche, M. Pellegrini, L. Pellegrini and B. Banaigs, Variation de la composition en diterpenes de Bifurcaria bifurcata sur les cotes atlantiques frangaises, ActaBot. Gallica, 142 (1995) 119-124. R. Vails, L. Piovetti, B. Banaigs, A. Archavlis and M. Pellegrini, (5)-13Hydroxygeranyl-geraniol-derived furanoditerpenes from Bifurcaria bifurcata, Phytochemistry, 39 (1995), 145-149. T. Wada, K. Kobata, Y. Hayashi and H. Shibata, Two chemotypes of Boletinus cavipes, Biosci. Biotech. Biochejrn., 59 (1995), 1036-1039. N. C. Gonnella, K. Nakanishi, V. S. Martin and K. B. Sharpless, General method for determining absolute configurations of acyclic allylic alcohols, J. Amer. Chem. Soc., 104 (1982) 3775-3776. H. Liu and K. Nakanishi, Additivity relation found in the amplitudes of excitonsplit circular dichroism curves of pyranose benzoates^ J. Amer. Chem. Soc., 103 (1981) 5591-5593. L. R. Smith and I. Kubo, The racemization of crinitol. Resolution of crinitol and of 3nonen-2-ol enantiomers by recycle-HPLC, via MTPA esters, J. Nat. Prod., 58 (1995) 1608-1613. J. A. Dale, D. L. Dull and H. S. Mosher, a-Methoxy-a-trifluoromethylphenylacetic acid, a versatile reagent for the determination of enantiomeric composition of alcohols and amines, J. Org. Chem., 34 (1969) 2543-2549. I. Ohtani, T. Kusumi, Y. Kashman and H. Kakisawa, High-field FT NMR application of Mosher's method. The absolute configurations of marine terpenoids, J. Amer. Chem. Soc., 113 (1991) 4092-4096. A. Horeau and A. Nouaille, Extension et simplification de la methode de determination de la configuration des alcool secondaires par "dedoublement partiel" VIII. Application a la genipine, Tetrahedron Lett., 12 (1971), 1939-1942. B. J. Gung, M. A. Wolf, K. Ohm and A. J. Peat, Conformational preferences of Cloxygenated acyclic chiral alkenes: The effect of vinyl and allyl substituents, Tetrahedron Lett., 34 (1993) 1417-1420. I. Kubo, M. Himejima, K. Tsujimoto, H. Muroi and N. Ichikawa, Antibacterial activity of crinitol and its potentiation, J. Nat. Prod., 55 (1992) 780-785. I. Kubo, H. Muroi and A. Kubo, Antibacterial activity of long-chain alcohols against Streptococcusmutans, J. Agric. Food Chem., 41 (1993), 2447-2450. I. Kubo, H. Muroi and A. Kubo, Structural functions of antimicrobial long-chain alcohols and phenols, Bioorg. Med. Chem., 3 (1995) 873-880. I. Kubo, H. Muroi, M. Himejima and A. Kubo, Antibacterial activity of long-chain alcohols: the role of hydrophobic alkyl groups, Bioorg, Med. Chem. Lett., 3 (1993) 1305-1308. L. F. Fieser and K. L. Williamson, Organic Experiments, D. C. Heath, Lexington, 1979, 4th ed., p. 148. I. Kubo, S. Komatsu, T. Iwagawa and D. L. Wood, Analytical and preparative separation of bark beetle pheromones by high-performance liquid chromatography, J. Chromatogr., 363 (1986) 309-314.
39 27 28 29 30 31 32 33 34 35 36 37
M. Kawakami, A. Kobayashi and K. Katoh, Volatile constituents of Rooibos tea {Aspalathus linearis) as affected by extraction process, J. Agric. Food Chem., 41 (1993) 633-636. H. S. Byun and R. Bittman, Stereospecific synthesis of thioether glycerophospholipids. Catalytic asymmetric epoxidation followed by in situ borohydride-mediated opening of glycidol with hexadecylmercaptan, J. Org. Chem., 59 (1994) 668-671. I. Kubo and M. Taniguchi, Polygodial, an antifungal potentiator, J. Nat. Prod., 51, (1988) 22-29. P. M. Davidson, Phenolic compounds, in Antimicrobials in Foods (A. L. Branen and P. M. Davidson, eds.). Marcel Dekker, New York, 1983, pp. 37-74. C. W. Norden, H. Wenzel and E. Keleti, Comparison of techniques for measurement of in vitro antibiotic synergism, J. Infect. Dis., 140 (1979) 441-443. M. Himejima and I. Kubo, Antimicrobial agents from the Anacardium occidentale (Anacardiaceae) nut shell oil, J. Agric. Food Chem., 39 (1991) 418-421. I. Kubo, H. Muroi and A. Kubo, Naturally occurring antiacne agents, J. Nat. Prod., 57 (1994) 9-17. G. Combaut and L. Piovetti, A novel acyclic diterpene from the brown alga Bifurcaria bifurcata, Phytochemistry, 22 (1983), 1787-1789. L. Semmak, A. Zerzouf, R. Vails, B. Banaigs, G. Jeanty and C. Francisco, Acyclic diterpenes from Bifurcaria biiurcata, Phytochemistry, 27 (1988), 2347-2349. M. N. Jones and D. Chapman, Micelles, Monolayers, and Biomembranes, Wiley-Liss, New York, 1995. F. Delia Pieta, M. C. Breschi, R. Scatizzi and F. Cinelli, Relaxing activity of two linear diterpenes from Cystoseira brachycarpa var. balearica on the contractions of intestinal preparations, Planta Med., 61 (1995), 493-496.
This Page Intentionally Left Blank
Atta-ur-Rahman (Ed.) Studies in Natural Products Chemistry, Vol. 20 © 1998 Elsevier Science B.V. All rights reserved.
41
Stereoselective Synthesis of Methylcyclopentanoid Monoterpenes A. Bianco
1. Introduction. 2. Structure and biogenesis of methylcyclopentanoid monoterpenes. 3. Synthesis of methylcyclopentanoid monoterpenes. 3.1. 2-Hydroxy-3-oxobicyclo[4.3.0]non-4-ene-type skeleton. 3.1.1. Synthesis via bicycloeptene derivatives. 3.1.2. Synthesis via bicyclooctene derivatives. 3.1.3. Synthesis via bicyclononadiene derivatives. 3.1.4. Diels-Alder reactions. 3.1.4.1. Intramolecular Diels-Alder reactions. 3.1.4.2. Intermolecular Diels-Alder reactions. 3.1.5. Photochemical cycloadditions. 3.1.6. Nitrile oxide cycloaddition. 3.2. 3-Oxobicyclo[4.3.0]nonan-2-one- or 4-one-type skeleton. 3.2.1. 3.2.2. 3.2.3. 3.2.4.
Tricyclo[3.3.0.0]octanone degradation. Favorskii rearrangement. Homer-Wadsworth-Emmons reaction. Norrish I type reaction.
1. Introduction
The higher plants routinely, rapidly and efficiently carry out syntheses that offer challenging synthetic targets to the greatest organic chemists. The biogenetic processes, starting from the simplest building bricks, create the asymmetric molecules
42
in a relatively simple manner, being the consequence of specific batteries of enzymes. We have the problem to invent something suitable to take the place of enzymes if we wish to prepare these natural products. Methylcyclopentanoid monoterpenes are a group of isoprenoids characterised by the presence in their skeleton of a cyclopentanoid residue. Both hydrophilic and hydrophobic compounds are known ( ref s 1-3 ), which may be both volatile and non volatile. Products of alkaloidal nature (ref 4 ) are also included in this family.
OOCH3
OOCH3
OOCH3
O 0-glc Loganin
CH3 Iridomyrmecin
Nepetalacton
Fig.l The principal groups of natural products belonging to this family of monoterpene derivatives are: glycosidic and non-glycosidic iridoids ( see fig 1, ref s 5-7 ), together with related compounds secoiridoids and bisiridoids, and monoterpene alkaloids ( see fig 2).
OOCH3
Gentianine
Fig. 2
43
Methylcyclopentanoid monoterpenes represent key intermediates of monoterpene metabolism of this type; in fact, starting from this skeleton, the typical biotransformation of the cyclopentanoid residue begins, as an oxidative cleavage. In the case of iridoids, they are ring opened to secoiridoids and are incorporated as monoterpenoid part of important groups of alkaloids: indole, ipecacuanha, cinchona, pyrroloquinoline alkaloids and related compounds (ref 8 ). Another aspect of methylcyclopentanoid monoterpenes is their biological role for the organisms which biosynthesise them. They are in fact often involved in the plant/insect and in the plant/plant biochemical interactions; the biochemical role of these compounds has been extensively studied in recent years and the role of methylcyclopentanoid monoterpenes in plant-animal and plant-plant interactions has been demonstrated (ref 9 ). Methylcyclopentanoid monoterpenes and their metabolites also show several biological activities in man and animals (ref 10 ). Therefore there were many reasons which attracted natural products chemists to take up on the total stereoselective synthesis of this class of isoprenoids In this article the stereoselective syntheses of methylcyclopentanoid monoterpenes are reviewed. The chemical procedures performed for the synthesis of glycosidic and non glycosidic iridoids will be presented.
2. Structure and biogenesis of methylcyclopentanoid monoterpenes
Methylcyclopentanoid monoterpenes are structurally characterised by a (1R,6S) 3oxobicyclo[4.3.0]nonane moiety. Two carbons, belonging to the isoprenoid unit, are generally linked to the 9 and 5 positions. So the basic skeleton is that depicted in fig.3.
44
Fig. 3 The biogenesis of this family of compounds constitutes a separate chapter in the metaboHsm of monoterpenes, and does not involve the carbocationic Ruzika's scheme but consists perhaps of an aldolic condensation-type process on an oxidated derivative of geraniol. The biogenesis of methylcyclopentanoid monoterpenes has been carefully studied allowing the key steps of the process to be depicted (ref s 11-13 ). The methylcyclopentanoid
monoterpenes
arise from
geranyl-PP via an
intramolecular stereocontroUed Mannich type condensation of a dialdehydic or a trialdehydic intermediate, as shown in fig.4. The resulting cyclopentanaldehydic compound has been named iridodial or iridotrial, depending on the nature of the biosynthesized compound and of its biogenetic pathway.
.CHO
OPP
^
k
_
R^^CHO R=CH3 or CHO
Fig.4
— •
1
V—CHO /^CHO R
R=CH3 or CHO
45
Iridodial and iridotrial intermediates can arise by different biogenetic pathways, giving rise to different groups of methylcyclopentanoid monoterpenes. Intramolecular hemiacetalization between an aldehyde group and the enolic form of a second aldehyde, affords the 2-hydroxy-3oxobicyclo[4.3.0]non-4-ene type structure depicted ( fig.5 ).
OR [^\—CHO
R R=CH3 or CHO
R=CH3 or CHO
R=CH3 or CHO R'=H or sugar
Fig. 5 The hemiacetalic C-2 function can be blocked by a sugar residue, affording the methylcyclopentanoid monoterpenes known as glycosidic iridoids. Otherwise the same function can be esterified giving rise to the non-glycosidic iridoids of plumeria or valeriana-type (fig.6).
CH2OAC
oX^-K^o
Isovaleroyl-O'
Valtrate
Fig. 6
Piumericin
46
Intramolecular redox reaction of iridodial or iridotrial intermediates afford two different skeleton of non-glycosidic iridoids: the iridomirmecin-type and the nepetalactone-type (fig.7).
Fig, 7 Reduction of one or both aldehydic functions of iridodial or iridotrial, responsible for the closure of the pyranoid ring, gives rise to the non-glycosidic iridoids, known as iridodiols, generally having only the methylcyclopentanoid moiety (fig.8 ).
OH OH
Fig.8 The iridodial intermediate can also suffer a well known transamination reaction, followed by intramolecular Schiff base formation, giving rise to the formation of 3azabicyclo[4.3.0]nonane-type
skeleton,
typical
of
monoterpene
alkaloids.
47
Heterocyclic ring formation can then lead to a piperidine or a pyridine-type ring system, giving rise to tiie two principal groups of monoterpene alkaloids (fig.9 ).
Fig, 9 In the end, it is necessary to cite, in this biogenetic discourse, the secoiridoid group which is derived from methylcyclopentanoid monoterpenes, even if it does not maintain the characteristic methylcyclopentanoid moiety. Secoiridoids arise, in fact, from the oxidative opening of the cyclopentane ring of both glycosidic or nonglycosidic iridoids by cleavage of the C-8/C-9 bond. hifig.10 is depicted the biogenetic transformation of loganin to secologanin.
COOCH3
COOCH3
COOCH3
OHC •^sC
o-gic
Loganin
Fig. 10
Secologanin
48
Secologanin is probably one of the best known secoiridoids, being the monoterpenic key intermediate in the biogenesis of indole and related alkaloids.
3. Synthesis of methylcyclopentanoid monoterpenes.
Numerous syntheses of methylcyclopentanoid monoterpenes have been reported, but we will restrict our discussion here to a selected number of the more general and stereoselective syntheses of the basic skeletons, giving particular attention to the stereoselective syntheses of optically active forms of these terpenes. hi view of the very different approaches, we prefer to divide the chapter into two topics. hi the first one ( section 3.1. ) we will consider the syntheses of methylcyclopentanoid monoterpenes having a hydroxyl group at the C-2 carbon and a double bond between the C-4 and C-5 carbons ( essentially glycosidic iridoids and related compounds, having both C-2 and C-4 carbons at the same oxidation level). hi the second one ( section 3.2. ) we will present the syntheses of methylcyclopentanoid monoterpenes having the C-2 and C-4 carbons at different oxidation levels (iridomyrmecin and nepetalactone-type compounds).
3.1.2-Hydroxy-3-oxobicyclo[4.3.0]non-4-ene-type skeleton. This skeleton is typical of iridoid glycosides, but several non-glycosidic iridoids, e.g. plumeria-type and valeriana-type compounds, are also characterised by the same skeleton.
49
It can be synthesised via several methods. Some of these employ bicyclic systems as starting material ( see sections 3.1.1. - 3.1.3. ), while others involve the construction of bicyclic iridoidic skeleton via cycloadditions ( see sections 3.1.4. 3.1.6. ). All the procedures lead only to the aglyconic moiety, the insertion of glucose being accomplished always in the final step.
3.1.1. Synthesis via bicycloeptene derivatives. The strategy, pioneered by Vandewalle, involved a completely stereospecific scheme based on the stereoselective fragmentation of precursors having a norbomane-type skeleton ( ref 14 ). The stereoselective synthesis of the suitable norl)omane-type precursors is shown in scheme 1. The norbomene 1, which is the starting materials for the synthesis of loganin depicted in scheme 2, has been obtained from cyclopentadiene and methyl Ecrotonate in classical Diels-Alder conditions, with a high endo-exo stereoselectivity.
^ COOCH3
, COOCH3
O
Scheme 1
2
50
After reduction with lithium aluminium hydride and upon treatment with mcMoroperbenzoic acid, exclusively the endo-dXcohoX cyclized to 2, with yields higher than 80%. Swem oxidation followed by reductive cleavage of the ether bond, afforded the desired norbomanone 3 in a stereoselective manner. Fragmentation of norbomanone-precursors like 3 can be performed by two different strategies, depending on the skeleton desired to be obtained. Fragmentation via Norrish I type reaction afforded
iridomyrmecin and
nepetalactone-type compounds and will therefore be discussed in section 3.2.4. Fragmentation via Baeyer-Villinger oxidation ( ref 15 ) allows access to the 2hydroxy-3-oxobicyclo[4.3.0]non-4-ene-type skeleton and the synthesis of loganin by this approach is reported in scheme 2.
kO^
u COOCH3
COOCH3
COOCH3 MEMO"
-
XHO
HO'"
Scheme 2 Norbomanone 3 has been first transformed into the chetal 4 by Swem oxidation and selective transacetalization with 2-methyl-2-ethyl-dioxolane. Oxidation with m-
51
chloro-perbenzoic acid gave the lactone 5 which has been opened to the methylcyclopentanoid derivative 6. The missing carbon has been introduced on the compound 6, after MEM protection of the hydroxyl fiinction, upon metallation with with a 1:1 mixture of tBuOK-LilCA ( compound 7 ). Simple acid work-up afforded the p-methyl acetal of loganin aglucone 8 which is a known intermediate in the synthesis of loganin.
3.1.2. Synthesis via bicyclooctene derivatives This approach has been first used by Sakan and Abe ( ref 16 ) for the total synthesis of the verbenalin aglycon 19 which confirmed the structure and configuration of the corresponding glucoside, verbenalin. The key bicyclooctene derivative 14 has been prepared in stereoselective manner as depicted in the scheme 3.
AcO
H3C
O
Is, 14
Scheme 3
COOH
O13
H3C
11
COOH
52
The dienone 9 has been stereoselectively methylated, from the less hindered endo face of the molecule, to compound 10 having the methyl group in an a configuration. Hydride reduction afforded to the formation of the alcohol in which the hydroxyl function was disposed in anti configuration with respect to the methyl group, again in consequence of the hydride attack from the less hindered face of the molecule. The secondary hydroxyl group has been then protected by acetylation ( compound 11). Permanganate/periodate oxidation of 11 afforded the diacid 12, having the bicyclooctane structure with the correct relative configuration of the chiral centers. The intermediate 12 has been transformed in acid medium to the lactone 13 which on lead tetraacetate oxidation gave the key bicyclooctene derivative 14.
-^
14
O
COOCH3
0
COOCH3 CHO "CHO
18
17
Scheme 3 contd Compound 14 has been oxidised with osmium tetroxide to the glycol 15 which has been protected as the acetonide 16. Oxidation in basic medium with ruthenium oxide afforded a ketoacid which has been transformed into the corresponding methyl ester 17.
53
The acetonide protecting group has been then removed in acid conditions and subsequent lead tetraacetate oxidation opened the cyclopentane ring because of the vicinal diolic function, furnishing the hemiacetalic structure 18. The compound 18 gave rise to the more stable hemiacetalic structure of verbenalol 19, corresponding to the methylcyclopentanoid monoterpenic structure of verbenalin. A similar strategy has been employed by Vandewalle et al in the total synthesis of verbenalin aglycone ( ref 17 ), but a different approach has been used for the stereoselective synthesis of the bicyclooctene key synthon.
COOCH3
V^^o 20 R=OH 21R=CI
22 R=0 23R=N2
^^
Scheme 4 Starting from 2-cyclopentene-l-acetic acid 20, the intermediate 24 has been constructed through a four step sequence as described in scheme 4. Acid 20 has been transformed to the acid chloride 21 which has been condensed with Meldrums acid to give, after solvolysis with metfianol, the p-keto ester 22. Subsequent treatment with/?-tosylazide gave the diazo compound 23 which has been stereoselectively cyclized to 2-carbomethoxy-tricyclo[3.3.0.0]octan-3-one 24 with copper acetylacetonate as catalyst. Tricycloderivative 24 is the starting product for the synthesis of verbenalol 19 reported in Scheme 5. Solvolysis of 24 in acetic acid and subsequent cyanoborohydride reduction has been performed in one pot to afford the alcohol 25 which, after dehydration, gave a,P-unsaturated ester 26 and successively the key compound 27, after methanolysis and Jones oxidation.
54
Selenenylation in the a-position to the carbonyl of 27 with subsequent direct oxidation, gave the enone 28. Double bond migration of the unsaturated ester function of 28 has been performed via allyUc bromination and subsequent reduction with zinc, yielding, in a satisfactory stereocontrolled way, the compound 29. Subsequent conjugate addition with dimethylcopperlithium yielded the desired isomer 30 with good stereoselectivity.
COOCH3
AcO
COOCH3
COOCH3
AcO
O 25
24
O
COOCH3
q
29
26
C00CH3
28
27
\ O
COOCH3
COOCH3
30
Scheme 5 The double bond of 30 has been cleaved with ozone and successive acid work-up of the reaction mixture afforded in one step the verbenalin aglycone 19.
55
3.1.3. Synthesis via bicyclononadiene derivatives This procedure has been used essentially for the total synthesis of genipin which has been described by Buchi et al ( ref 18 ) and which allowed the confirmation of the structure of this compound as well as the stereochemical assignments. The procedure is depicted in scheme 6 and starts from the bicyclononadiene derivative 31, prepared by thermal decomposition of the ethyldiazoacetate adduct of cyclooctatetraene ( ref 19 ), which has been reduced with lithium in ammonia to the bicyclononadiene derivative whose methylester 32 is the starting product.
COOH
COOCH3
31
32
OOOCH3
r
COOCH3
r
HO'
C00CH3 N
HO^.^"'^^^-^
^N.^
CHO
CHO
OH
OH
36
33
35
34
Scheme 6 Osmium tetroxide oxidation of 32 gave a mixture of the isomeric tetraols 33 whose vicinal diolic function on the cyclopentane ring has been regioselectively cleaved with one mole of lead tetraacetate to give the dihaldehydic derivatives 34 which have been isolated as lactols 35. Periodate cleavage of the isomeric lactols 35 afforded the dihaldehyde 36.
56 COOCH3
COOCH3
COOCH3
OHC
Scheme 6 contd Regioselective intramolecular aldolic condensation of 36 with piperidinium acetate gave only the compound 37 with the desired 2-hydroxy-3-oxobicyclo[4.3.0]non-4ene-type skeleton. The regioselectivity of this reaction can be explained on the basis of a less hindered
transition
state
which
corresponds
to the
formation
of
the
methylcyclopentanoid derivative 37. (+)-genipin 38 has then been prepared by a regioselective reduction of the free aldehyde function of the intermediate 37 with lithium tri-/-bythoxyaluminium hydride.
3.1.4. Diels-Alder reactions The Diels-Alder reaction has been used for the synthesis of the iridoidic skeleton, starting from both acyclic (described in section 3.1.4.1.) and cyclic (descibed in section 3.1.4.2.) intermediates.. 3.1.4.1. Intramolecular Diels-Alder reactions. This approach has been proposed by Tietze et al which constructed a suitable acycKc intermediate shown in scheme 7. By means of an intramolecular Diels-Alder
57
reaction ( ref. 20 ) the direct preparation of the iridoidic-type skeleton has been described as depicted in scheme 7.
OCH3
Scheme 7 3.1.4.2. Intermolecular Diels-Alder reactions An intermolecular Diels-Alder reaction has been also employed starting from a suitable cyclic diene and the iridoidic skeleton has been prepared in a stereoselective manner (ref 21) as shown in scheme 8.
40
cCf41
39
H I
4r° 42
R=H or COOCH3 R', R"= Alkyl
H I
OR"
Hr° OR" 43
Enantiomeric mixture
Scheme 8 The cyclopentene-carbaldehyde 39 reacts with the enol-ether 40 to form the adduct 41, having the skeleton of 3-oxobicyclo[4.3.0]non-l-ene. An alcohol has been then regioselectively and stereoselectively added (compound 42 ) at the double bond from
58
the less hindered p side of the molecule. Finally a regioselective acid catalysed elimination of an alcohol afforded the 2-alkoxy-3-oxobicyclo[4.3.0]non-4-ene moiety ( compound 43), characteristic of methylcyclopentanoid monoterpenes. The reaction can be performed using the enol-ether 40 with both hydrogen or carbon
substituents; depending
on the
employed
enol, the 2-alkoxy-3-
oxobicyclo[4.3.0]non-4-ene-type skeleton may be prepared in substituted or unsubstituted forms at 5 position.
3.1.5. Photochemical cycloadditions The
photochemical
addition
of
fimctionalized
cyclopentenes
and
tricarbonylderivatives has been also used for the preparation of iridoidic skeleton, via a bicylo[3.2.0]heptane intermediate, as shown in the scheme 9.
o
H
HsCOOC^
OH
COOCH3
cti
COOCH3
COOCH3
H I
H
44
Scheme 9 This procedure is an adaptation of a photoannulation reaction, originally developed by de Mayo ( ref 22 ) and leads initially to the stereoselective formation of a cyclobutanol ring (intermediate 44 ) which undergoes a spontaneous ring opening to the typical iridoidic dialdehyde ( intermediate 45 ) which is theoretically in equilibrium with the lactol iridoidic moiety ( intermediate 46 ), as depicted in the scheme 9. The first two syntheses of loganin aglycone 58 have been performed in a similar manners by Buchi, Tietze et al ( see scheme 10-13, ref 23 ) and by Partridge et ah.
59
( see scheme 14, ref. 24 ). They differ in the structure of the starting cyclopentene derivative. Buchi started from 3-cyclopentenol 47 which is photochemically added to the enol double bond of 2-formyhnalonaldehyde 48 in a stereoselective way (scheme 10 ).
H3COOC
THPO-^
1
V ^
COOCH3
>=0 THP
OH
47
48
COOCH3 THPi
50 and 50a
Scheme 10 The hemiacetalic iridoidic intermediate 49 obtained has been successively transformed into the two corresponding enantiomers methylacetals 50 and 50a and the secondary alcoholic function on the cyclopentane ring oxidised to a carbonyl group (enantiomeric mixture 51 and 51a obtained). The missing one carbon unit is introduced at this stage utilising the reactive aposition to the carbonyl and different procedures have been employed, generally in relation to the desired iridoid. In the case of the first synthesis of loganin ( see scheme 11 ) the ketonic intermediate 51 ( as an enantiomeric mixture ) has been formylated in high regioselective way to the aldehyde 52 as the major product, owing to the steric
60 hindrance constituted by the carbomethoxyl group which is more important than the hindrance of methoxyl group in consequence of the structural constitution of the molecule. Aldehyde 52 has been successively derivatized with w-buthyhnercaptan to produce the thiomethylene derivative 53.
COOCH3
COOCH3
COOCH3
o=rtS
OHC^H, 51
._„ n-BuS"'
. . . / ^^^ ^H3 53
52 Major products
Enantiomeric mixture
COOCH3
COOCH3 COOCH3
H3C
OCH3 55R=H 56 R=Ts
^^sC
54
0CH3
0CH3 54 and 54a
COOCH3
COOCH3
COOCH3
H T
H T
AcO'
AcO' H3C
0CH3 57
>- AcO--<
I
^sC
0-glcAc4 59
Scheme 11 Desulphurization and reduction of 53 produced a mixture of epimeric ketones 54 and 54a which have been transformed into the thermodynamically more stable ketone 54 via sodium methoxide treatment.
61 As a general rule the substituents on the cyclopentane ring in 3 configuration in this type of molecules suffer a lower steric hindrance with the consequent major thermodynamic stability for compounds having substituents in this absolute configuration. The introduction of a secondary hydroxyl function on the cyclopentane ring in the desired syn configuration with respect to the methyl, has been performed in three steps, firstly by reducing the ketone function with sodium borohydride. The more stable anti hydroxyl ( compound 55 ) has been obtained and, to invert its configuration, it has been esterified with p-toluensulfonate ( compound 56 ), and substituted, in bimolecular nucleofilic substitution conditions, with acetate (compound 57). The classical glucosylation with 2,3,4,6-tetraacetylglucose, afforded the acetate of loganin 59, via the aglycone 58. A simple modification of this procedure has been performed by Tietze (ref 25-28) as shown in scheme 12. COOCH3
COOCH3
COOCH3
H I
HO-
')nr. HOOC
H i.
OCH3
HOOC
60 and 60a
0CH3
61 and 61a /
COOCH3
AcO (I
I
HOH2C
OCH3
63 Scheme 12
COOCH3
62
The procedure has been utiUsed to synthesise the hydroxyloganin, the key ring intermediate in the metabolism of iridoids to secoiridoids and subsequently to indole and related alkaloids having this monoterpenic part. The difference in the procedure consists essentially in the different introduction of the missing one carbon unit, at the same stage after the photochemical addition, utilising methyhnagnesium carbonate. The ketone 51, prepared as an enantiomeric mixture as described in scheme 9, is regioselectively carboxylated in the a position to give the p-ketoacid 60 which, without any manipulation, is immediately stereoselectively reduced to the Phydroxyacid 61, with sodium borohydride. Tietze proposed a thermodynamic control in the high regioselectivity of carboxylation of 51 and a steric control, as consequence of convex geometry of molecule, in the stereoselectivity of reduction of 60. Resolution of the enantiomeric mixture can be performed at this step, after acetylation of the secondary hydroxyl, by separation of diastereoisomeric salts 62 and 62a with 1-phenylethylamine. The carboxyl group of the desired enantiomer of 62 is then reduced to a hydroxymethyl group in the intermediate 63 which can afford hydroxyloganin 72 ( ref 25-28 ) or 7-epihydroxyloganin 68 ( ref 25, 28 ) following two different procedures as depicted in scheme 13. Diacetate 64 is transformed into the hemiacetal 66 by a mixture of acetic and perchloric acid in water. Glucosylation of 66 with 2,3,4,6-tetra-O-acetyl-P-D-glucose in the presence of boron trifluoride afforded the hexaacetate of 7-epihydroxyloganin 67 and, after alkaline hydrolysis, the corresponding iridoid 68.
63
A\
COOCH3
COOCH3
RO"'
/
ROH2C
AcO"
HT
ACOH2C
0CH3
64 R=Ac 65 R=Ms
COOCH3
RO' "
^^
.„rtS
n ROH2C
AcO—<
I
I
OH^r ACOH2C
H i _ . OCH3 69
—
COOCH3 AcO-
w.r ACOH2C
0-glcR4
67 R=Ac 68R=H
66
COOCH3
HT
COOCH3
RO—<
Hi.. 70
ROH2C
I 0-glcR4 71 R=Ac 72R=H
Scheme 13 For the synthesis of hydroxyloganin 72, the same starting intermediate, as dimesylate 65, is treated with tetraethylammonium acetate to invert the configuration at C-7. Hydrolysis of acetal as before allowed to prepare the hemiacetal 70, and successive glucosylation afforded hydroxyloganin hexaacetate 71 and thereafter hydroxyloganin 72. An improvement in the glucosylation procedure has been performed by Tietze ( ref 29 ) which utilized P-trimethylsilyl-2,3,4,6-tetraacetylglucose which reacted with the acetylated hemiacetalic fimction in the presence of catalytic amounts of trimethylsilyl trifluoromethanesulfonate in acetonitrile or liquid sulphur dioxide at -30 or -50 T respectively.
64
Loganin acetate 59 has been rapidly obtained by Partridge et al.X scheme 14, ref. 24 ) starting from enatiomerically pure (-)-(lS,2R)-2-methyl-3-cyclopentenyl acetate 76.
H3COOC AcO'
H3C-<^
H3C 73
COOCH3
AcO-Y
I
^sC
I 0-glcAc4
59
48
76
74R=H 75 R=Ms
COOCH3
AcO—<
I
H3C
OH 58
Scheme 14 The optically pure starting material has been prepared from the prochiral 5methylcyclopentadiene 73 by hydroboration with (+)-bis(cis-pinan-trans-3-yl)borane. (-)-(lR,2R)-2-methyl-3-cyclopentenol
74 obtained has been mesylated (
compound 75 ) and the desired (-)-(lS,2R)-2-methyl-3-cyclopentenyl acetate 76 has been prepared by displacement with acetate on heating with tetraethylammonium acetate. This olefin undergoes photoannelation in regioselective and stereoselective manner with methyl-diformyl acetate 48 to produce directly the loganin aglycone derivative 58 in about 20% yield. Classical treatment with 2,3,4,6-tetra-O-acetyl-D-glucose in anhydrous conditions, in the presence of boron trifluoride etherate, afforded loganin pentaacetate 59.
65
A further utilisation of the Patemo-Buchi enone photoannulation reaction has been performed by Chaudhuri et al ( ref 30 ) who, by employing 5-(trimethylsilyl)-l,3cyclopentadiene 77 in acetonitrile at -50 °C ( see scheme 15 ), obtained in a regioselective way only the photoadduct 78, by reaction with methyl-diformyl acetate 48.
H3COOC
MeaSi
-O
H ?°°^"'
MeaSi
48
77
78
COOCH3
R
MeaSi
u 9^^^"3
H 0CH3 L.
80 R=CH3C0
79
Scheme 15 The intermediate 78 is stabilized by acetalization with methanol ( compound 79 ) and the introduction of missing carbon can be easily performed in stereoselective way by allylic displacement of the silyl group with acetyl chloride or other reagents (compound 80).
66
3.1.6. Nitrile oxide cycloaddition The Claisen rearrangement - nitrile oxide cycloaddition sequence has been adapted to the synthesis of methylcyclopentanoid monoterpenes by Curran et al (ref. 31-32 ). This reaction sequence is in fact a useful, stereocontroUed annulation procedure in a carbocyclic ring system which the authors demonstrated to be applicable to the synthesis of heterocyclic systems.
o ^ CHsOOC^ . k . ^O R
OEt 82
83
OMs
N
O
OEt 86
85
^ 87
Scheme 16
88
84
67
The starting glycal 81 has been prepared by Ferrier rearrangement of D-xylal; the acetalic P-anomer has been employed in the synthetic procedure. As shown in scheme 16, the nature of substituted acetic acid which esterifies the secondary hydroxyl depends on the target structure. freland-Claisen rearrangement of 81, followed by methylation, afforded the intermediate 82 as a single stereoisomer. DIBAL reduction to the aldehyde and successive WoUemberg homologation afforded the key nitro-olefin 83. The nitrile oxide cycloaddition has been performed on 83 under Mukaiyama conditions giving the isoxazoline 84 in about 50% yields with high stereocontrol of the annulation reaction. The
2-hydroxy-3-oxobicyclo[4.3.0]nonane-type
skeleton,
typical
of
methylcyclopentanoid monoterpenes, has been then constructed in a stereospecific and regiospecific manner. Successive steps can be designed according to the target molecular moiety. In the case depicted in scheme 16, nickel-Raney reduction of 84 provided the Phydroxyketone 85 which can be easily transformed to the desired skeleton by mesylation (compound 86) and successive treatment with DBU. The 2-hydroxy-3-oxobicyclo[4.3.0]non-5-ene-type structure ( compound 87 ) has been obtained which in turn has been equilibrated in the same conditions to the thermodynamically more stable 2-hydroxy-3-oxobicyclo[4.3.0]non-4-ene-type one ( compound 88). The reported model scheme had shown that Claisen rearrangement-nitrile oxide cycloannulation represented an excellent procedure for the stereoselective synthesis of 2-hydroxy-3-oxobicyclo[4.3.0]non-4-ene-type skeleton differently substituted on the cyclopentane ring.
68
3.2.3-Oxobicyclo[4.3.0]nonan-2-one- or 4-one-type skeleton.
Different approaches have been proposed for the stereoselective synthesis of methylcyclopentanoid
monoterpenes
oxobicyclo[4.3.0]nonan-2-one-type)
with and
nepetalactone-type iridomirmecin-type
skeleton
(3-
skeleton
(3-
oxobicyclo[4.3.0]nonan-4-one-type). We will divide the discussion on the basis of the key reactions used in the synthetic strategy.
3.2.1. Tricyclo[3.3.0.0]octanone degradation. 2-Carbomethoxy-tricyclo[3.3.0.0]octan-3-one 24, obtained as described in section 3.1.2., has been utilized as a chiral starting material for the preparation of isoiridomirmecin 92 (ref 17, scheme 17).
H3C
COOCH3
COOCH3
O 89
24
H3C OSi{CH3)3 CH3 91
Scheme 17
90
69
As shown in scheme 17, compound 24 has been methylated in a stereocontroUed way by reaction with methyl iodide in the presence of lithium diisipropylamide, affording the derivative 88. Reaction of 88 with dimethylcopperiithium afforded, again in a stereocontroUed way, the ketoester 89. The hydrolysis of ester function of ketoester 89 led to the decarboxylation, affording a single ketone 90. The kinetic enolate derived from ketone 90 has been trapped as the trimethylsislyl derivative 91. Ozonolysis of 91, followed by reductive work-up with sodium borohydride, afforded directly the isoiridomyrmecin 92.
3.2.2. Favorskii rearrangement. The starting idea of this approach arises from the knowledge that fiinctionalized cyclopentanecarboxylates can be obtained from the Favorskii rearrangement of cyclohexanone derivatives (ref 33 ). (+)-carvone 93 has been chosen as the starting cyclohexanone derivative and it has been transformed into the chlorohydrin derivative 95 via the epoxide intermediate 94, as described in scheme 18.
THPO.
^
o 93
Scheme 18
94
95
70
The monoepoxide 94 has been obtained by oxidation of (+)-carvone 93 with hydrogen peroxide in alkaline medium (NaOH/MeOH) for 1 h at room temperature. Treatment of 94 with chlorotrimethylsilane in acetonitrile/dimethylsulphoxide opened the epoxide affording, in high regioselective yields, the corresponding chlorohydrin which has been transformed, without isolation, to its tetrahydropyranyl ether 95. When 95 has been treated with sodium methoxide in methanol at room temperature, the Favorskii rearrangement occurred in a stereoselective manner and the cyclopentanecarboxylate 96 has been obtained in high yields as described in scheme 19.
THPO. THPO'
CI "tY
'COOCH3
o
95
96
Scheme 19 In schemes 20 and 21 are depicted the strategies for the stereoselective transformations
of the key intermediate 96 in the methylcyclopentanoid
monoterpenes with iridomyrmecin- and nepetalactone-type skeleton. For the synthesis of dihydronepetalactone 99, the intermediate 96 has been manipulated as depicted in scheme 20. The key step is represented by the stereoselective hydroboration of 96 with disiamylborane and by the successive oxidation, which led to the formation of the free primary alcoholic function of the intermediate 97. The stereoselectivity of hydroboration is due to the attack of the bulk borane from the less hindered (3-side of
71
the molecule and allowed to have the methyl group in the intermediate 97 in the required a-configuration.
THPO'
THPOCOOCH3
96
97
H \
HO'
99
n? 98
Scheme 20 The hydrolysis of 97 in alkaline conditions, followed by acid treatment, allowed the intramolecular lactonization, affording the hydroxylactone 98. Barton-type deoxygenation of 98 yielded the expected (+)-dihydronepetalactone 99. Alternatively ( see scheme 21 ), the same key intermediate 96 can be transformed into the iridomyrmecin 102. The compound 96 has been transformed into the acetate 100 by reduction with lithium aluminium hydride, followed by acetylation of the free primary hydroxyl and successive deprotection of the secondary hydroxyl. Barton-type deoxygenation of 100, with the same procedure previously described in scheme 20, gave the acetate 101 which is a known intermediate in the synthesis of iridomyrmecin 102.
72
THPO' COOCH3
96
H f
OAc 102
101
Scheme 21
3.2.3. Homer-Wadsworth-Emmons reaction. The Homer-Wadsworth-Emmons reaction is an important methodology used in the synthesis of natural products, but side reactions in many cases do not allow the application of this reaction in stereoselective synthesis. However, Nangia et al ( ref 34 ) recently described, by using the HomerWadsworth-Emmons reaction in a controlled way, the stereoselective synthesis of boschnialactone as depicted in scheme 22. R-pulegone 103 is known to give rise to a rearrangement product 104 as a mixture ofsyn and anti isomers in which (approximately 6:4) the syn one prevails.
73
C00CH3
105
104
103
/ OEt
107
106
Scheme 22 Lithium aluminium hydride reduction of the mixture 104, followed by a chromatographic purification, allowed the preparation of the alcohol 105 as pure stereoisomer. Ozonolysis in buffered conditions, using dichloromethane and sodium hydrogen carbonate, afforded the p-hydroxy alcohol 106 which has been esterified with diethylphosphonoacetic acid in the presence of DCC to the key cyclopentanoid derivative 107. The ester 107 has been submitted to the Homer-Wadsworth-Emmons reaction, using diisopropyl ethyl amine as the base in the presence of lithium chloride. Under these conditions, after 16 h the lactone 108 has been obtained in high yields in a regioselective way, without (3-elimination and a-epimerization.
74
II .OEt ^OEt
^ 0 107
108
109
Scheme 22 contd Highly stereoselective hydrogenation of 108 from the less hindered exo face of the molecule, afforded boschnialactone 109. The authors also showed the possibility, by employing suitable starting products, such as S-pulegone, to obtain iridomyrmecin, isoiridomyrmecin and teucriumlactone with the same Homer-Wadsworth-Emmons reaction.
3.2.4. Norrish I type reaction. Norbomanone-type compounds can be fragmented by a Norrish reaction giving with high stereoselectivity iridomyrmecin-like compounds. Vandewalle et al ( ref 15 ) have demonstrated an alternative route which starts from the norbomanone 3, whose synthesis has been described in scheme 1, and from its epimer 110 which has been prepared in a similar manner as reported in scheme 23. The well known endo adduct 111 of cyclopentadiene and maleic anhydride is the starting material for the preparation of nomomanone 110. The compound 111 has been reduced to the diol 112. Treatment with mchloroperbenzoic acid, in the same conditions previously described in scheme 1 for the preparation of 3, afforded the diol 113.
75
As in the case of the preparation of 3, a cyclization occurred between the two syn primary and secondary alcohoUc fiinctions, with formation of an additional heterocyUc ring.
Hcr-^
111
-f
'
-
^
HO
no
113
Scheme 23 Regioselective tosylation of the primary free alcohoHc function of 113, followed by reductive removal of the tosylate, Swem oxidation of secondary free alcoholic function and reductive cleavage of the ether bond of the tetrahydrofurane ring, gave the required norbomanone 110. Norrish I type reaction has been carried on the norbomanone-type compound 3 and on its epimer 110 (see scheme 24 ). The described procedure allowed to obtain, with satisfactory yields, the lactols 114 and 115, in which the required 4-hydroxy-3-oxobicyclo[4.3.0]nonanane-type skeleton has been prepared in a single step and in a satisfactory stereocontrolled manner. Depending on the required configuration of the methyl group on the cyclopentane ring, the lactols 114 and 115 have been manipulated as depicted in scheme 24.
76
OH
H3C
3 p-methyl llOa-methyl
9^
H3C
116
114 p-methyl 115a-methyl
ccr
H3C
109
Scheme 24 The lactol 115, after oxidation of hemiacetalic fiinction and saturation of the double bond, gave boschnialactone 109. The lactol epimer 114, on introduction of the a-methylene group by means of the Grieco's method, has been transformed into teucriumlactone 116.
References 1. J.M.Bobbitt and K.P.Segebarth, The iridoid glycosides and similar substances in, W.I.Taylor and A.R.Battersby (Ed), Cyclopentanoid terpene derivatives. Marcel Dekker hic. New York, 1969. 2. A.Bianco, The Chemistry oflridoids in, Atta-ur-Rahman (Ed), Studies in Natural Products Chemistry, Elsevier, 1990, vol. 7.
77
3. G.W.K.Cavill Insect terpenoids and nepetalactone, in, W.LTaylor and A.R.Battersby (Ed), Cyclopentanoid terpene derivatives. Marcel Dekker Inc., New York, 1969. 4. G.A.Cordell, Monoterpene alkaloids, in, R.H.Manske (Ed), The alkaloids. Academic Press, New York, 1977, vol. 16. 5. L.J.El Naggar and J.L.Beal, J. Nat Prod., 43, 649 (1980). 6. C.A.Boros and F.R.Stermitz, J. Nat. Prod., 53, 1055 (1990). 7. C.A.Boros and F.R.Stermitz, J. Nat. Prod., 54, 1055 (1991). 8. M.Luckner, Secondary metabolism in microorganism, plants, and animals, Springer-Verlag, Berlin 1990. 9. J.B.Harbome, Introduction to ecological Biochemistry, Academic Press, London, 1989. 10. H.Inouye, Iridoids, in Methods in Plant Biochemistry, Academic Press, London 1991, vol. 7. 11. S.Damtoft, Phytochemistry, 11, 1929 (1983). 12. F.Bellesia, R.grandi, U.M.Pagnoni, A.Pinetti and R.Trave, Phytochemistry, 23, 83 (1984). 13. H.Inouye and S.Uesato, Prog. Chem. Org. Nat. Prod., 50, 169 (1986). 14. P.Callant, H.De Ville and M.Vandewalle, Tetrahedron, 37, 2079 (1981). 15. P.Callant, P.Storme, E.Van der Eycken and M.Vandewalle, Tetrahedron Letters, 24, 5797 (1983). 16. T.Sakan and R.Abe, Tetrahedron Letters, 2471 (1968). 17. P.Callant, R.Ongena and M.Vandewalle, Tetrahedron, 37, 2085 (1981). 18. G.Buchi, B.Gubler, R.S.Schneider and J.Wild, J. Am. Chem. Soc, 89, 2776 (1967). 19. K.F.Bangert and V.Boekelheide, J. Am. Chem. Soc, 86, 905 (1964). 20. L.F.Tietze and T.Eicher, Reaktionen und Synthesen im organisch-chemischen Praktikum, Thieme, Stuttgart 1981, p.364. 21. L.F.Tietze, Chem. Ber., 107, 2491 (1974). 22. P.de Mayo, Ace. Chem. Res., 4, 41 (1971).
78
23. G.Buchi, J.A.Carlson, J.E.Powell and L.F.Tietze, J, Am, Chem. Soc, 92, 2165 (1970). 24. J.J.Partridge, N.K.Chadha and M.R.Uskokovic, J, Am. Chem, Soc, 95, 532 (1973). 25. L.F.TiQtzQ.Angew. Chem. Int. Ed Engl., 22, 828 (1983). 26. L.¥.TiQtzQ,Angew. Chem. Int. Ed. Engl., 12, 757 (1973). 27. L.F.Tietze, Chem. Ber., 107, 2499 (1974). 28. A.R.Battersby, N.D.Westcott, K.H.Glusenkamp and L.F.Tietze, Chem. Ber., 114, 3439(1981). 29. L.F.Tietze, R.Fischer and G.Remberg, LiebigsAnn. Chem., 971 (1987). 30. R.K.Chaudhuri, T.Ikeda and C.R.Hutchinson, J. Am. Chem. Soc, 106, 6004 (1984). 31. D.P.Curran, P.B.Jacobs, R.L.Elliot and B.H.Kim, J. Am. Chem. Soc, 109, 5280 (1987). 32. B.H.Kim, P.B.Jacobs, R.L.Elliot D and. P.Curran, Tetrahedron, 44, 3079 (1988). 33. E.Lee and C.H.Yoon, J. Chem. Soc. Chem. Commun., 479 (1994). 34. A.Nangia, G.Prasuma and P.B.Rao, Tetrahedron Letters, 35, 3755 (1994).
Current Address Professor Armandodoriano Bianco Dipartimento di Chimica - Universita La Sapienza Piazzale Aldo More 5,1-00185 Roma (Italy) Fax 39 6 490631 E-mail
[email protected]
Atta-ur-Rahman (Ed.) Studies in Natural Products Chemistry, Vol. 20 © 1998 Elsevier Science B.V. All rights reserved.
79
Chemical Constituents of Taxus Species V.S. Parmar and A. Jha 1. INTRODUCTION The genus Taxus belongs to the family Taxaceae and consists of much branched trees or shrubs. Taxaceae is a family of five genera: Amentotaxus Pilger, Austrotaxus Compton, Pseudotaxus Cheng, Taxus Linn, and Torreya Am (1). Various species of this genus are also trivially termed as yew and are specified by the region of their occurrence, e.g. Himalayan yew, European yew, Canadian yew, etc. They are evergreen shrubs or trees. The wood of Taxus is one of the heaviest of soft woods. It is also mechanically strong and durable. Its timber is oily and irregular growth rings in the wood provide decorative value. Different Taxus species have proved to be of special significance among phytochemists in recent years because they have been found to possess a number of biological activities. Taxus baccata is a poisonous plant (all parts except the fleshy aril) and has been recorded as a fish poison. Its leaves possess tremendous medicinal properties in Unani system of medicine: they are antispasmodic and emmenagogue and are used for epilepsy and as lithontriptic (2). A tincture made from young shoots has been in use for diarrhoea and severe biliousness. Vohora and Kumar in 1971 reported that the water extract of the leaves oiTaxus baccata possesses good tranquilizing activity (3). The chemical constituents of different Taxus species have been studied for over a hundred years. Taxane alkaloids, diterpenoids with taxane skeleton, lignans, biflavonoids, steroids, sugar derivatives and diterpenes possessing tropone skeleton are commonly found to occur in this genus. The phytochemistry of the genus Taxus has evoked a great deal of interest because of the occurrence of antitumour and antileukemic taxanes, molting hormones, alkaloids, antineoplastic diterpenes and other physiologically important compounds in its various species, in particular because of the importance of taxol/paclitaxel (Taxol is a registered trademark of Bristol-Myers Squibb Co., hence the generic name paclitaxel should be used instead), the world known new antitumour drug. This has made Taxus as one of the most intensely investigated genus of all the plant genera. A few reviews have appeared in the literature (4-7) on this subject while the one that covered maximum information on taxoids, the typical secondary metabolite of the yew tree was published in 1993. Phytochemistry of Taxus species, being a hot topic, a number of reports on the isolation of newer metabolites poured in thereafter. The latest review (5), to our knowledge, covers the literature on the subject from 1987 to mid 1995 and at least fifty new compounds have been reported from the species Taxus after that. There is no updated comprehensive review that enlists all the isolates from various Taxus species. Our present review covers the literature upto June 1996 listing all chemical constituents isolated from different species of Taxus giving due emphasis to the biological activities possessed by them.
80
2. TAXANE DERIVATIVES Taxanes are typical cyclic diterpenoids. A normal taxane (I) contains an eight membered ring sandwiched between two six membered rings, but there are numerous compounds which have rearranged taxane skeleta. 3,11-Cyclotaxanes (11) are tetracyclic systems with an additional bond between C-3 and C-11. Taxanes having ring system III are called 11(15—> 1) aZ?eotaxane. They have linearly fused five, seven and six membered rings. A six/ten/six membered ring system (FV) is known as 2(3—>20) abeoiaxants. An 11(15—>1), 11 (10—>9)bisabeoi^x?ine having skeleton V is also known. Compounds with skeleton VI are referred to as pretaxanes as the bond between C-3 and C-8 is not yet formed.
x < \
IV
VI
2.1 Normal Taxanes The naturally occurring diterpenoids with the taxane skeleton are the typical constituents of Taxus. The constituents of the yew became the active subject of phytochemical and synthetic work since the discovery of terpenes belonging to the taxane group (8-10). Roberto and Jelmoni (11) reported a case of poisoning following the ingestion of berries of T. baccata. The alkaloid taxine is the toxic constituent that occurs in the leaves and berries, while the aril is free of alkaloids. Taxine is in fact a mixture of at least 11 compounds, only five of which [taxine A (229) and B (70), 13-deoxo-13a-acetyloxytaxine B (30), 13deoxo-13a-acetyloxy-l-deoxytaxine B (31) and 13-deoxo-13a -acetyloxy-1-deoxy-nor-taxine B (35)] have been structually characterized so far. The action of the alkaloid was only apparent after ingestion of the berries when the latter were chewed. The leaves of T. cuspidata
81
and T. floridana also tested positive for alkaloids (12). The symptoms of taxine poisoning are mainly associated with cardiac and respiratory disturbances and death results from heart failure, accompanied by respiratory paralysis (13). The unusual diterpene, taxol (116) (14) was reported in 1971 by Wani etal. (15) as the major cytotoxic, antineoplastic (16) and antileukemic constituent occurring in yew (1719). It was found to possess confirmed activity in the L-1210, P-388 and P-1534 leukemia, the B-16 melanoma and the Walker 256 carcino-sarcoma m vivo assays. It is speculated that to some extent the activity of taxol may be due to the easily cleaved allylic a -hydroxy ester function at C-13 which may be capable of acting as a leaving group under physiological conditions. Taxol is an interesting drug in that it appears to act by a mechanism that is different from other known anticancer drugs; it has been recognized as a strong antimitotic agent (20). This important biological activity has been related to the in vitro inhibition by taxol and some of its derivatives of the depolymerization process of tubulin. It acts by promoting microtubule formation (21-23) by decreasing the lag time for microtubule assembly and shifting the equilibrium in favour of the microtubule (24). Taxol blocks the processes, essential for prostate tumour cell (PC-3ML) invasion and metastasis (25). The taxol content in various parts of several Taxus species have been determined (26-28). The activity of taxagifine (82) is lesser than that of taxol (ID^^ 5 x lO^M, cf. 10^ for taxol) (29). The taxane esters 10-deacetyltaxol (114), 7-e/7i-10-deacetyltaxol (120), 10deacetylcephalomannine (135) and 7-epr-lO-deacetylcephalomannine (138) have KB activities (ED^Q, g/ml) 2.7X10-2, 3.4x10% 3.1 X 10- and 4.6X10-2, respectively (30). 19Hydroxybaccatin III (104) was inactive in vivo in the PS mouse lymphocytic leukemia system at the doses tested (0.26-4.3 mg/kg). The greater water solubilities of these more polar taxane derivatives {Le. 114 and 135) may help to circumvent in vivo toxicities of the parent compounds and could show some clinical advantages over taxol and cephalomannine (30). The KB and P388 activities of cephalomannine (134) are roughly comparable to those of taxol (116). Cephalomannine gave typical T/C values in the range 152-180 at dose levels of 1-3.3 mg/kg against PS, while taxol showed T/C values of 148-152 in the dosage range 1.4-2.2 mg/kg. Both these compounds showed cytotoxicity (ED^^) against KB cell cultures at 10'^ g/ml, whereas baccatin III (102) had an ED^^ of 2.0 g/ml and 16-hydroxybaccatin I (92) had an ED^^ of 2.9 g/ml (31). Some of the taxoids isolated recently have been demonstrated to be equally or in some cases more potent anti-tumour agents than taxol. Taxol C (129), isolated from the bark of T.media possesses antitumour activity (e.g. IL^^ against L1210 murine leukemia cells of 3.6±0.3 nM) higher than that of taxol (e.g. 57.0±3.0 nM) and is also active against adriamycin resistant cells (32). Taxol C possesses selective cytotoxicity in the NCI human cell line screen (33). 10Deacetyltaxol C, A^-methyltaxol C (130) and taxol D (133) also showed activity close to that of taxol in the tubulin assembly assay (32,33). Table 1 lists the different taxanes isolated thus far from different Taxus species.
82
TABLE 1 Normal taxane derivatives isolated from different Taxus species. Compound
Species
References
Taxa-4(20),ll-diene-5a,9a,10p,13a-tetraol (1) T. haccata
(34,35)
16,2a,5a,9a,106,13a-Hexaliydroxytaxa4(20),ll-diene (2)
T. chinensis
(36,37)
Taxusin (3)
T. baccata T, hrevifolia T. cuspidata T. floridana T. mairei T. yunnanensis
(38,39,40) (39) (41,42) (39) (43-46) (47)
Taxa-4-(20),ll-diene-5a,76,9a,106,13apentaol pentaacetate (4)
T. haccata T. mairei
(38) (43,48,49)
Taxa-4-(20),ll-diene-2a,5a,9a,106,13apentaol pentaacetate (5)
T. baccata T. mairei
(38) (48)
Taxa-4-(20),ll-diene-2a,5a,76,9a,106,13ahexaol hexaacetate (6)
T. baccata
(38)
2-Deacetyl-5-decinnamoyltaxinine J (7)
T. canadensis T. wallichiana T. yunnanensis
(50,51) (52) (53)
Taxa-4(20),ll-diene-5a-hydroxy16,76,9a,106-tetraacetate (8)
T. baccata
(40)
5-Decinnamoyltaxinine J (9)
T. brevifolia T. yunnanensis
(54) (53)
2-Deacetoxydecinnamoyltaxinine J (10)
T. baccata T. wallichiana
(55) (56)
Decinnamoyl-l-hydroxytaxinine J (11)
T. baccata
(55)
2-Deacetyldecinnamoyltaxinine E (12)
T. baccata
(55)
Taxa-4(20),ll-diene-5a,9a,106,13a-tetraol9a,106-diacetate (13)
T. baccata T. mairei
(38) (43,48,49)
83
2a,5a,9a-Trihydroxy-10p,13a-diacetoxytaxa-4(20),ll-diene (14)
T. chinensis
(57)
16,5a-Dihydroxy-9a, 106,13ot-triacetate2a-benzoate taxa-4(20),ll-diene (15)
T. chinensis
(36,37)
16,5a, 13a-Trihydroxy-9a, 106-diacetate-2abenzoate taxa-4(20),ll-diene (16)
T. chinensis
(36,37)
Taxa-4(20),ll-diene-2a,5a,76,9a,106pentaol 7a,9a, 106-triacetate-2a-amethylbutyrate (17)
T. haccata
(38)
Taxa-4-(20),ll-diene-2a,5a,76,106-tetraolT. baccata 5a,7p,10p-triacetate-2a-a-methylbutyrate(18) T. mairei
(38) (48,49)
Taxa-4(20),ll-diene-lp,2a,5a,19-tetraol9a,10p,13a-triacetate (19)
T. chinensis
(58)
Taxinine E (20)
T. cuspidata T. mairei T. yunanensis
(59) (48) (60)
Taxinine J (21)
T. cuspidata T. mairei T. yunanensis
(59) (61,62) (47,60)
2a-Deacetoxytaxinine J (22)
T. baccata T. cuspidata T. mairei T. wallichiana T. yunnanensis
(40) (63) (61) (52,56,64) (47)
2a,13a-Dihydroxy-9a, 106-diacetoxy5a-cinnamate taxa-4(20),ll-diene (23)
T. chinensis
(58,65)
106-Hydroxy-2a,9a,13a- triacetoxy5a- ciimamate taxa-4(20),ll-diene (24)
T. chinensis
(58,65)
9a,106,13a-Triacetoxy-5a-cinnamoyltaxa-4(20),ll-diene (25)
T. chinensis T. cuspidata T. mairei
(65) (63) (66)
l-Hydroxy-2-deacetyltaxinine J (26)
T. wallichiana
(52)
2a,9a-Dihydroxy-106,13a-diacetoxy5a-cinnamate taxa-4(20),ll-diene (27)
T. media
(67)
84
2a, lOfi-Dihy droxy-9a, 13a-diacetoxy5a-cinnamate taxa-4(20),ll-diene (28)
T. media
(67)
16,13a-Dihydroxy-9a, 106-diacetate2a-benzoate-5a-cinnamatetaxa-4(20), 11-diene (29)
T. chinensis
(36,37)
13-Deoxo-13a-acetyloxytaxine B (30)
T. haccata
(68)
13-Deoxo-13a-acetyloxy-l-deoxytaxine B (31)
T. baccata
(68)
2'-Desacetoxyaustrospicatin (32)
T. baccata T. cuspidata T. wallichiana
(70) (63,71) (72)
7,2'-Didesacetoxyaustrospicatin (33)
T. cuspidata T. wallichiana
(32) (72,69)
Taxuyunnanine D (34)
T. yunnanensis
(47)
13-Deoxo-13a-acetyloxy-l-deoxy-nortaxine B (35)
T. baccata
(68)
2a-Acetoxy-2'-deacetyl-l-hydroxyaustrospicatine (36)
T. baccata
(55)
Taxuspine P (37)
T. cuspidata
(73)
Taxuyunnanine C (38)
T. chinensis T. yunnanensis
(77) (47)
Taxuyunnanine G (39)
T. yunnanensis
(74,76)
Taxuyunnanine H (40)
T.yunnanensis
(76)
Taxuyunnanine I (41)
T. yunnanensis
(76)
Taxuyunnanine J (42)
T. yunnanensis
(76)
2a,5a, lOfi-Triacetoxy- 146-propanoy 1oxy-4(20), 11-taxadiene (43)
T. chinensis
(77)
2a,5a,106-Triacetoxy-146-(2'-methyl)propanoyloxy-4(20),ll-taxadiene (44)
T. chinensis
(77)
Taiwanxan (45)
T. mairei
(78,79)
85
Taxuyunnanine B (46)
T. yunnanensis
(47)
2a,5a,106-Triacetoxy-146-(2'-methyl)butanoyloxy-4(20), 11-taxadiene (47)
T. chinensis T. cuspidata
(77) (42)
Taxa-4(20),ll-cliene-106-methoxy2a,5a-diacetoxy- 146-a-methyIbutyrate (48)
T. haccata
(40)
Yunnanxane (49)
T. chinensis T. yunanensis
(77) (60,80)
Taxinine A (50)
T. chinensis T. cuspidata
(81) (63,82,83)
76-Acetoxytaxinine A (51)
T. mairei
(48)
Taxinine H (52)
T. cuspidata
(84)
2,10-Di-O-acetyl-5-decinnamoyltaxicin I (53)
T. baccata
(55)
Triacetyl-5-decinnamoyltaxicin I (54)
T. baccata
(55)
Taxuspine F (55)
T. cuspidata
(32)
Taxuspine G (56)
T. cuspidata
(32)
9a,10p-Diacetyltaxicin I (57)
T. cuspidata
(85)
5-Cinnamoyltaxincin I triacetate (58)
T. cuspidata
(63)
10-Deacetyltaxinine B (59)
T. cuspidata
(83)
2-0-Acetyl-5-0-cinnamoyltaxicin I (60)
T. baccata
(86)
Taxinine (61)
T. T. T. T.
(87,88) (81) (63,71,75,83,84,89-91) (43)
Taxinine B (62)
T. cuspidata
(59,63,71,75,83,89,91)
5-Cinnamoyl-9,10-diacetyltaxicin I (63)
T. baccata
(92)
5-Cinnamoyl-9-acetyltaxicin-I (64)
T. baccata
(93)
5-Cinnamoyl- 10-acetyltaxicin-I (65)
T. baccata
(93)
5-Cinnamoyl-9-acetyltaxicin-II (66)
T. baccata
(93)
canadensis chinensis cuspidata mairei
86
5-Cinnamoyl-10-acetyltaxicin-II(67)
T. haccata
(93)
l,9a-Dihydroxy-2a,106-diacetoxyT. media 5a-cinnamoyltaxa-4(20),ll-diene-13-one(68)
(67)
l,106-Dihydroxy-2a,9a-diacetoxyT. media 5a-cinnamoyltaxa-4(20),ll-diene-13-one(69)
(67)
Taxine B (70)
T. haccata
(94,95)
Taxinell (71)
T. haccata T. cuspidata
(96) (63,89)
Taxine I (72)
T. haccata
(95,97,98)
2,9-Dideacetyltaxine II (73)
T. haccata
(99)
9-Deacetyltaxine I (74)
T. haccata
(99)
2,10-Dideacetyltaxine II (75)
T. haccata
(99)
10-Deacetyltaxine I (76)
T. haccata
(99)
5-Decinnamoyltaxagifine (77)
T. canadensis T. chinensis
(50,51) (100)
5-Decinnamoyl-5-acetyltaxagifine(78)
T. chinensis
(100)
Taxinine M (79)
T. hrevifolia T. cuspidata
(101) (83)
2-Deacetyl-5-decinnamoyltaxagifine (80)
T. canadensis T. chinensis
(50) (65)
19-Debenzoyl-19-acetyltaxinine M (81)
T. wallichiana
(102)
Taxagifine (82)
T. haccata T. cuspidata
(29,35) (83,103)
Taxacin (83)
T. cupsidata
(83,103)
5-Decinnamoyl-ll-acetyl-19-hydroxytaxigifine (84)
T. yunnanensis
(53)
Taxuspine L (85)
71 cuspidata
(104)
TaxchinA (86)
T. chienensis
(105,106)
Taxchin B (87)
T. chienensis
(105,106)
87
5a,76,9a,106,13a-Pentaacetoxy-2abenzoyloxy-4a,20-dihydroxytax-l 1-ene (88)
T. mairei
(107)
7B,9a,106,13a,20-Pentaacetoxy-2abenzoyloxy-4a,5a-dihydroxytax-ll-ene (89)
T. mairei
(107)
Taxumairol A (90)
T. mairei
(108)
Baccatin I (91)
T. baccata
(34,109)
16-Hydroxybaccatin I (92)
T. T. T. T.
(109) (110) (48) (31,64)
16-Hydroxy-7-deacetylbaccatin I (93)
T. baccata T. brevifolia T. media
(111) (112,113) (114)
ip-Hydroxy-7,9-dideacetylbaccatin I (94)
T. canadensis T. chinensis T. mairei
(51) (115) (108)
5-Deacetylbaccatin I (95)
T. baccata T. yunanensis
(109) (116)
16-Acetoxy-5,7,10-deacetylbaccatin I (96)
T. canadensis
(50,117)
16-Hydroxy-2,5,7,10-tetradeacetylbaccatin I (97)
T. chinensis
(58)
l-Acetoxy-5-deacetylbaccatin I (98)
T. mairei T. yunanensis
(108,118) (60)
l-Hydroxy-2,7,9-trideacetylbaccatin I (99)
T. yunnanensis
(53)
16,9a-Dihydroxy-46,20-epoxy-2a,5a,76,106, 13a-pentacetoxy-tax-ll-ene (100)
T. brevifolia
(112)
76-Acetoxy-9-acetylspicataxine(101)
T. media
(119)
Baccatin III (102)
T. baccata T. brevifolia T. cuspidata T. yunanensis
(34,43,111,120-123) (124,125) (19) (60,126)
Baccatin V (103)
T. baccata
(127,128)
baccata chinensis mairei wallichiana
19-Hydroxybaccatin III (104)
71 haccata T. chinensis T. wallichiana T. yunanensis
(35) (36) (30) (116)
10-Deacetylbaccatin III (105)
T. haccata T. brevifolia T. canadensis T. cuspidata T. wallichiana T. yunanensis
(122,129-131) (54,111,125,132,133) (50,51) (83) (52,134) (116,135)
9-Hydroxy-lO-deacetylbaccatin III (106)
T. haccata
(136)
1-Acetyl-lO-deacetylbaccatin III (107)
T. canadensis
(50)
l-Dehydroxybaccatin III (108)
T. yunanensis
(116)
7-epi-lO-Deacetylbaccatin III (109)
T. canadensis
(51)
7-Xylosyl-lO-deacetoxybaccatin III (110)
T. yunnanensis
(53)
19-Hydroxy-7-e/7i-baccatin III (111)
T. chinensis
(137)
13-e;?i-10-Deacetylbaccatin III (112)
T. haccata
(123)
2-Debenzoyl-2-tigloyl-10-deacetylbaccatin III (113)
T. haccata
(123)
10-Deacetyltaxol (114)
T. haccata T. hrevifolia T. canadensis T. cuspidata T. wallichiana T. yunnanensis
(35) (124,125) (51) (83) (30) (135,138)
106-Hydroxybutyrate-lO-deacetyltaxol A (115^) T. haccata
(111)
Paclitaxel [Taxol (116)]
(15,17,26,35,111, 122,130,139,140) (124,125,132,141,142) (50,51) (143,144) (15,17,19,26,63,83,91) (17,26) (31,52,134) (60,126,138,145,146)
T. haccata T. hrevifolia T. canadensis T. chinensis T. cuspidata T. media T. wallichiana T, yunnanensis
89 7-Xylosyl-lO-deacetyltaxol A (117)
T. baccata T. yunanensis
(111) (60)
7"Xylosyltaxol A (118)
T. baccata
(111)
7-epi-Taxo\ (119)
T. brevifolia T. canadensis
(147) (51)
7-ep/-10-Deacetyltaxol (120)
T. yunnanensis
(135)
lO-Deacetyltaxol-7-xyloside (121)
T. baccata T. brevifolia T. wallichiana T. yunnanensis
(70) (125,132) (52) (60)
7-Xylosyltaxol (122)
T. brevifolia T. yunnanensis T. wallichiana
(132) (53) (52)
10-Deacetyltaxol-2',7-diacetate(123)
T. brevifolia
(54)
Taxol-2',7- diacetate (124)
T. brevifolia
(54)
Yunnanxol (125)
T. yunnanensis
(145)
7-Epitaxuyannanine A (126)
T. yunnanensis
(138)
7-Epi-lO-deacetyltaxuyannanine A (127)
T. yunnanensis
(138)
10-Deacetyltaxuyannanine A (128)
T. yunnanenis
(138)
Taxol C (129)
T. media T. yunnanensis
(148) (149)
A^-Methyltaxol C (130)
T. media
(148)
7-Xylosyltaxol C (131)
T. baccata
(111)
7-Xylosyl-lO-deacetyltaxol C (132)
T. baccata T. wallichiana
(70,111) (52)
A^-Debenzoyl-A^-butanoyltaxol [Taxol D (133)] T. media
(119)
Cephalomannine (134)
(35,120,122,150) (124,125,132,151,152) (50,51) (19,83)
T. T. T. T.
baccata brevifolia canadensis cuspidata
90 T. wallichiana T. yunnanensis
(31,52,134) (60,126,138,145)
10-Deacetylcephalomannine (135)
T. haccata T. brevifolia T. cuspidata T. wallichiana T. yunnanensis
(35) (124) (83) (30) (135,138)
lO-ft-Hydroxybutyrate-lO-deacetyltaxol B (136)
T. haccata
(111)
7-ep/-Cephalomanine (137)
T. media
(153)
7-e/7/- 10-Deacetylcephalomannine (138)
T, yunnanensis
(135)
7-Xylosyl-lO-deacetyltaxol B (139)
T. haccata
(HI)
7-Xylosyltaxol B (140)
T.haccata
(111)
lO-Deacetylcephalomannine-7-xyloside (141)
T. hrevifolia
(132)
146-Hydroxy-lO-deacetylbaccatin III (142)
T. wallichiana
(154)
2-Debenzoyl-146-benzoyloxy10-deacetylbaccatin III (143)
T. wallichiana
(155)
10-Deacetyl-lO-oxo-baccatin V(144)
T. chinensis
(137)
lO-Deacetyl-lO-dehydro-7-acetyltaxol A (145) T. media
(114)
10-Deacetyl-10-oxo-7-e;?f-taxol(146)
T. hrevifolia
(147)
7 -Xylosyl-10-deacatyltaxol D (147)
T. haccata
(70)
10-Deacetyl- 10-oxo-7-e/7/taxuyannanine A (148)
T. yunnanensis
(138)
Baccatin IV (149)
T. T. T. T.
(34,121) (113) (61) (64)
Baccatin VI (150)
T. haccata
(111,121)
l-Dehydroxybaccatin IV (151)
T. haccata T. mairei
(121) (44,49,61)
haccata hrevifolia mairei wallichiana
91
1-Acetylbaccatin IV (152)
T. yunanensis
(116)
4-Deacetylbaccatin IV (153)
T. media
(119)
l-Dehydroxy-4-deacetylbaccatin IV (154)
T. mairei
(118)
7,9-Deacetylbaccatin IV (155)
T. brevifolia T. canadensis
(113) (51)
1-Dehydroxybaccatin VI (156)
T. mairei
(62)
9-Dihydro-13-acetylbaccatin III (157)
T. brevifolia T. canadensis T. chinensis
(113) (50,51,156) (115)
lO-Hydroxyacetylbaccatin VI (158)
T. canadensis
(51)
7,9,10-Trideacetylbaccatin VI (159)
T. canadensis
(51)
7-e'/7/-9,10-Trideacetylbaccatin VI (160)
T. canadensis
(51)
Taxuspine E (161)
T. cuspidata
(32)
9p-//-9-Dihydro-19-acetoxy-10-deacetylbaccatin III (162)
T. baccata
(86)
9,10-Dideacetyl-9,10-dibenzoylbaccatin VI (163)
T. brevifolia
(157)
10-Deacetyl-lO-benzoylbaccatin VI (164)
T. brevifolia
(157)
7-Deacetyl-7-benzoylbaccatin VI (165)
T. brevifolia
(157)
Baccatin VII (166)
T. baccata
(121)
Taxuspine N (167)
T. cuspidata
(73)
Yunnanxamine (168)
T. yunnanensis
(145)
Taxagifine III (169)
T. chinensis
(65)
4-Deacetyltaxagifine-III (170)
T. chinensis
(65)
Taxuspine K (171)
T. cuspidata
(104)
92
1
R-|=R3=R4=R5~OH, R2=R6=R7=H
2
R-|=R3=R4=R5=R6=R7=OH, R2=H
3
Ri=R3=R4=R5=OAc, R2=R6=R7=H
4
Ri=R2=R3=R4=R5=OAc, R6=R7=H
5
R-|=R3=R4=R5=R7=OAc, R2=R6=H
6
Ri=R2=R3=R4=R5=R7=OAc, R6=H
7
Ri=R7=0H, R2=R3=R4=R5=OAc, R6=H
8
Ri=OH, R2=R3=R4=R6=OAc, R5=R7=H
9
Ri=OH, R2=R3=R4=R5=R7=OAc, R6=H
10 Ri=OH, R2=R3=R4=R5=OAc, R6=R7=H 11 R-,=R6=0H, R2=R3=R4=R5=R7=OAc 12 Ri=R7=0H, R2=R6=H, R3=R4=R5=OAc 13 Ri=R5=0H, R2=R6=R7=H, R3=R4=OAc 14 R-,=R3=R7=OH, R2=R6=H, R4=R5=OAc 15 Ri=R6=0H, R2=H, R3=R4=R5=OAc, R7=0Bz 16 Ri=R5=R6=OH, R2=H, R3=:R4=OAc. R7=0Bz 17 Ri=OH, R2=R3=R4=OAc, R5=R6=H, R7=OCOCH(CH3)C2H5 18 Ri=R2=R4=OAc, R3=R5=R6=H, R7=OCOCH(CH3)C2H5
21
Ri =:R5=H, R2=R3=R4=R6=0AC Ri =:R2=R3=R4=R6=OAc, R5=H
22
Ri =:R2=R3=R4=0AC, R5=R6=H
23
Ri =:R5=H, R2=R3=OAc, R4=R6=OH
20
24 Ry- :R5=H, R2=R4=R6=OAc, R3=0H 25
Ri =:R5=R6=H, R2=R3=R4=OAC
Ry. :R2=R3=R4=OAc, R5=R6=OH 27 Ry. :R5=H, R2=R6=OH, R3=R4=OAc 28 Ry ;R5=H, R2=R4=OAc, R3=R6=OH 29 Ry :H, R2=R3=OAc, R4=R5=OH, R6=0Bz 26
93 AcO
AcO
.OH
R3
R2
Ri
AcO\^^^* R5 Re 30 Ri=H, R2=R5=R6=OH. R3=R4=OAc 31 Ri=R5=H, R2=R6=OH, R3=R4=OAc 32 Ri=R2=R3=R4=OAc, R5=R6=H 33 Ri=R5=R6=H, R2=R3=R4=OAc
19
DAc
AcO\^^^^
AcO.
OH
34
Aca 35 AcO AcO
oAc O
^ H ^
AcO
AcO
OAc OAc
AcO OAc 37
94 R3
R2
38 Ri :R3P=R4: R5=0Ac, R2=H 39 Ri :R5=0AC, R2=H, R3ft=R4=OH 40 Ri =R3p=0H R2=H, R4=OCOC2H5,R5=OAc 41 Ri =R3p=0H R2=H, R4=OCOCH(CH3)2. R5=0Ac 42 Ri =OAc, R2 R5=H, R3p=R4=OH 43 Ri =R3p=R5=|OAc, R2=H, R4=OCOC2H5 44 Ri =R3p=R5='OAc, R2=H, R4=OCOCH(CH3)2 45 Ri OH, R2:R3p=R5=OAc, R4=OCOCH(CH3)C2H5 46 Ri R2=R3p= R5=0Ac. R4=OCOCH(CH3)C2H5 47 Ri R3p=R5=OAc, R2=H, R4=OCOCH(CH3)G2H5 48 Ri R5=0AC , R2=H, R3p=OCH3. R4=OCOCH(CH3)C2H5 49 Ri :R3P=R! '5=OAc, R2=H, R4=OCOCH(CH3)CH(OH)CH3 R4
R5
50 51 52 53 54 55 56 57
R3
R2
^6
Ri=OH, R2=R5=H, R3=R4=R6=OAc Ri=OH, R2=R3=R4=R6=OAc, R5=H Ri=R3=R4=R6=OAc, R2=R5=H Ri=R3=R5=OH, R2=H, R4=R6=OAc Ri=R5=0H, R2=H, R3=R4=R6=OAc Ri=OH. R2=R3=R4=R6=OAc, R5=H Ri=R6=0H, R2=R5=H, R3=R4=OAc Ri=R5=R6=OH, R2=H, R3=R4=OAc
95 R3
R2
58 59 60 61 62 63 64 65 66 67 68
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
69
Ri = H, R2=R5=OAc, R3=R4=OH
R2
70 71 72 73 74 75 76
H, R2=R3=R5=OAc, R4=0H R2=R5=OAc, R3=0H, R4=H H, R2=R3=R4=OH, R5=0Ac R4=H. R2=R3=R5=OAC R2=R3=R5=OAc, R4=H H, R2=R3=OAc, R4=R5=OH H, R2=0Ac, R3=R4=R5=OH H. R2=R4=R5=OH, R3=0Ac R4=H, R2=0Ac, R3=R5=OH R4=H, R2=R5=OH, R3=0Ac H, R2=R4=OH. R3=R5=OAc
Ri
Ri=R2=R3=OH, R4=0Ac Ri=R2=R4=OAc, R3=H Ri=R2=R4=OAc, R3=0H Ri=R4=0H. R2=0Ac, R3=H Ri=R3=0H. R2=R4=OAc Ri=OAc, R2=R4=OH, R3=H Ri=R4=0Ac, R2=R3=OH
77 R i = R 4 = 0 H , R2=H, R3=0Ac 78 Ri=R3=0Ac, R2=H. R4=0H 79 Ri=R4=0H, R2=0Bz, R3=0Ac 80 Ri=R3=R4=OH, R2=H 81 Ri=R4=0H, R2=R3=OAc 82 Ri=OCOCH:CHPh, R2=H, R3=0Ac, R4=0H 83 Ri=OCOCH:CHPh, R2=0Bz, R3=0Ac, R4=0H 84 Ri=R2=0H, R3=R4=OAc
96 85 Ri :R4=0Ac, R2=H, R3=0H 86 Ri O H , R2=H, R3=R4=OAc 8 7 R i =:R4=0Ac. R2=H, R3=0C0CH:CHPh 88 Ri :OBz, R2=R3=OH, R4=0Ac 89 Ri :OBz, R2=R4=OH, R3=0Ac 90 Ri :R2=0H, R3=0Bz, R4=0Ac
91 92 93 94 95 96 97 98 99
OAc OAc
AcQ
AcO^^^^"
=R2=R3=R4=R5=R7=OAc, R6=H =R2=R3=R4=R5=R7=OAC, R6=0H =R3=R4=R5=R7=0AC, R2=R6=OH =R4=R5=R7=OAC, R2=R3=R6=OH =0H,
R2=R3=R4=R5=Fl7=OAc, R6=H
=R2=R4=OH, R3=R5=R6=R7=OAC =R2=R4=R6=R7=OH, R3=R5=OAc =0H,
Rs^^^"
R2=R3=R4=R5=R6=R7=OAc
=R4=R5=0AC, R2=R3=R6=R7=OH
100 R =R2=R4=R5=R7=OAc, R3=R6=OH 101 R =OCOCH2CH(Ph)NMe2. R2=R3=R4=R5=R7=OAc. R6=H
102 R
=R4^=R5=OH, R2=H, R3=0AC
103 R
=R4a=R5=OH. R2=H, R3=0Ac
104 R
=R2=R4a=R5=OH, R3=0AC
105 R
=R3=R4^^=R5=OH, R2=H
106 R
=R2=R3=R4a=R5=OH
107 R
=R3=R4a=OH, R2=H, R5=0AC
108 R
=R4„=0H, R2=R5=H, R3=0Ac
109 R
=R3=R4ot=R5=OH, R2=H
110 R
=axylosyl, R2=R3=H, R4„=R5=OH
111 R
= R2=R4a=R5=OH, R3=0AC
112
=R3=R4p=R5=OH, R2=H
R
R.
HO^^^
\
OH t)
113
OAc
t)Bz OAc
97
114Rip=R2=OH, R3=0Bz 115 Rip=OH. R2=OCOCH2CH(OH)CH3. R3=0Ac 116 Rip=OH, R2=0Ac, R3=0Bz 117 Rip=axylosyl, R2=0H, R3=0Ac 118 Rip=0-xylosyl, R2=R3=0Ac 119 Ri«=OH, R2=0Ac, R3=0Bz 120 Ri„=R2=0H. R3=0Bz 121 Rip=axylosyl, R2=0H, R3=0Bz 122 Rip=axylosyl, R2=0Ac, R3=0Bz R
AcO
P
OAc
OH t)Bz OAc
123 R=OH 124R=OAc
OH t)Bz OAc
125
126 Ria=OH, R2=0Ac, R3=H 127 Ri^=R2=0H, R3=H 128 Rip=R2=0H, R3=H
C51
129 Rip=OH, R2=0Ac, R3=H 130 Rip=OH, R2=0Ac, R3=CH3
Ph-
131 Rip=0-xylosyl, R2=OAc, R3=H 132 Rip=0-xylosyl, R2=OH, R3=H
OH t)Bz OAc
98 Acq
o
OH R3
OAc
134 Rip=OH. R2=0Ac, R3=0Bz 135 Rip=R2=0H, R3=0Bz 136 Rip=OH, R2=OCOCH2CH(OH)CH3, R3=0Ac 137 Ria=OH, R2=0Ac, R3=0Bz 138 Ri„=R2=0H. R3=0Bz 139 Rip=0-xylosyl, R2=OH, R3=OAc 140 Rip=0-xylosyl, R2=R3=0Ac 141 Rip=0-xylosyl. R2=OH, R3=OBz
142 Rip=R3=R4=R5=R6=OH. R2=H, R7=0Bz 143 Rip=R3=R4=R6=R7=OH. R2=H, R5=0Bz 144 Rip=R4=R6=OH, R2+R3=0, R5=H 145 Rip=OAc, R2+R3=0, R4=0C0CH(0H)CH(Ph)NHBz, R5=H, R6=0H, R7=0Bz 146 Ria=OH. R2+R3= =0, R4=0C0CH(0H)CH(Ph)NHBz, R5=R6=H, R7=0Bz 147 Rip=0-xylosyl. R2=R5=H, R3=R6=OH. R4=0C0CH(0H)CH(Ph)NHC0C3H7, R7=0Bz 148 Ria=OH. R5=R6=H, R2+R3= =0. R4=OCOCH(OH)CH(Ph)NHCOC5Hii, R7=0Bz
99 R4
149 150 151 152 153 154 155 156
Ra
=R2p=R3=R4=R5=R7=OAc, R6=0H, R8=H =R2p=R3=R4=R5=OAc, R6=0H, R7=0Bz. R8=H =R2p=R3=R4=R5=R7=OAC, R6=R8=H =R2p=R3=R4=R5=R6=R7=OAC, R8=H =R6=0H, R2p=R3=R4=R5=R7=OAc, R8=H = 0 H , R2p=R3=R4=R5=R7=OAc, R6=R8=H =R4=R5=R7=0AC, R2p=R3=R6=OH, R8=H =R2p=R3=R4=R5=OAc, R6=R8=H, R7=0Bz
157
R =R4=R5=OAc, R2p=R3=R6=OH, R7=0Bz, R8=H
158 159 160 161 162 163 164 165 166 167 168
R =R2p=R3=R5=OAc, R4=R6=OH, R7=0Bz, R8=H =R5=0Ac, R2a=R3=R4=R6=OH, R7=0Bz, R8=H =R5=0Ac, R2p=R3=R4=R6=OH, R7=0Bz, R8=H =R2p=0Ac, R3=R4=R5=R6=OH, R7=0Bz, R8=H =R8=0Ac, R2p=R3=R4=R5=R6=OH. R7=0Bz =R2p=R5=OAc, R3=R4=R7=OBz. R6=0H, R8=H
R R R R R
=R2p=R3=R5=OAc, R3=R7=OBz, R6=0H, R8=H =R3=R4=R5=0AC, R2p=R7=OBz, R6=0H, R8=H =R6=0H, R2p=R3=R4=R5=OAc, R7=OCOC5Hii, R8=H =R2p=R3=R7=OAc. R4=0Bz, R5=OCOCH2CH(Ph)NMe2, R6=0H, R8=H =R4=0Ac, R2p=R3=R6=OH, R5=0C0CH(0H)CH(Ph)NHBz, R7=0Bz, R8=H
Acq
g>Ac
AcO^^^'
HO^^^"
OH
169 R=OAc 170 R=OH
O
171
oAc
100
2.2 3,11 'Cyclotaxanes 3,11-Cyclotaxanes (Table 2) can be formed upon irradiation of corresponding 13-oxotaxa-11-enes (63,86,158). However, such naturally occurring compounds have^"- geometry in the cinnamoyl side chain, while the irradiated products are a mixture of E- and Zdiastereoisomers. Thus, it is difficult to infer that these compounds are artefacts. TABLE 2 3,11-Cyclotaxanes isolated from different Taxus species. Compound
Species
Taxinine K (172)
T. cuspidata
(82)
Taxinine L (173)
T. cuspidata
(82)
5-Cinnamoyl-lO-acetylphototaxicin I (174)
T. baccata
(158,159)
Taxuspine C (175)
T. cuspidata
(63)
References
9-0-Acetyl-5-0-Cinnamoylphototaxicin I (176) T. baccata
(86)
Taxuspine H (177)
(32)
172 173 174 175 176 177
T. cuspidata
Ri=OH, R2=R3=R5=OAc, R4=H Ri=R2=R3=R5=OAc, R4=H Ri=OCOCH:CHPh, R2=R4=R5=OH, R3=0Ac Ri=OCOCH:CHPh, R2=R3=R5=OAc, R4=H Ri=OCOCH:CHPh, R2=0Ac, R3=R4=R5=OH Ri=OCOCH2CH(NMe2)Ph, R2=R3=R5=OAc, R4= :H
2.3 11(15—>l)-Abeotaxanes A number of taxoids isolated from different Taxus species, on structural reinvestigation were found to contain a rearranged nortaxoid skeleton or 11(15—>iyabeo taxoids, as they are more correctly described (133,160,161) and not a taxane skeleton as originally proposed. Brevifoliol (181) was the first natural taxoid with 11(15—>iyabeoiaxant skeleton which was initially assigned a normal taxane skeleton (162) but was later corrected to the
101
11(15—>l)-a6eotaxane skeleton (57,133,163). In a similar way a number of taxoids whose basic structure, based upon their spectroscopic data were previously reported as derivatives of originally proposed structure of brevifoliol with the normal taxane skeleton or by considering them as baccatin VI derivatives have now been proposed to be rearranged 11(15—>l)-abeotaxanes (mainly by HMBC spectrum and X-ray studies). Taxchinin A (189) was the first naturally occurring taxoid to be correctly assigned the 11(15—>l)-flbeotaxane skeleton (164) and that with an oxetane ring was taxchinin B (220) (137). However, the fact that the first example of a taxoid with 11(15—>l)-afee(9taxane skeleton was a rearrangement product of taxol (19) raises the question as to whether all these compounds are simply artefacts. Although this possibility cannot be completely ruled out, the fact that the rearranged taxoids are being obtained from different species by different research groups, coupled with the fact that rearrangement of taxol requires rather vigorous conditions, suggests that some, if not all of the isolated nortaxoids are genuine natural products. Table 3 contains 11(15—>l)-a6eotaxanes isolated so far from various species of yew. TABLE 3 11(15—>l)-A/?eotaxanes isolated from different Taxus species. Compound
Species
References
Taxchinin D (178)
T. chienensis
(105,106)
Taxchinin E (179)
T. chienensis
(106,165)
Taxchinin G (180)
T. chienensis
(105,106)
Brevifoliol (181)
T. hrevifolia T. wallichiana
(125,133,162) (134)
13-Acetylbrevifoliol (182)
T. hrevifolia T. wallichiana
(133) (64)
9-Deacetyl-9-benzoyl-10-debenzoylbrevifoliol (183)
T. hrevifolia
(160)
10-Debenzoyl-2a-acetoxybrevifoliol (184)
T. wallichiana
(102)
7-Deacetoxy-lO-debenzoylbrevifoliol (185)
T. wallichiana
(161,166)
10-Debenzoylbrevifoliol (186)
T. wallichiana
(161,166)
2a-Acetoxy-7-deacetoxy-10-debenzoylbrevifoliol (187)
T. haccata
(86,161)
9-Deacetyl-9-benzoyl-10-debenzoyltaxichinA(188)
T. haccata
(131)
102 Taxchinin A (189)
T. baccata T. chinensis T. wallichiana
(98,161,167) (137,164) (64,134)
106-Benzoyloxy-16-hydroxy-5a-(3'-dimethyl- T. brevifolia amino-3'-phenylpropanoyloxy-76,9a,13atriacetoxy-ll(15—>l)-fl^eotaxa-4(20),lldiene (190)
(133)
106-Benzoyloxy-16-hydroxy-5a-(3'-methylamino-3'-phenyl)-propanoyloxy-76,9a,13atriacetoxy-ll(15—>l)-aZ?eotaxa-4(20),lldiene (191)
T. brevifolia
(133)
Taxuspine A (192)
T. brevifolia T. cuspidata
(133) (63)
Taxchinin H (193)
T. chienensis T. wallichiana
(106,165) (102)
Taxuspine J (194)
T. cuspidata
(32)
Taxuspine M (195)
T. cuspidata
(104)
Taxacustone (196)
T. cuspidata
(85)
Taxuspine 0 (197)
T. cuspidata
(73)
5 -0-(6-£)-Glucopyranosyl)106-benzoyltaxacustone (198)
T. cuspidata
(85)
Taxayuntin G (199)
T. yunnanensis
(168)
Yunantaxusin A (200)
T. yunnanensis
(169)
TaxuchinA(201)
T. chinensis
(110)
Taxacustin (202)
T. cuspidata T. wallichiana
(83) (52)
7,9,10-TrideacetylflZ7eobaccatin VI (203)
T. baccata
(92)
Taxayuntin (204)
T. baccata T. cuspidata T. wallichiana T. yunnanensis
(170) (83) (52) (145,171,172)
103
7,13-Dideacetyl-9,10-didebenzoyltaxchinin C (205)
T. brevifolia
(160)
4-Deacetyl-9,10-didebenzoyl-9,10diacetyltaxchinin C (206)
T. media
(72)
10-Debenzoyltaxchinin C (207)
T. media
(72)
10-Debenzoyl-lO-acetyltaxchinin C (208)
T. media
(72)
Taxchinin K (209)
T. chienensis
(106,165)
Taxchinin I (210)
T. chienensis
(106,165)
Taxuyunnanine F (211)
T. yunnanensis
(172,173)
10,13-Deacetyl a^eobaccatin IV (212)
T. wallichiana
(174)
Taxayuntin E (213)
T. yunnanensis
(175)
Taxayuntin F (214)
T. yunnanensis
(175)
Taxayuntin A (215)
T. yunnanensis
(176)
13-Acetyl-13-decinnamoyltaxchinin B (216)
T. baccata
(177)
7, 9-Dideacetyltaxayuntin (217)
T. yunnanensis
(178)
10-Benzoyloxy-2,4-diacetoxy-5,20-epoxyl,7,9,13-tetrahydroxy-ll(15—>1)abeoiaxsine (218)
T.brevifolia
(113)
Taxchinin C (219)
T. chinensis
(137)
Taxchinin B (220)
T. chinensis T. cuspidata
(137) (16)
Taxchinin J (221)
T. chienensis
(106,165)
13-Deacetoxy-13,15-epoxy-ll(15—>1)abeo-13-epi-b^cc2iim VI (222)
T. media
(72)
10,15-Epoxy-ll(15—>l)-fl^^o10-deacetylbaccatin III (223)
T. wallichiana
(155)
Taxuyunnanine E (224)
T. yunnanensis
(172,173)
104
178 179 180 181 182 183 184 185 186 187 188 189 190 191
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
O H , R2=R3=R5=R6=OAc, R4=0Bz : 0 H . R2=R3=R6=OAc. R4=0Bz, R5=0C0CH:CHPh :R4=0H, R2=R3=R5=R6=OAc :R5=0H, R2=R3=OAc. R4=0Bz, Re^H OH, R2=R3=R5=OAc, R4=0B2, R6=H :R4=R5=OH, R2=0Ac. R3=0Bz, R6=H :R4=R5=OH, R2=R3=R6=OAC :R4=R5=OH, R2=R6=H, R3=0AC :R4=R5=OH, R2=R3=OAc, R Q ^ H
R.^^^^"'
:R4=R5=OH, R 2 = H . R 3 = R 6 = 0 A C :R4=R5=OH, R 2 = R 6 = O A C , R 3 = 0 B Z :R5=0H, R 2 = R 3 = R 6 = O A C , R 4 = 0 B Z
OCOCH2CH(Ph)NMe2, R2=R3=R5=OAc, R4=0Bz, R6=H Ri=
192
Ri=R2=R4=OAc, R3=0Bz, R5=H
193
Ri=R2=0Ac, R3=0Bz. R4=0H. R5=H
194
Ri=R2=R3=R4=OAc. R5=H
195
Ri=R2=R4=OAc, R3=0H. R5=H
OAc
PAC R3
196 R i = R 3 = 0 H , R2=H 197 R i = R 2 = 0 H , R3=0Ac
199
198 Ri=0-D-glucosyl, R2=H, R3=OBz
200 Ri=R5=0H. R2=R3=OAc, R4=0Bz
R i = H , R2=R4=OH, R3=R5=OAc
105
AcQ
QAc
OAc AcQ
pAc
OAc
t>Ac
Aca 201
222
9
OH
223 202 R =R2=R3=R6=OAc, R4=R5=OH 203 R =R5=0Ac, R2=R3=R4=OH, R6=0Bz 204 R =R2=R3=R6=OAc, R4=0Bz, R5=0H 205
=OAc, R2=R3=R4=R5=OH, R6=0Bz
206
= 0 H , R2=R3=R4=R5=OAc, R6=0Bz
207
=R2=R5=OAc, R3=R6=OBz, R4=0H
208
=R2=R4=R5=OAc, R3=R6=OBz
209
=R2=R5=R6=OAc, R3=R4=OBz
210
=R2=R5=OAc, R3=R6=OBz, R4=0H
211
=R2=R3=R5=R6=OAc, R4=0H
212
=R2=R3=R6=OAc, R4=R5=OH
213
=R2=R3=OAc, R4=R5=OH, R6=0Bz
214
=R2=R6=OAc, R3=0Bz, R4=R5=OH
215
=OAc, R2=R6=OBz, R3=R4=R5=OH
216
=R2=R3=R5=R6=OAc, R4=0Bz
217 218 219 220 221
R R R R R
PBz
AcO^^^"'
=R6=0Ac, R2=R3=R5=OH, R4=0Bz =R6=0Ac, R2=R3=R5=OH, R4=0Bz =R2=R5=OAc, R3=R4=R6=OBz =R2=R3=R6=OAc, R4=0Bz, R5=0C0CH:CHPh =R2=R6=OAc, R3=0Bz, R4=0H, R5=0C0CH:CHPh
224
OAc
106
2.4 2(3—>20)-Aheotaxanes These compounds have a distinct biogenetic origin than the other taxoids, resulting from a transannular cyclisation, which is different from that involved in the formation of normal taxanes (92). They are tricyclic systems with a ten membered ring sandwiched between two six membered rings. Isolates of this class from Taxus species are listed in Table 4. TABLE 4 2(3—>20) A^eotaxanes isolated from different Taxus species. Compound
Species
References
Taxin B (225)
71 yunnanensis
(179)
2-Deacetyltaxin B (226)
T. yunnanensis
(179)
Deaminoacyltaxine A (227)
T. baccata
(92)
Taxuspine B (228)
T. cuspidata
(63)
Taxine A (229)
T. cuspidata
(180,181)
7-0-Acetyltaxine A (230)
T. baccata
(55)
2-Deacetyltaxine A (231)
T. baccata
(55,182)
AcOl'"
225 226 227 228 229 230 231
Ri=OH, R2=R3=R4=OAc Ri=R4=0H, R2=R3=OAc Ri=R2=R3=OH, R4=0Ac Ri=OCOCH:CHPh. R2=R4=OAc, R3=0H Ri=0C0CH(0H)CH(NMe2)Ph, R2=R3=OH, R4=0Ac Ri=0C0CH(0H)CH(NMe2)Ph, R2=R4=OAc, R3=0H Ri=0C0CH(0H)CH(NMe2)Ph, R2=R3=R4=OH
107
2.5 11(15—>1), 11(10—>9) Bisabeotaxane The only known taxoid with 11(15—>1), 11(10—>9)bisabeoi?iX?Lnt skeleton is wallifoliol (232) from T. wallichiana (134). A benzil-benzilic acid type rearrangement of 10-dehydro10-deacetyl-11(15—>l)-flfeeobaccatin III (A) might be the biosynthetic pathway of this compound. OH
HO""
AcO
232
2.6 Pretaxoids Paclitaxel, because of its unique mode of action and enormous medicinal potential is under an intensive research effort. The core structure of taxol consists of four rings (six membered A and C rings, eight membered B ring and four membered D ring) and a very little is known about the biosynthesis of this taxane core. Verticillol, a natural product isolated from Scidopitys verticillata, with rings B, C and D not yet formed has been much in the focus of speculation about the biosynthesis of the taxane skeleton (6,183). Verticillol, however differs in the stereochemistry at the C-1 and lacks oxygenation at C-2, C-5, C-7, C-9, C-10 and C-13 and numerous attempts of its cyclisation have failed (184). Very recently a novel pretaxoid, canadensene (233) in which rings B,C and D are not yet formed has been isolated from T. canadensis (185). The isolation of canadensene in the genus Taxus and its structural similarity with the core structure of taxol and related taxanes has considerable importance for biosynthetic studies. Two more such compounds were isolated from T. chinensis (Table 5).
Verticillol
TABLE 5 Pretaxoids isolated from different Taxus species. Compound
Species
References
Canadensene (233)
T. canadensis
(185)
Taxachitriene A (234)
T. chinensis
(186)
Taxachitriene B (235)
T. chinensis
(186)
108 OAc
OAc
233 Ri=OAc, R2=R3=OH 234 Ri=R2=0Ac, R3=0H 235 Ri=R2=0H, R3=0Ac
AcO^^^^"'
3. LIGNANS Lignans are found in several species of Taxus. Secoisolariciresinol (236), isotaxiresinol (249), isolariciresinol (250) and isotaxiresinol-6-methyl ether (251) are found in several species of Taxus (39,187). Secoisolariciresinol (236), isotaxiresinol (249) and taxiresinol (255) were isolated by Majumdar et a/.(188) from T. haccata, whereas a-conidendrin (252) was isolated from T. marei (43,45). Table 6 lists various lignans isolated from the genus Taxus. TABLE 6 Lignans isolated from different Taxus species. Compound
Species
References
Secoisolariciresinol (236)
T T. T. T T
(-)-4-0-Methyl-3'-0-demethylsecoisolariciresinol (237)
T baccata
(187)
(-)-3-Dimethylsecoisolariciresinol (238)
T. baccata
(192)
2-(3,4-Dimethoxybenzyl)-3(3,4-methylenedioxybenzylidene)butane-1, 4-diol (239)
T baccata
(193)
(-)-2-(3, 4-Methylenedioxybenzyl)-3(3,4-dimethoxybenzylidene)butane-l,4-diol (240)
T. baccata
(194)
baccata brevifolia cuspidata floridana mairei
(39,187,188,190) (39) (39) (39) (43,44,49,191)
109
(-)-2-(3,4-Methylenedioxybenzyl)-3(3,4-methy lenedioxybenzy lidene)butane-1, 4-diol (241) Hydroxymatairesinol (242)
T. media T. wallichiana
(119) (189)
(-)-Matairesinol (243)
T. haccata
(194)
(-)-2-Epinortrachelogenin (244)
T. media
(119)
Isoliovil (245)
T. wallichiana
(189)
4'-0-Demethylsuchilactone (246)
T. haccata
(193)
(-)-Isohibalactone (247)
T. haccata
(194)
(-)-Hibalactone (248)
T. haccata
(194)
Isotaxiresinol (249)
T. haccata T. hrevifolia T. cuspidata T. floridana T. mairei
(39,187,188,190) (39) (39,195) (39) (43,44,49,60,191)
Isolariciresinol (250)
T. haccata T. hrevifolia T. cuspidata T.floridana
(39,187) (39) (39,195) (39)
Isotaxiresinol-6-methyl ether (251)
T. haccata T. hrevifolia T. cuspidata T. floridana
(39) (39) (39) (39)
a-Conidendrin (252)
T. haccata T. mairei T. wallichiana
(194) (43,45) (189)
6-Conidendrin (253)
T. wallichiana
(189)
Lariciresinol (254)
T. cuspidata
(39)
110
Taxiresinol (255)
T. baccata
(188)
Z>-Sesamin (256)
T. mairei
(44)
4-Hydroxysesamin (257)
T. mairei
(44)
RiO.
OH 236 Ri=R3=Me, R2=H 237 Ri=R2=Me, R3=H 238 R-|=R2=H, R3=CH3
239 Ri+R2=CH2, R3=R4=CH3 240 Ri=R2=CH3, R3+R4=CH2 241 Ri+R2=R3+R4=CH2
H3CO,
OCH3
242 R=OH 243 R=H H3CO.
246 Ri=OH, R2=0Me 247 Ri+R2=OCH20
Ill H3CO,
CH2OH
RpO'
CH2OH
249 Ri=R2=H 250 Ri=CH3; R2=H 251 Ri=H; R2=CH3
248
H3CO.
H3CO.
H3CO.
254 R=Me 255 R=H
256 R=H 257 R=OH
112
4. FLAVONOIDS Taxus species contain the biflavonoids mainly of the amentoflavone series. A1% emulsion of flavonoidal mixture obtained from T. haccata (196) with tween-80, suitably diluted with normal saline or physiological solution was used by Vohora et al (197). for all studies on pharmacological properties with reference to nervous system. Their observations showed CNS effects by flavonoidal mixture as evidenced by potentiation of pentobarbitone narcosis, hypothermia and delayed reaction of fasted rats in Hebb-William maze. Flavonoidal mixture also showed antipyretic and analgesic effects. Table 7 lists all the flavonoids isolated from the genus Taxus. TABLE 7 Flavonoids isolated from different Taxus species. Compound
Species
References
Ginkgetin (258)
T haccata T canadensis T cuspidata T. wallichiana
(196) (88) (91,198,199) (200,201)
Sciadopitysin (259)
T haccata T. hrevifolia T canadensis T. cuspidata T. wallichiana
(196,202) (75) (88) (91,198,199) (200,201)
Sequoiaflavone (260)
T haccata T wallichiana
(196) (200,201)
Sotetsulflavone (261)
T haccata T. cuspidata
(203,204) (198)
Kayaflavone (262)
T cuspidata
(198)
Amentoflavone (263)
T. haccata T wallichiana
(205) (201,205)
4',7,7"-Tri-0-methylamentoflavone (264)
T. haccata
(206)
4',4",7,7"-Tetra-0-methylamentoflavone (265)
T haccata
(205,206)
113
4',7"-Di-0-methylamentoflavone(266)
T. haccata
(205)
(+)-Taxifolin (267)
T. mairei
(49)
Kaempferol (268)
T. hrevifolia
(75)
Quercetin (269)
T. brevifolia T. cuspidate
(75) (91)
Isorhamnetin (270)
T. brevifolia T. cuspidata
(75) (91)
RiO,
258 R-i=R2=CH3', R3=R4=H 259 Ri=R2=R4=CH3; R3=H 260 Ri=CH3; R2=R3=R4=H 261 R-j=R2=R4=Hi R3=CH3 262 R-|=R3=R4=CH3; R2=H 263 R-|=R2=R3=R4=H 264 Ri=R2=R3=CH3, R4=H 265 R-|=R2=R3=R4=CH3 266 R-|=R4=H, R2=R3=CH3
268 R=H 269 R=OH 267
270 R=0CH3
114
5. STEROIDS Phytoecdysteroids, the well-known molting hormones are another important class of naturally occurring organic compounds isolated from Taxus species. Insect molt hormone activity associated with extracts of yew leaves has been reported by Takemoto et a/. (207). Table 8 lists phytoecdysteroids alongwith other common steroids isolated from the yew. These consist of a number of closely related active compounds (insect metamorphosis hormones) possessing insect molting activity. The most common of these phytoecdysteroids is ecdysterone (271). TABLE 8 Steroids isolated from different Taxus species. Compound
Species
References
Ecdysterone (271)
T. baccata T. chinensis T. cuspidata
(208,209) (210) (211,212)
Taxisterone (272)
T. cuspidata
(15,213)
Ponasterone A (273)
T. brevifolia T. cuspidata
(113) (211)
Makisterone A (274)
T. cuspidata
(214)
Campesterol (275)
T. cuspidata
(89)
6-Sitosterol (276)
T. baccata T. brevifolia T. canadensis T. cuspidata T. floridana T. mairei T. wallichiana
(39) (39) (88) (39) (39) (39,43,44,49) (52)
Daucosterol (277)
T. wallichiana
(52)
Stigmasterol (278)
T. cuspidata
(89)
p-Sitostenone (279)
T. mairei
(191)
115
271 Ri=OH 272 Ri=H
273
276 R=H 277 R=glucosyl
278
279
116
6. SUGAR DERIVATIVES A novel glycoside, taxicatin (280) was isolated from the leaves of T.haccata (215-218). The glycosides of aliphatic and aromatic alcohols, as well as of monoterpene alcohols and eugenol have been detected in Taxaceae (219). Recently we have isolated betuloside (283) from T. haccata, reported its absolute stereochemistry and have found it to possess hepatoprotective activity (220). Table 9 lists various glycosides and other sugar derivatives isolated from the genus Taxus. TABLE 9 Glycosides isolated from different Taxus species. Compound
Species
References
Taxicatin (280)
T. baccata T. canadensis
(215-218) (88)
(7?)-Taxiphylline (281)
T. haccata T. cuspidata
(221) (222)
(5)-Dhurrin (282)
T. baccata
(221)
Betuloside [Rhododendrin (283)]
T. haccata T. canadensis
(130,196,220) (88)
L-4-/7-Coumaroyl-m>'o-inositol (284)
T. haccata
(223,224)
D-1-O-Methyl-mMco-inositol (285)
T. haccata
(225)
Taxuside (286)
T. haccata
(187,192)
Triglochinine (287)
T. haccata
(221)
Isotriglochinine (288)
T. haccata
(221)
Raffinose (289)
T. haccata
(217,226)
Z)-Pinitol (290)
T. haccata
(225)
Sequoitol (291)
T. haccata
(225)
117
CN
\
O
>=< I OH
281 R=a-0-glucosyl 282 R=p-0-glucosyl
OCHa
280
-OH
/
O HO
287 288
CH2OH OH
H
H
290
OH
H
OH
291
118
7. MISCELLANEOUS Kojic acid (294), a y-pyrone, isolated from T. mairei is a typical microbial metabolite and fungal contamination of the plant extract might be a reason of its formation (227). The diterpenestaxamairinsA(297)and B (298) possessing tropone skeleton displayed inhibitory activity [IC^^ 30.21 g/ml for taxamairin A and 26.78 g/ml for taxamairin B] against hepatoma cells in vitro (228). (+)-Abscissic acid (317) was extracted from the seeds of T. haccata (229-231). The needles of T. haccata contained 26 carboxylic acids, 80% of which were shikimic (335) and quinic acids (336) (232). Rhodoxanthin (300) has been found to be present in all the species of Taxaceae (87,233). Escholtzxanthone (301) was isolated from T. haccata leaves (234). Various compounds isolated from genus Taxus which are not otherwise classified in the text are listed in Table 10. TABLE 10 Novel compounds of different types isolated from Taxus species. Compound
Species
References
Coniferaldehyde (292)
T. mairei
(43,235)
Vanillin (293)
T. mairei
(43,191)
Kojic acid (294)
T. mairei
(227)
10-Nonacosanol (295)
T. mairei
(227)
Brevitaxin (296)
T. brevifolia
(236)
Taxamairin A (297)
T. mairei
(228,237)
Taxamairin B (298)
T. mairei
(228,237)
Taxamairin C (299)
T. mairei
(236)
Rhodoxanthin (300)
all species
(87,233)
Escholtzxanthone (301)
T. haccata
(234)
3-Phenylpropanol (302)
T. haccata
(187)
3-(3',4'-Dihydroxyphenyl)propanol(303)
T. haccata
(187)
3-(4'-Hydroxy-3'-methoxyphenyl)propanol (304)
T. haccata
(187)
119 3-(4-Hydroxyphenyl)propyl tetracosanoate (305)
T. canadensis
(88)
3-(4-Hydroxyphenyl)propyl pentacosanoate (306)
T. canadensis
(88)
3-(4-Hydroxyphenyl)propyl hexacosanoate (307)
T.canadensis
(88)
3-(4-Hydroxyphenyl)propyl dotriacontanoate (308)
T. canadensis
(88)
3-(4-Hydroxyphenyl)propyl tetratriacontanoate(309)
T. canadensis
(88)
4-(4'-Hydroxyphenyl)-2/?-butanol [(-)-Rhododend^ol^etuligenol (310)]
T. brevifolia T. baccata
(133) (187,196,238)
4-(4'-Hydroxyphenyl)-25-butanol (311)
T. baccata
(239)
4-(3',4'-Dihydroxyphenyl)-2/?-butanol (312) T. baccata
(187,238)
4-(3'-Methoxy-4'-hydroxyphenyl)2/?-butanol (313)
T. baccata
(187,238)
Deglycosylicariside B^ (314)
T. wallichiana
(240)
Dehydrovomifoliol (315)
T. wallichiana
(240)
Vomifoliol (316)
T. wallichiana
(240)
Abscissic acid (317)
T. baccata
(229-231)
d5-5,cis-9-Octdecadienoic acid (318)
T. baccata T. cuspidata
(241) (242)
Vanillic acid (319)
T. baccata
(243)
Pyrocatechuic acid (320)
T. baccata
(243)
Protocatechuic acid (321)
T. baccata
(243)
p-Resorcylic acid (322)
T. baccata
(243)
120
Gentisic acid (323)
T. baccata
(243)
Y-Resorcylic acid (324)
T. baccata
(243)
Pholoroglucinic acid (325)
T. baccata
(243)
Gallic acid (326)
T. baccata
(243)
Syringic acid (327)
T. baccata
(243)
o-Hydroxyphenylacetic acid (328)
T. baccata
(243)
/7-Hydroxyphenylacetic acid (329)
T. baccata
(243)
Homoprotocatechuic acid (330)
T. baccata
(243)
Cinnamic acid (331)
T. baccata
(243)
/7-Coumaric acid (332)
T. baccata
(243)
Ferulic acid (333)
T. baccata
(243)
Caffeic acid (334)
T. baccata
(243)
Shikimic acid (335)
T. baccata
(232,243)
Quinic acid (336)
T. baccata
(232,243)
Benzoic acid
T, baccata
(243)
2-Hydroxy-, 3-hydroxy- and 4-hydroxybenzoic acids
T. baccata
(243)
CHO
CHO
OCH3 OH
292
293
294
295
121
297 R=OH 298 R=0CH3
296 0CH3
301
OH
HO'
302 R=H 303 R=OH 304 R=OMe
305 306 307 308 309
n= 22 n= 23 n= 24 n= 30 n= 32
122
>^N)H
HO
312 R=H 313 R=Me
310 R 311 S
315
314
316
COOH 317
COOH 318
COOH 319 Ri=H, R2=OCH3, R3=0H 320 Ri=R2=0H, R3=H 321 Ri=H, R2=R3=OH 322 Ri=R3=0H, R2=H
COOH 324 Ri=OH, R2=H 325 Ri=R2=0H
COOH
3 2 8 R i = O H , R2=R3=H 329 Ri=R2=H, R3=0H 330 Ri=H, R2=R3=OH
123 COOH
R2
HO//,,^ ^ C O O H
COOH
Ri
331 332 333 334
Ri=R2=H Ri=H, R2=0H Ri=0CH3, R2=0H Ri=R2=0H
OH
335
336
8. CONCLUSIONS This review of literature covering phytochemical investigations on ten Taxus species have resulted in the isolation of nearly three hundred and fifty compounds belonging to the classes of taxanes, lignans, flavonoids, steroids, sugar derivatives, aromatic acids, etc. Last few years have witnessed a revolution in the phytochemistry of the yew tree; it is evident from the figures that out of the 246 references cited in this review, 151 range in the period 1990-96. Pharmaceutical industries are concentrating too much on this genus to obtain paclitaxel (taxol) and equivalent compounds of paclitaxel. As paclitaxel has become an approved agent to cure cancer, issues regarding its supply have now come to the forefront. The way the yew trees are being cut world-wide to obtain this drug, it is estimated that the source of supply would last for only 5-10 years (244) and it cannot be regarded as an environmentally acceptable source. Of late, four possibilities of supply are being considered: (i) find a better source for the supply of paclitaxel such as a different species or a cultivar of Taxus, or a different plant part or cultivation condition, (ii) semi-synthesis of paclitaxel from a more abundant precursor, (iii) total synthesis of paclitaxel, and (iv) tissue culture production of paclitaxel or its close precursor (245). Thus, we clearly visualise that this area demands still more intensive research to make it fruitful, and this updated and comprehensive review will help fellow scientists in locating information in one source. A cknowledgement We thank the Danish International Development Agency (DANIDA, Denmark) for financial assistance to carry out phytochemical investigations on a few Taxus species.
124
REFERENCES 1 2 3 4 5 6
7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
J.C. Willis, in: H.K.A. Shaw (Ed), A Dictionary of the Flowering Plants and Ferns, 7th Ed, (Cambridge University Press, Cambridge), 1966, pp. 1132. In: S.P. Ambasta (Ed), The Useful Plants of India, (CSIR, New Delhi), 1986, pp. 622. S.B. Vohora and I. Kumar, Planta Med., 2 (1971) 100-107. I. Morelli, Fitoterapia, 47 (1976) 31-38 N. Khan and N. Parveen, J. Sc. Ind. Res., 46 (1987) 512-516; B. Das and A. Kashinath, ibid. 55 (1996) 349-360. D.G.I. Kingston, A.A. Molinero and J.M. Rimoldi, in: Ed W.Herz, G.W. Kirby, R.E. Moore, W. Steglich and C. Tamm. (Eds), Progress in the Chemistry of Organic Natural Products, Springer, New York 1993, pp. 1-206. G. Appendino, Nat. Prod. Reports, (1995) 349-360. R.W. Miller, J. Nat. Prod., 43 (1980) 425-437. lUPAC Commission on Nomenclature of Organic Chemistry, Eur. J. Biochem., 86 (1978) 1-8. B. Lythgoe, K. Nakanishi and S. Uyeo, Proc. Chem. Soc, London, (1964) 301; Chem. Abstr. 62 (1965) 2. U. Roberto and A. Jelmoni, Chem. Abstr., 11 (1917) 2829. K. Tatsuo, T. Mitsuo, N. Aya and T. Yoshino, J. Pharm. Soc. Japan, 76 (1956) 611612. J.A. Nicholson, Chem. Abstr., 28 (1934) 4482. B.D. Hilton, G.N. Chmurny and G.M. Muschik, J. Nat. Prod., 55 (1992) 1157-1161. M.C. Wani, H.L. Taylor, M.E Wall, P. Coggon and A.T. McPhail, J. Am. Chem. Soc, 93 (1971) 2325-2327. C. Bogdan and A. Ding, Chem. Abstr., 117 (1992) 163472. K.M. Witherup, S.A. Look, M.W. Stasko, T.J. Ghiorzi, G.M. Muschik and G.M. Cragg, J. Nat. Prod., 53 (1990) 1249-1255. T. Iwakuma, Chem. Abstr., 117 (1992) 142747. S.H. Hoke (II), J.M. Wood, R.G. Cooks, X.H. Li and C.J. Chang, Anal. Chem., 64 (1992) 2313-2315. D. Cohen, S.M. Higman, S.I.H. Hsu and S.B. Horwitz, J.Biol. Chem., 267 (1992) 20248-20254. J. M. Andreu, J. Bordas, J.F. Diaz, J. Garcia de Ancos, R. Gil, F.J. Medran, E. Nogales, E. Pantos and E. Towns-Andrews, J. Mol. Biol., 226 (1992) 169-184. K. Tsuji, A. Ueno and T. Ide, Cell Struct. Funct., 17 (1992) 139-144; Chem. Abstr., 117 (1992) 103720. A.D. Bershadskii, O.Y Ivanova, L.A. Lyass, O.Y Pletyushkina, V.M. Vasilev and I.M. Gelfand, Tsitologiya, 34 (1992) 18-22; Chem. Abstr., 117 (1992) 42466. RB. Schiff, J. Fant and S.B. Horwitz, Nature, 277 (1979) 665-667. M.E. Stearns and M. Wang, Cancer Res., 52 (1992) 3776-3781. N. Vidensek, R Lim, A. Campbell and C. Carison, J. Nat. Prod., 53 (1990) 16091610.
125
27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
S.M. Edgington, Biotechnology, 9 (1991) 933-934; Chem. Abstr., 115 (1991) 263123. S.O.K. Auriola, A.M. Lepisto, T. Naaranlahti and S.P. Lapinjoki, J. Chromatog., 594 (1992) 153-158; Chem. Abstr., 116 (1992) 221667. G. Chauviere, D. Guenard, C. Pascard, F. Picot, P. Potier and T. Prange, J. Chem. Soc, Chem. Commun., (1982) 495-496. J.L. McLaughlin, R.W. Miller, R.G. Powell and C.R. Smith (Jr), J. Nat. Prod., 44 (1981) 312-319. R.W. Miller, R.G. Powell, C.R. Smith (Jr), E. Arnold and J. Clardy, J. Org. Chem., 46 (1981) 1469-1474. J. Kobayashi, A. Inubushi, H. Hosoyama, N. Yoshida, T. Sasaki and H. Shigemori, Tetrahedron, 51(1995) 5971-5978. W. Ma, G.L. Park, G.A. Gomez, M.H. Nieder, H. Mathew, T.L. Adams, J.S. Aynsley, O.R Sahai, R.J. Smith and R.W. Stahlhut, J. Nat. Prod., 57 (1994) 116-122. W.R. Chan, T.G. Halsall, G.M. Hornby, A.W. Oxford and W. Sabel, K. Bjamer, J. Chem. Soc. (D), (1966) 923-925. G. Chauviere, D. Guenard, F. Picot, V Senilh and P. Potier, C. R. Seances Acad. Sci. Ser. 2, 293 (1981) 501-503; Chem. Abstr., 96 (1982) 177920. Z. Zhang and Z. Jia, Huaxue Xuebao, 49 (1991) 1023-1027; Chem. Abstr., 116 (1992) 148188. Z. Jia and Z. Zhang, Chin. Sci. Bull., 36 (1991) 1967-1969; Chem. Abstr. 117 (1992) 8234. D.P. Delia Casa de Marcano and T.G. Halsall, J. Chem. Soc, Chem. Commun., (1969) 1282-1283. H. Erdtman.and K. Tsuno, Phytochemistry, 8(1969) 931-932. G. Topeu, N. Sultana, F. Akhtar, H. Rahman, T. Hussain, M.I. Choudhary and A. Rahman, Nat. Prod. Lett., 4 (1994) 93-100; Chem. Abstr. 121 (1994) 175187. M. Miyazaki, K. Shimizu, H. Mishima.and M. Kurabayashi, Chem. Pharm. Bull., 16 (1968) 546-548. T. Sugiyama, T. Oritani and T Oritani, Biosci. Biotechnol. Biochem., 58 (1994) 19231924. C.L. Liu, Y.C. Lin, Y.M. Lin and F.C. Chen, Tai-wan K'O Hsueh, 38 (1984) 119-125; Chem. Abstr., 103 (1985) 165998. L.C. Chuang, K.J. Chen, Y.S. Lin and F.C. Chen, Chem. Abstr., 116 (1992) 148178. C.L. Lee, Y. Hirose and T. Nakatsuka, Mokuzai Gakkaishi, 21 (1975) 249-256; Chem. Abstr., 83 (1975) 133681. T.I. Ho, G.H. Lee, S.M. Peng, M.K. Yeh, F.C. Chen and W.L. Yang, Acta Crystallogr., C43 (1987) 1378-1380. H. Zhang, Y Takeda, Y. Minami, K. Yoshida, T. Matsumoto, W. Xiang, O. Mu and H. Sun, Chem. Lett., (1994) 957-960. M.K. Yeh, J.S. Wang, L.R Liu and F.Q. Chen, J. Chin. Chem. Soc, 35 (1988) 309-313; Chem. Abstr., 110(1989)111670. L.C. Chuang, K.J. Chen, Y.S. Lin and F.C. Chen, Taiwan K'O Hsueh, 42 (1989) 2935; Chem. Abstr., 112 (1990) 175629.
126
50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74
L.O. Zamir, M.E. Nedea, S. Belair, F. Sauriol, O. Mamer, E. Jaeqmain, F.I. Jean and F.X. Gameau, Tetrahedron Lett., 33 (1992) 5173-5176. L.O. Zamir, M.E. Nedea, Z.H. Zhon, S. Belair, G. Caron, F. Sauriol, E. Jaeqmain, F.I. Jean, F.X. Gamean and O. Mamer, Can. J. Chem., 73 (1995) 655-665. J.Z. Zhang, Q.C. Fang, X.T. Liang, C.H. He, M. Kong, W.Y. He, and X.L. Jin, Phytochemistry, 40 (1995) 881-884. W.M. Chen, P.L. Zheng and J.Y. Zhou, Yaxue Xuebao, 29 (1994) 207-214; Chem. Abstr. 121(1994)17512. D.G.I. Kingston, D.R. Hawkins and L. Ovington, J. Nat. Prod., 42 (1982) 466-470. L. Barboni, P. Gariboldi, G. Appendino, R. Enriu, B. Gabetta and E. Bombardelli, Liebigs Ann., (1995) 345-349. S.K. Chattopadhyay and R.R Sharma, Phytochemistry, 39 (1995) 935-936. Z.R Zhang, H. Wiedenfield and E. Roeder, Phytochemistry, 38 (1995) 667-670. Z. Jia and Z. Zhang, Chin. Sci. Bull., 36 (1991) 1174-1177; Chem. Abstr. 116 (1992) 55524. M.C. Woods, H.C. Chiang, Y. Nakadaira and K. Nakanishi, J. Am. Chem. Soc, 90 (1968) 522-523. W.M. Chen, PL. Zhang, B. Wu. and Q.T. Zheng, Yaoxue Xuebao 26 (1991) 747-754; Chem. Abstr., 116 (1992) 143382. J. Liang, Z. Min and M. Niwa, Haoxue Xuebao, 46 (1988) 1053-1054; Chem. Abstr., 110 (1989) 132150. Z.D. Min, H. Jiang and J.Y. Liang, Yaoxue Xuebao, 24 (1989) 673-677; Chem. Abstr. 112(1990) 73852. J. Kobayashi, A. Ogiwara, H. Hosoyama, H. Shigumori, N. Yoshida, T. Sakaki, Y Li, S. Iwasaki, M. Naito and T. Isuruo, Tetrahedron, 50 (1994) 7401-7416. S.K. Chattopadhyay, G.C. Saha, M. Kulshrestha, R.P. Sharma and S. Kumar, Indian J. Chem., 35B (1996) 175-177. Z. Zhang and Z. Jia, Phytochemistry, 30 (1991) 2345-2348. M.K. Yeh, J.S. Wang, L.P Liu and F.C. Chen, Phytochemistry, 27 (1988) 1534-1536. G.N. Chmumy, J.V. Paukstelis, A.B. Alvarado, M.T. McGuire, K.M. Snader, G.M. Muschik and B.D. Hilton, Phytochemistry, 34 (1993) 477-483. G. Appendino, H.C. Ozen, I. Fenoglio, P. Gariboldi, B. Gabetta and E. Bembardelli, Phytochemistry, 33 (1993) 1521-1523. J.Z.Zhang, Q.C. Fang, X.T Liang and C.H. He, Chin. Chem. Lett., 5 (1994) 497-500. Y Guo, B. Diallo, M. Jaziri, R. Vanhaelen-Fastre, M. Vanhaelen and R.Ottinger, J. Nat. Prod., 58 (1995) 1906-1912. Y Konda, T. Sasaki, X.L. Sun, X. Li, M. Onda, H. Takayanaga and Y Harigaya, Chem. Pharm. Bull., 42 (1994) 2621-2624. L. Barboni, P. Bariboldi, E. Torregiani, G. Appendino, G. Cravatto, G. Bombardelli, B. Gabetta and D. Viterbo, J. Chem. Soc, Perkin Trans. 1, (1994) 3233-3238. J. Kobayashi, H. Hosoyama, T Katsui, N. Yoshida and H. Shigemori, Tetrahedron, 52 (1996) 5391-5396. H.J. Zhang, H.D. Sun and Y Take da. Chin Chem. Lett., 6 (1995) 483-486; Chem. Abstr., 123 (1995) 165090.
127
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98
S. Tachibana, K. Itoh, K. Ohkubo and G.H.N. Towers, Mokuzai Gakkaishi, 40 (1994) 1394-1397; Chem. Abstr., 122 (1995) 156279. H. Zhang and H. Sun, J. Nat. Prod., 58 (1995) 1153-1159. W. Ma, R.W. Stahlhut, T.L. Adams, G.L. Park, W.A. Evans, S.G. Blumenthal, G.A. Gomez, M.H. Nieder and P.J. Hylands, J. Nat. Prod., 57 (1994) 1320-1324. T.I. Ho, Y.C. Lee, S.M. Peng, M.K. Yeh, F.C. Chen .and W.L. Yang, Acta Crystallogr., C43 (1987) 1380-1382. M.K. Yeh, J.S. Wang, W.L. Yang and F.C. Chen, Chem. Abstr., 110 (1989) 54471. W. Chen, P. Chang, B. Wu and Q. Zheng, Chin. Chem. Lett., 2 (1991) 441-442; Chem. Abstr. 116(1992)191082. H.C. Chiang, Shih Ta Hsueh Pao, 20 (1975) 147-150; Chem. Abstr. 84 (1976) 118448. H.C. Chiang, M.C. Woods, Y Nakadaira and K. Nakanishi, J. Chem. Soc, Chem. Commun., (1967) 1201-1202. X.J. Tong, W.S. Fang, J.Y Zhou, C.H. He, W.M. Chen and Q.C. Feng, Yaoxue Xuebao, 29 (1994) 55-60; Chem. Abstr., 121 (1994) 31107. T. Takahashi, J. Pharm. Soc. Japan., 51 (1931) 401-414; Chem. Abstr. 25 (1931) 4553. X.J. Tong, W.S. Fang, J.Y. Zhou, C.H. He, W.M. Chen and Q.C. Fang, J. Nat. Prod., 58 (1995) 233-238. G. Appendino, H.C. Ozen, P. Gariboldi, B. Gabetta and E. Bombardelli, Fitoterapia, 64 (1993) 47-51. G. Bourbeau, Laval. Med., 19 (1954) 511 and 637; Chem. Abstr. 48 (1954) 12371. C.E. Olsen, V.S. Parmar, S. Gupta, K.S. Bisht, S Malhotra and R. Singh, Indian J. Chem., 36B (1997) "in press". F. Yoshizaki, M. Madarame, C. Takahashi and S. Hisamichi, Shoyakugaku Zasshi, 40 (1986) 429-431; Chem. Abstr. 107 (1987) 130861. M. Kurono, Y. Nakadaira, S. Onuma, K. Sasaki and K.Nakanishi, Tetrahedron Lett., (1963) 2153-2160. S. Tachibana, A. Matsuo, K. Itoh and T Oki, Mokuzai Gakkaishi, 40 (1994) 10081013; Chem. Abstr., 123(1995) 86266. G. Appendino, G. Cravotto, R. Enriu, J. Jakupovic, P. Gariboldi, B. Gabetta and E. Bombardelli, Phytochemistry, 36(1994) 407-411. G. Appendino, P. Gariboldi, A. Pisetta, E. Bombardelli and B. Gabetta, Phytochemistry, 31 (1992) 4253-4257. L. Ettouali, A. Ahond, C. Poupat and R Potier, J. Nat. Prod., 54 (1991) 1455-1458. E. Graf, S. Weinandy, B. Koch and E. Breitmaier, Liebigs Ann. Chem., 7 (1986) 11471151; Chem. Abstr., 105 (1986) 60786. B. Lythgoe, in: R. H. F. Manske (Ed.), The Alkaloids, Academic Press, New York 10 1968, pp. 597-626. J.N. Baxter, B. Lythgoe, B. Scales, S. Trippett and B.K. Blount, Proc. Chem. Soc, (1958) 9-10; Chem. Abstr., 52 (1958) 11098. G. Appendino, S. Tagliapietra, H.C. Ozen, P. Gariboldi, B. Gabetta, E. Bombardelli, J. Nat. Prod., 56 (1993) 514-520.
128
99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123
L.H.D. Jenniskens, E.L.M. Van Rozendaal, T.A. van Beek, P.H.G. Wiegerinck, and H.W. Scheeren, J. Nat. Prod., 59 (1996) 117-123. Z. Zhang, Z. Jia, Z. Zhu, Y. Cui, J. Cheng and Q. Wang, Planta Med., 56 (1990) 293294. J.A. Rentier, G.M. Chmumy, S.A. Look and K.M. Witherup, J. Nat. Prod., 54 (1991) 893-897; Chem. Abstr. 115 (1991) 110643. L. Barboni, P. Gariboldi, E. Torregiana, G. Appendino, M. Varese, B. Gabetta and E. Bombardelli, J. Nat. Prod., 58 (1995) 934-939. F. Yoshizaki, M. Fukuda, S. Hisamichi, T. Ishida and Y In, Chem. Pharm. Bull., 36 (1988) 2098-2102. X.X. Wang, H. Shigemori and J. Kobayashi, Tetrahedron, 52 (1996) 2337-2342. B. Li, K. Tanaka, K. Fuji, H. Sun and T.Taga, Chem. Pharm. Bull., 41 (1993) 16721673. K. Fuji, K. Tanaka, B. Li, T. Shingu, T. Yokoi, H. Sun and T. Taga, Tetrahedron, 51 (1995) 10175-10188. J. Liang and D.G.I. Kingston, J. Nat. Prod., 56 (1993) 594-599. YC. Shen, H.R. Tai and C.Y Chen, J. Nat. Prod., 59 (1996) 173-176. D.P. Delia Casa de Marcano and T.G. Halsall, J. Chem. Soc, (D), (1970) 1381-1382. S. Zhang, C.T.L. Lee, K. Chen, Y Kashiwada, D.C. Zhang, A.T. McPhail and K.H. Lee, J. Chem. Soc, Chem. Commun., (1994) 1561-1562. V. Senilh, S. Blechert, M. Colin, D. Guenard, F. Picot, P. Potier and P. Varenne, J. Nat. Prod., 47 (1984) 131-137. A. Chu, L.B. Davin, J. Zajicek, N.G. Lewis and R. Croteau, Phytochemistry, 34 (1993) 473-476. R.S. Bhakuni, J.B. Hanuman, R. Davies and J. Johnson, Phytochemistry, 41 (1996) 863-866. B. Gabetta, F. Perelongo, G. Zini, L. Barboni, G. Rafaiani, P. Ranzugliz, E. Torregiani, G. Appendino and G. Cravotto, Phytochemistry, 40 (1995) 1825-1828. S. Zhang, W.M. Chen, and YH. Chen, Yaoxue Xuebao, 27 (1992) 268-272; Chem. Abstr., 117 (1992) 44581. Z. Zhang and Z. Jia, Phytochemistry, 29 (1990) 3673-3675. L.O. Zamir, M.E. Nedea, S. Belair, F. Sauriol, O. Mamer, E. Jacqmain, F.I. Jean and F.X. Gameau, Tetrahedron Lett., 33 (1992) 5173-5176. J. Lian, Z. Min, M. Mizuno, T. Tanaka and M. linuma, Phytochemistry, 27 (1988) 3674-3675. G. Appendino, G. Cravotto, R. Enriu, P. Gariboldi, L. Barboni, E. Torregiani, B. Gabetta, G. Zini and E. Bombardelli, J. Nat. Prod., 57 (1994) 607-613. D.R Delia Casa de Marcano, T.G. Halsall and G.M. Hornby, J. Chem. Soc, Chem. Commun., (1970) 216-217. D.R Delia Casa de Marcano, T.G. Halsall and G. Thomas, J. Chem. Soc, Chem. Commun., (1975) 365-366. D.R. Lauren, D.J. Jensen and J.A. Donglas, J. Chromatogr., 712 (1995) 303-309. B. Gabetta, P. de Bellis, R. Pace, G. Appendino, L. Barboni, E. Torregiani, P. Gariboldi and D. Viterbo, J. Nat. Prod., 58 (1995) 1508-1514.
129
124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146
K.M. Witherup, S.A. Look, M.W. Stasko, T.G. McCloud, HJ. Issaq, G.M. Muschik, J. Liq. Chromatogr. 12 (1989) 2117-2132; Chem. Abstr, 112 (1990) 165067. N.C. Vance, R.G. Kelsey, and T.E. Sabin, Phytochemistry, 36 (1994) 1241-1244. C. Rao, X. Liu, RL. Zhang, W.M. Chen and Q.C. Fang, Yaoxue Xuebao, 26 (1991) 510-514; Chem. Abstr., 116 (1992) 55596. D.R Delia Casa de Marcano, T.G. Halsall, E. Castellano and O.J.R. Hodder, J. Chem. Soc, Chem. Commun., (1970) 1382-1383. E.E. Castellano and O.J.R. Hodder, Acta Crystallogr., 29B (1973) 2566-2570. V. Senilh, F. Gueritte, D. Guenard, M. Colin and R Potier, C. R. Seances Acad. Sci., Ser. 2, 299 (1984) 1039-1043; Chem. Abstr., 102 (1985) 214620. S.K. Chattopadhyay, V.K. Tripathi, R.S. Thakur, R.R Sharma and S.R Jain, Indian J. Chem., 33B (1994) 409-411. Y. Guo, B. Diallo, M. Jaziri, R. Vanhealen - Fastre, M. Vanhaelen and R. Ottinger, J. Nat. Prod., 59 (1996) 169-172. K.V. Rao, Pharm. Res., 10 (1993) 521-524; Chem. Abstr., 118 (1993) 240556. A. Chu, M. Furlan, L.B. Davin, J. Zajicek, G.H.N. Towers, CM. Soucy-Breau, S.J. Rettig, R. Croteau and N.G. Lewis, Phytochemistry, 36 (1994) 975-985. D.G. Vander Velde, G.L Georg, S.R. Gollapudi, H.B. Jampani, X.Z. Liang, L.A. Mitscher and Q.M. Ye, J. Nat. Prod., 57 (1994) 862-867. W.M. Chen, RL. Zhang, J.Y. Zhon, X. Liu and Q.C. Fang, Yaoxue Xuebao, 29 (1994) 751-757; Chem. Abstr. 123 (1995) 209763. R. Margraff, D. Bezard, J.D. Bourzat and A. Commercon, Bioorg. Med. Chem. Lett., 4 (1994) 233-236. K. Fuji, Tanaka, B. Li, T. Shinga, H. Sun and T. Taga, J. Nat. Prod., 56 (1993) 15201531. Z. Hongjie, Y. Takeda, T. Matsumoto, Y. Minami, K. Yoshida, X. Wei, M. Quing and S. Handong, Heterocycles, 38 (1994) 975-980. B.V. Sorochinskii and A.I. Prokhnevskii, Khim-Farm. Zh., 25 (1991) 45-46; Chem. Abstr., 114 (1991) 199242. B.V. Sorochinskii, A.I. Prokhnevskii and D.M. Grodzinskii, Khim-Prir Soedin, (1990) 702-703; Chem. Abstr. 114 (1991) 178005. D.W. Jennings, H.M. Deutsch, L.H. Zalkow and A.S. Teja, J. Supercrit. Fluids, 5 (1992) 1-6; Chem. Abstr., 116 (1992) 262349. N.C. Wheeler, K. Jech, S. Masters, S.W. Brobst, A.B. Alvarado, A.J. Hoover and K.M. Snader, J. Nat. Prod. 55 (1992) 432-440. L.X. Xu and A.R. Liu, Yaoxue Xuebao, 24 (1989) 552-555; Chem. Abstr., 112 (1990) 3779. L.X. Xu and A.R. Liu, Yaoxue Xuebao, 26 (1991) 537-540; Chem. Abstr., 116 (1992) 124148. W.M. Chen, J.Y. Zhou, RL. Zhang and Q.C. Fang, Chin.Chem. Lett., 4 (1993) 699702; Chem. Abstr., 121 (1994) 5056. X. Liu, D. Wu and Z. Wang, Chin. Sci. Bull., 38 (1993) 1129-1132; Chem. Abstr., 121 (1994) 200868.
130
147 148 149
150 151
152 153 154 155 156 157 158 159 160 161 162 163
164 165 166 167
C.H.O. Huang, D.G.I. Kingston, N.F. Magri, G. Samaranayake and F.E. Boettner, J. Nat. Prod., 49 (1986) 665-669. L. Barboni, P. Gariboldi, E. Torregiani, G. Appendino, B. Gabetta and E. Bombardelli, Phytochemistry, 36 (1994) 987-990. H. Zhang, Y. Takeda, Y. Minami, K. Yoshida, N. Unemi, Q. Mu, W. Xiang, T. Matsumota and H. Sun, Yunnan Zhiwu Yanjiv, 15 (1993) 424-426; Chem. Abstr., 121 (1994) 78282. F.R. Vanhaelen, B. Diallo, M. Jaziri, M.L. Faes, J. Homes and M. Vanhaelen, J. Liq. Chromatogr., 15 (1992) 697-706; Chem. Abstr., 116 (1992) 200943. M.W. Stasko, K.M. Witherup, T.J. Ghiorzi, T.G. McCloud, S. Look, G.M. Muschik and H.J. Issaq, J. Liq. Chromatogr., 12 (1989) 2133-2143; Chem. Abstr., 112 (1989) 51523. S.D. Harvey, J.A. Campbell, R.G. Kelsey and N.C. Vence, J. Chromatogr., 587 (1991) 300-305; Chem. Abstr., 116 (1992) 101991. P. De Bellis, M. Lovati, R. Pace, F. Peterlongo and G.F. Zini, Fitoterapia, 66 (1995) 521-524. G. Appendino, P. Gariboldi, B. Gabetta, R. Pace, E. Bombardelli and D. Viterbo, J. Chem. Soc, Perkin Trans. I, (1992) 2925-2929. G. Appendino, H.C. Ozen, P. Gariboldi, E. Torregiani, B. Gabetta, R. Nizzola, and E. Bambardelli, J. Chem. Soc, Perkin Tran.I, (1993) 1563-1566. G.P. Gunawardana, U. Premachandran, N.S. Burres, D.N. Whittem, R. Henry, S. Spanton and J.B. McAlpine, J. Nat.Prod., 55 (1992) 1686-1689. A. Chu, J. Zajicek, L.B. Davin, N.G. Lewis, and R.B. Croteau, Phytochemistry, 31 (1992) 4249-4252. G. Appendino, P. Lusso, P. Gariboldi, E. Bombardelli and B. Gabetta, Phytochemistry, 31 (1992) 4259-4262. E. Bombardelli and B. Gabetta, Eur. Pat. Appl. Ep 559018; Chem. Abstr., 120 (1994) 8781. R. Chen and D.G.I. Kingston, J. Nat. prod., 57 (1994) 1017-1021. G. Appendino, L. Barboni, P. Gariboldi, E. Bombardelli, B. Gabetta and D. Viterbo, J. Chem. Soc.,Chem., Commun., (1993) 1587-1589. F. Balza, S. Tachibana, H. Barrios and G.H.N. Towers, Phytochemistry, 30 (1991) 1613-1614. G.I. Georg, S.R. Gollapudi, G.L. Grunewald, C.W. Gunn, R.H. Himes, B.K. Rao, X.Z. Liang, YW. Mirhom and L.A. Mitcher, Bioorg. Med. Chem. Lett., 3 (1993) 13451348. K. Fuji, K. Tanaka, B. Li, T. Shingu, H. Sun and T. Taga, Tetrahedron Lett., 33 (1992) 7915-7916. K. Tanaka, K. Fuji, T. Yokoi, T. Shingu, B. Li and H. Sun, Chem. Pharm. Bull., 42 (1994) 1539-1541. L. Barboni, P. Gariboldi, E. Torregiani, G. Appendino, B. Gabetta, G. Zini, and E. Bombardelli, Phytochemistry, 33 (1993) 145-150. G. Appendino, S. Tagliapietra, H.C. Ozen, P. Gariboldi, B. Gabetta and E. Bombardelli, Phytochemistry, 36 (1994) 987-990.
131
168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194
Q. Yue, Q.C. Fang and X.T. Liang, Chin. Chem. Lett., 6 (1995) 225-228; Chem. Abstr., 122, 261096. S. Zhang, C.T.L. Lee, Y. Kashiwada, K. Chen, D.C. Zhang and K.H. Lee, J. Nat. Prod., 57 (1994) 1580-1583. B. Das, K.V.N.S. Srinivas, S. Padma Rao and J.S. Yadav, Indian J. Chem., 34B (1995) 672-673. C. Rao, Z.Y. Zhou, W.M. Chen, Y Lu and Q.T. Zheng, Xaxue Xuebao, 29 (1994) 355339; Chem. Abstr., 121 (1994) 226361. H. Zhang, Y Takeda and H. Sun, Phytochemistry, 39 (1995) 1147-1151. H.J. Zhang, H.D. Sun and Y Takeda, Chin. Chem. Lett., 6 (1995) 479-482; Chem. Abstr., 123 (1995) 165091. S.K. Chattopadhyay, R.P. Sharma, G. Appendino and P. Gariboldi, Phytochemistry, 39 (1995) 869-870. Q. Yue, Q.C. Fang, X.T. Liang and C.H. He, Phytochemistry, 39 (1995) 871-873. W.M. Chen, J.Y Zhou, P.L. Zhang and Q.C. Fang, Chin. Chem. Lett., 4 (1993) 695698; Chem. Abstr., 120 (1994) 294098. B. Das, S.R Rao, K.V.N.S. Srinivas, J.S. Yadav and R. Das, Phytochemistry, 38 (1995) 671-674. S.Z. Zhong, Z.X. Hua and J.S. Fan, J. Nat. Prod., 59 (1996) 603-605. Q. Yue, Q.C. Fang, X.T. Liang, C.H. He and X.L. Jing, Planta Med., 61 (1995) 375377. E. Graf, Angew. Chem., 68 (1956) 249-250. E. Graf, Arch. Pharm., 291 (1958) 443-449; Chem. Abstr. 53 (1959) 4335. C. Poupat, A. Ahond and R Potier, J. Nat. Prod., 57 (1994) 1468-1469. L.O. Zamir, M.E. Nedea and F.X. Gameau, Tetrahedron Lett., 33 (1992) 5235-5236. M.J. Begley, C.B. Jackson and G. Paltenden, Tetrahedron Lett., 26 (1985) 3397-3400. L.O. Zamir, Z.H. Zhou, G. Caron, M.E. Nedea, F. Sauriol and O. Mamer, J. Chem. Soc, Chem. Cummon., (1995) 529-530. W.W. Fang, Q.C. Fang, X.T. Liang, Y Lu and Q.J. Zheng, Tetrahedron, 51(1995) 8483-8490. B. Das, M. Takhi, K.V.N.S. Srinivas and J.S. Yadav, J.S. Phytochemistry, 36 (1994) 1031-1033. R.B. Majumdar, R. Srinivasan and K. Venkataraman, Indian J. Chem., 10 (1972) 677680. R.W. Miller, J.L. McLaughlin, R.G. Powell, R.D. Plattner, D. Weisleder and C.R. Smith (Jr.), J. Nat. Prod., 45 (1982) 78-82. F.E. King, L. Jurd and T.J. King, J. Chem. Soc, (1952) 17-24. D.H. Guo, H.M. Ko, J.M. Lai, T.H. Chiu, T.S. Wu, CM. Teng and S.C. Kuo, Chim. Pharm. J., 46 (1994) 175-183; Chem. Abstr., 121 (1994) 292369. B. Das, M. Takhi, K.V.N.S. Srinivas and J.S. Yadav, Phytochemistry, 33 (1993) 14891451. B. Das, S.R Rao, K.V.N.S. Srinivas and J.S. Yadav, Phytochemistry, 38 (1995) 715717. B. Das, S.R Rao, K.V.N.S. Srinivas and J.S. Yadav, Fitoteropia, 66 (1995) 475.
132
195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219
Y. Zhou, C. Yu and Y Zhu, Zhongcaoyao, 13 (1982) 1-2; Chem. Abstr. 97 (1982) 178717. M.S.Y Khan, I. Kumar, J.S. Prasad, G.R. Nagarajan, M.R. Parthasarathy and H.G. Krishnamurty, Planta Med., 30 (1976) 82-85. S.B. Vohora, I. Kumar, S.A. Shah and M.S.Y. Khan, Indian J. Med. Res., 71 (1980) 815-820. K. Tatsuo and S, Tokunosuke, Yakugaku Zasshi, 78 (1958) 1010-1013; Chem. Abstr., 53 (1959) 3203. Y Konda, T. Sasaki, T. Kagawa, H. Takayanagi, Y Harigaya, X.L. Sun, X. Li, and M. Onda, J. Hetrocycl. Chem., 32 (1995) 1531-1535. N. Parveen, H.M. Taufeeq and N.U.D. Khan, J. Nat. Prod., 48 (1985) 994. L. Qiu, M. Lian, Z. Ma and G. He, Zhiwu Xuebao, 31 (1989) 54-56; Chem. Abstr., I l l (1989) 191505. I. Aljancic, K. Popovic and M.Stefanovic, J. Serb. Chem. Soc, 60 (1995) 265-267; Chem. Abstr., 122 (1995) 261125. D.M. Gactana, F.R. Pier and M.R. Anna, Chem. Abstr., 58 (1963) 4502. D.M. Gactana, F.R. Pier, M.R. Anna and B. Enzo, Chem. Abstr., 57 (1962) 16537. B. Das, S.R Rao, K.V.N.S. Srinivas and J.S. Yadav, Fitoterapia, 65 (1994) 189. VS. Parmar, A. Vardhan, K.S. Bisht, N.K. Sharma, R. Jain, R Taneja, O.D. Tyagi and P.M. Boll, Indian. J. Chem., 32B (1993) 601-603. T. Takemoto, S. Ogawa, N. Nishimotoand H. Hoffmiester, Z. Naturforsch., 22B (1967) 681-682. J.G. Lloyd-Jones, H.H. Rees and T.W. Goodwin, Phytochemistry, 12 (1973) 569-572. YD. Kholodova, L.R Pasternak and A.I. Apostolov, Ukr. Biokhim. Zh., 48 (1976) 533-535; Chem, Abstr., 85 (1976) 139777. R.L. Nei, Chih Wu Hsueh Pao, 21 (1979) 82; Chem. Abstr., 91 (1979) 9403. S. Imai, S. Fujioka, K. Nakanishi, M. Koreeda and T. Kurokawa, Steroids, 10 (1967) 557-565. RV. Ripa, E.A. Martin, S.M. Cocciolone and J.H. Alder, Phytochemistry, 29 (1990) 425-427. K. Nakano, T. Nohara, T. Tomimatsu and M. Nishikawa, Phytochemistry, 21 (1982) 2749-2751. B.G. Bums and M.W. Gilgan, Can. J. Chem., 55 (1977) 1129-1134. C. Lefebvre, Arch. Pharm., 245 (1907) 486-492; Chem. Abstr., 2 (1908) 689. K.W. Merz and R. Preuss, Arch. Pharm., 279 (1941) 134-148; Chem. Abstr., 35 (1941) 6261. K.W. Merz and R. Preuss, Arch. Pharm., 281 (1943) 205-216; Chem. Abstr., 38 (1944) 5883. L.H. Herissey and C. Lefebvre, Arch. Pharm., 245 (1907) 481-485; Chem. Abstr., 2 (1908) 689. YM. Merkx and A.B. Sevendsen, J. Essent. Oil. Res., 2 (1990) 207-208; Chem. Abstr., 114 (1991) 39196.
133
220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245
VS. Parmar, A. Vardhan, P. Taneja, R. Sinha, G.K. Patnaik, S.C. Tripathi, P.M. Boll and S.Larsen, J. Chem. Soc, Perkin Trans. I, (1991)2687-2690. A. Nahrstedt, Chromatog. J., 177 (1979) 157-161. M.A. Rosen, K.J.F. Famden, E.E. Conn and K.R. Hanson, J. Biol. Chem., 250 (1975) 8302-8308. R Dittrich and T. Danboek, Plant Physiol., 59 (1977) 279-281; Chem. Abstr. 86 (1977) 136344. J. Heilemann, V. Wray and D. Strack, Phytochemistry, 29 (1990) 3487-3489. R Dittrich, M. Gietl and O. Kandler, Phytochemistry, 11 (1971) 245-250. L.H. Herissey and C. Lefebvre, J. Pharm. Chim., 26 (1907) 56-62; Chem. Abstr., 1 (1907) 2811. R Yoshizaki, M. Fukuda and S. Hisamichi, Chem. Abstr., 110 (1989) 21128. J. Liang, Z. Min, M. linuma, T. Tanaka and M. Mizuno, Chem. Pharm. Bull., 35 (1987) 2613-2614. I. Jones and E.V. Lynn, J. Am. Pharm. Assoc, 22 (1933) 528-531; Chem. Abstr. 27 (1933) 5782. M.T. Le-Page-Degivry, C. Bulard and B.V. Milborrow, Chem. Abstr., 72 (1970) 107799. M.T. Le-Page-Degivry, Chem. Abstr., 74 (1971) 1146. M.T. Le-Page-Degivry, Chem. Abstr., 79 (1973) 123804. B. Czeczuga, Biochem. Syst. Ecol., 14 (1986) 13-15; Chem. Abstr. 104 (1986) 203907. C. Bodea, E. Nicoara and T. Salontai, Rev. Roumaine Chim., 9 (1964) 517-521; Chem. Abstr., 62(1965)14735. V.E. Tyler (Jr.), J. Am. Pharm. Assoc. Sci. Ed., 49 (1960) 683-684; Chem. Abstr., 55 (1961) 3009. R.L. Arslanian, D.T. Bailey, M.C. Kent, S.L. Richheimer, K.R. Thornburg, D.W. Timmons and Q.Y. Zheng, J. Nat. Prod., 58 (1995) 583-585. J. Liang, Z. Min, T. Tanaka, M. Mizuno and M. linuma, Huaxue Xuebao, 46 (1988) 21-25; Chem. Abstr., 108 (1988) 183672. B. Das, M. Takhi, H.M.S. Kumar, K.V.N.S. Srinivas and J.S. Yadav, Phytochemsitry, 33 (1993) 697-699. S.R. Rajathar, D.D. Sawaikar, T. Ravindranathan and B.A. Nagasampagi, Phytochemistry, 39 (1995) 259-260. G. Appendino, H.C. Ozen, R. Enriu, L. Barboni, B. Gabetta and G.F. Zini, Fitoerapia, 64 (1993) 396-398; Chem. Abstr., 121 (1994) 5059. R.V. Madrigal and C.R. Smith, Lipids, 10 (1975) 502-504; Chem. Abstr., 83 (1975) 149490. Y Itabashi and T. Takagi, Yukagaku, 31 (1982) 574-579; Chem. Abstr., 97 (1982) 212686. S. Luczak and L. Swiatek, Fitoterapia, 66 (1995) 469. D.G.I. Kingston, Pharmacol. Ther., 52 (1991) 1-34. S. Borman, Chem. Eng. News. September 2 (1991) 11.
This Page Intentionally Left Blank
Atta-ur-Rahman (Ed.) Studies in Natural Products Chemistry, Vol. 20 © 1998 Elsevier Science B.V. All rights reserved.
135
Withanolides, Biologically Active Natural Steroidal Lactones : A Review A.S.R. Anjaneyulu, D. S. Rao, P.W. Lequesne
INTRODUCTION Withanolides mainly Solanaceae
in the SolsLnaceous
occur
is a large family comprising over 2000 species which
have great economic and medicinal importance. potato (Solanum tuberosum) 3
2
brinjal 4
melongena esculentum
) , chili ( Capsicum frutescens ) , ) and tobacco {Nicotiana tobaccum
includes
several
medicinally
{ Atropa
nightshade
These are generally Solanaceous
The important cash crops among
annual shrubs. are
plants.
belladona
important 7
) ,
the
plants
(ambergine)
( S.
tomato ( Lycopersium ) . This family
plants
like
thorn
apple
the deadly ( Batura
8
9
stramonium ) , Solanum species
xanthocarpum
12
constituents.
.
the poisonous henbane especially s. dulcamara
{Hyoscyamus niger , S. indicum
)^ and and S .
These herbs are well known for their alkaloidal In the indigenous
tubers and the leaves great importance.
Withania
Ayurvedic medicinal system the 13 14 and Physalis species have
Occurrence of Withanolides During the last two and a half decades many withanolides and their related compounds have been isolated from Withania other Solanceous
species
physiological
activity.
and
some
of
Withanolides
from the following species :~
them
possess
have been
and
remarkable
isolated
so far
136 Withania 1. 2. 3.
species
W, somnifera I/, coagulins
15
W, arboritus
Physalls
(frutescens)
20 alkekengi •. . 21a,b,29 P. minima P.
22
angulata 23 viscosa
2^a,b
P. pubescens C.
Datura species
D.
D. stromoniufli
2.
D,
1.
£.
G.
5.
W.
6
P. ixocarpa
7.
P
peruviana
8.
P
iancifolia
9.
P.
10.
P.
obtusifolia
19
species
Nicandra
25 26a ,b 27
phyladelphica 28 curasavica
28
31
4,
D. ferox
5.
D.
4.
J.
31,31a
tatura
29a
: physaloides
34
Lycium species ; 1.
F.
30
quercifolia 32,33 D. metel
Nicandra
aristata
;
I.
3.
W.
species
P.
P.
17
18
4.
Lycium
Jaborosa
chinense 35
species
: 36
leucotricha
1.
J. integrifolia
2.
J. Jbergii^^
5.
J. odonelliana
3.
J. magellanica
6.
J. sativa
3.
A. australis
4.
A.
39,39a, 40
Acnistus species : 1. 2.
41 A. Jbreveflorus GresiJb 42 A. ramifluoruiD ffeirs
H.
Trechonaetes laciniata
I.
lochroma 1.
Griseb 44 arborescens
43
45
species
lochroma cocconeum
46
lochroma
fuchsioides
46a
137 J.
Witharingia
K.
Tubocapsicum
L.
Dunalis 1.
W.
coccoloides 48 anonaium
species
;
australis
JD.
47
49
D.
2.
D.
tuJbuiosa
49a
Deprea species ; D. orinocensis 50
N.
2.
procumbens
51
origan!folia 52
Salpichroa
Withanolides : Chemical Classification The
withanolides
are
a
group
of
naturally
occurring
steroids built on an ergostane skeleton, in which C-22 and C-26 are appropriately oxidised in order to form a "S-iactone ring*
The name withanolide was originally proposed by Lavie et al 53 for a group
of
steroidal
lactones
of
the
ergostane
six-membered lactone in the nine carbon side chain-
series
with
a
The names in
current use for structure (1) are either withanolide, or according to the Chemical Abstracts system, 22-hydroxyergostan-26-oic 26,22-olide. are
acid-
In the CAS Chemical Substances index the compounds
catalogued
as
ergost
derivatives.
The
name
ergost-26,22-olide based on lUPAC rules, does not seem to be used. 54 The generic 'witha steroids' which has been proposed does not seem to have gained much popularity. carboxylic
For compounds with a modified
skeleton and or side chain, only
CA names
used, along with the trivial names.
(1)
Withaphysalin B ( 2 )
are being
138 Withaferin known
A
(12) the
Aswagandha)
was
Subsequently, withaferin
a
A
first
isolated
number
of
(12)
withanolides.
active
were
constituent
Withania
Indian medicinal plant,
somnifera
by
Lavie
compounds
isolated
The interesting
of
Dun
et
al.
in
structurally
and
these
well 1965.
related
to
known
as
were
biological activities
the
(Sanskrit :
elicited
by
withaferin A (12) and its congeners augmented the search for this type of compound, and the number of withanolides from different plants
has
already
surpassed
two
hundred.
Withanolides
are
generally defined as C-28 steroidal lactones built on a skeleton of ergostane intact or rearranged. There
exist
several
this group of compounds.
interesting
review
articles
on
To make a comprehensive account of these
compounds and to depict an overall picture of withanolides, this review was highlighted with some recent developments in the field till the end of August 1996. Withanolides
generally
contain
28
carbon
atoms
with
polyoxygenated functionalities.
These compounds in general possess
the a, 0-unsaturated-l-oxo-2-ene
in ring A and a 5-lactone between
C-22
and
saturated A
C-26
in
the
side
chain.
A
few, however,
contain
a
6-lactone system. common
feature
of
all
known
withanolides,
including
the related modified ergostane derivatives, is oxidation at C-1, C-22 and C-26.
Over 90% of withanolides
contain
a
1-oxo-group.
C-26 is oxidised in most instances.to the carboxylic acid level, thus allowing the formation of a 26,22 lactone. In contrast to the lactone, which in most instances is a ,3 -unsaturated, the precursor a ,0 -unsaturated
lactol
is
never
found
as
such,
but
found
as
epoxylactols or the corresponding epoxylactones. In addition to the oxidative processes at the above three centres, one of the characteristic features of the plants producing withanolides
is
their
extraordinary
ability
to
introduce
oxygen
functions at almost every position of the carbocyclic skeleton and side chain.
Till now, there are only one secondary (C-11) and two
tertiary (C-8 and C-9) carbon atoms which have not been found to be oxidised. Withanolides are classified into two major groups
.
139 A - Withanolides with an unmodified skeleton a) with a regular.: 6-oriented side chain b)
with an unusual «-oriented side chain.
B - Withanolides with modified carbocyclic skeletons or side chains These withanolides were classified initially on the basis of chemotypes of Withania
species
depending on the region of the
plant collected, to the compounds obtained as most of these have been
initially
several
isolated
withanolides
Solanaceae species,
the Withania
from
have
been
family, eg. Physalis Acnistus
species.
isolated
species.
species.. from
other
Later
on
species
of
Datura species,,
Jaborosa
Chemically, these may be classified as
ergostane derivatives-
From their structural pattern, these can be
broadly divided into seven groups. 1.
5B,63-epoxides
2.
6a,7a-epoxides
3.
5-enes
4.
Intermediate
5.
5a,6 a-epoxides
6.
63,73-epoxides
7.
Phenolic withanolides
compounds
Among these the 53 ,63-epoxides are most common. the compounds possess a 43-hydroxy1 group. which possess an a ,3 -unsaturated-Y-lactone 25 lactone A (61), the rest have ^-lactones. Withanolides 5a-hydroxyl
eg.
originate from number,
having
lycium
5 3,63 -epoxides.
eg. withanolide
B
generally
(62) and
are
Lavie
et
contain
believed
The 5-enes also form a
(107).
G
system, eg. ixocarpa-
6a ,7a -epoxides
substance
Most of
Except for four members
to
sizable
al. suggested
that
60,70-epoxides are originated from 5-enes by migration of A -ene to .6-ene with simultaneous hydroxylation at C-5 followed by epoxidation on A . inspection of the intermediates suggests that most of them originate from 53,63-epoxides either by trans-diaxial 181 or diequatorial opening. Sarma et al. suggested that 134 chlorowithanolides are formed by the reaction of chloride ion present in the plant with the 53,63-epoxide system (Tables la-ln) . Hydroxylation Hydroxylation
is
a
common
feature
in
withanolides.
Hydroxyl at C-4 is the most common feature in 53 ,63-epoxides, eg.
TABLE
la
Compound
Hydroxyls Epoxide Ene
140
5 3,6 8-EPOXIDES UTE 17&
SIDE CEAIN
Other groups
m.p.
("C)
[ UjD
Source
Ref.
Without hydroxyls :
Withaphysalin B (2)
2, 24
18-20 lactol 161-62 (EtOAc) (epimers)
-
P. minima
64
Monohydroxy Compounds :
27-deoxywithaferin A ( 3 )
48
5%,6%
2,24
--
268-9 (EtOAc)
+
101.5
W. somnifera ( S . African variety)
65
48-Hydroxy-5B ,6%-epoxy1-0~0-22R-wltha-2,14,24trienolide (4)
4%
5%,6%
2,14,24
--
239-40(~to~c)
+
122
W. a r i s t a t a Pauq
66
4~-hydrory-l-ox0-58,6%epoxy-wltha (24S,25K)dihydro-2-enolide ( 5 )
48
5%.68
2
--
252 (CHC13-EtOkc)
+
32.5
W. somnifera
65
Jaboroaalacrone A ( 6 )
27
5%,613
2,24
--
215-20
+
95
58,68
2,24
4-0x0
273-4 (EtOAc)
+
113.5
~ U E - H Y ~ ~ O X ~ - ~ , ~ - ~ ~ O X 20 O -8
58 ,6%-epoxy-ZOR,22R-
( s . "African variety) Jaborosa i n t e g r e f o l i a
67
W. somnifera
68
LiUll
(s. African Vs.
Chemotype 111)
w i tha-2,24-dienolide (7)
2WE-iLydroxy-l,4-dioxo5 8, bbepoxy-20R,22Rw i :ha-2-enoli de ( 8 )
20 B
58,bB
2
&ox0
260-63
+
2,3-Di.hydro lactone A ( 9 )
27
5%,68
24
--
180-82 (EtOAc)
_-
49.2
-do-
68
-do-
69
Compound
Hydroxyls Epoxide Ene
[ QID
Other groups m.p. ("C)
2:3, 24:25-Tetrahydro-27deoxywithaferin A (10)
209-210
+ 17.4
2,3-dihydro-27-deoxywithaferin A (11)
236-37 (EtOAc)
- 3.0
Source Acnis tus brevifluorus
-do-
Ref. 70
70
Dthydroq Compounds
Withaferin A (12)
4e, 27 56,6e
2,24
--
243-45
+
114
2,3-dihydrowithaferin A
46,17a 5 6,6%
24
--
229-30
+
8.0
27-Deoxy-14C-OHwfthaferin A (14)
4e,lk
2,24
--
265-67
+ 67
17 *Hydroxy-27-deoxywithaferin A -4acetate (15)
4~,17a 56,66
2,24
--
195-96 (EtOH)
+
175
U. somnifera Dun
66
Withacnistin i16)
46,18
56,66
2,24
--
130-35 (amorphous solid)
+
123
A. aroborescecs
44
4 6,27-Dihydroxy-58,66epoxy-1-0x0-22R-witha2,14,24-trieno1l.de (17)
40,27
50,66
2,14,24 --
256-59
+
98
U. frutescens Pauq
17
Jaborosalactone L
17427 56,66
--
214-15
+ 49
( 13)
(18)
5 ,6
2,24
W.somnifera Dun
71
-do-
71
-do-
72
(lndian Cfiemotype)
141
56,@-EPOXIDES
Compound
Hydroxyls Epoxide Ene
142
TABLE la
( Ccntd. )
WITH 176- SIDE CHAIN
Other groups m.p.
[a ID
("C)
Source
Withanolide D (19)
48,20 8 55,@
2,24
253-55
+
80
W. somnifera
24,25-Dihydro-withanolide D ( 2 0 )
46,20 8 5 8,68
2
275 (EtOAc)
+
14
Y. somnifera ( 5 . African variety)
7 a,17a-Dihydroxy-55,65epoxy-1-oxo-22R-witha2,24-dienolide (21)
7a,17a
55,68
2,24
252-54 (MeOH)
V i scosalactone A' ( 2 2 )
45,27
55,65
24
4 8,2Gcl-Dihydroxy-l-oxo5 8,68 -epoxy-ZOR,22R-
45,20 5 58,68
24
A withanolide isomeric to withaferin A (24)
4~,27
24 q25a-epoxywi thanelide D ( 2 5 ) Jabarosalactone 0 ( 2 6 )
witha-24-enolide (23)
Irrnrcrnclide(Z7) Physagulin A ( 2 8 )
-* -28.0
2,24
*
48,208 58,65
2
*
*
17a,19 5 4 6 8
24
*
*
5 8,65
73
(Chsmorype 111)
W. somnifera
65 74
(Seeds)
* 277-80 (Acetone )
Ref.
*
P. Viscosa
23
W. s o n n i f e r a
68
(5. African Vs. Ctmotype 111) W. o b t u s i f o l i a
(Sudan)
4 EJ16cr-OAc5 8,66
2,24
146-54 (EtOAc)
14a,l%-OAc 5 3,65
2,24
A whi.te powder
--
+
21
19
P . angulata
75
Jabarosa l e u c o t r i c h a Leaves Iochroma coccinium
76
P . angulata
77
46
TABLE la ( Ccntd. ) :B.;6E-EPOKu)JS WITH 178- SIDE C M I N
Compound
Hydroxyls Epoxide Ene
[a ID
Other groups m.p. ("C)
)
17a ,19
5 46B
24
--
287-90
--
Jaborosalactone W (26b)
193,28
5 8,6E
24
--
220-22
---
27-Hydroxywithanolide D (29)
4 E,208,27
5 E,6E
2,24
--
202 (4,27dtacetate)
+ 17
1 4-Hydroxywithanoltde D (30)
@,14 5208 5 B,6B
2,24
--
211-13 (EtOAc) (4-acetate)
-
17a-Hydroxywithanoltde D (31)
48,17a,20
5E,6E
2,24
--
196-97 ( Et0Ac (4-acetate)
+ 2
7~-Hydroxywithanolide D (32)
48,78,208
5E,6E
2,24
--
260 (Acetone:Hex)
+
78- k e toxywithanolide D (33)
48,78-OAc 20
5 8,6 8
2,24
--
173-75
17-Isowithanolide E(34)
14a,17a,208 58,68
2,24
--
262 (EtOAc)
Physapubescin (35) (26-eptmers)
4!3,15a-OAc, 5 E,6 E 26
2
Jaborosalactone V @&
Source
Ref.
Jaborosa leucotricha 39a -do-
39a
R-Lhydroxy Compounds :
22,26-lactol
W. somifera Dun (Chemotype 111)
18
118.5
A.
78
-do-
78
-do-
78
australis
43
Griseb
-+
Noncrystalline
21.3
--
A.
arborescens
79
Y. somnifera (Chemotype LII)
80
P. pubescens L
81 143
144
TABLE la ( Ccntd. ) 56,68-EPOXU)ES kT’M 17% SIDE CHAIN Compound
Viscosalactone B
(36)
Physapubenolide
(37)
Hydroxyls
38,48,27
Epoxide
Ene
Other groups
[ a ID
m.p. ( “ C )
*
58,68
144-45
48,148 , 1 5 - 58,68
* +
76
OAc Substance A
(38)
Withangulatin A
(39)
Ref.
P . viscosa
23
P . pvbescens (Waltair variety)
24b
W . somnifera (Egyptai.n variety)
82
83
14a,17a,208 55,M
2,24
--
*
48,14a,
5@,68
2,24
--
152-53
+
23.9
P . angulata
58,68
2,24
--
148-53
+
71.9
Iochroma f u s c h s i o i d e s 46a
5B,68
2,24
--
b
58,68
--
38,48,206 2 4 a , 258
55,63
15cl-OAc 1.8-Acetoxywithanolide D
*
Source
3 , 18-OAc
(39a) Tetrahydroxy Compounds Substance C (@-OHsubstance A) (40) Withajardin B
(41)
45,14a 17a,208
17a ,25
21,24-cy
*
*
*
*
W . somnifera (Egyptfan variety)
82
*
Deprea o r l c e n s i s
50
*
P . angulata Frli.age
84
methyl
Pentahydroxy Compounds: Physangultde
(42)
145 Fig.la.5p,6p-Epoxides with 17p-side chain
3 R, =OH,R2 = R3=H 4. R, = OH,R2 = R3=H 5. R, =OH,R2=R3=H, 24,25-di-H 6. Ri = R2=H,R3=OH 7 R, = = 0 , R2 = OH, R3 = H 8. R, = = 0 , R2 = OH,R3 = H, 24,25-di H 9. R, = R2 = H,R3 = OH, 2,3-diH 10. R, = OH,R2 = R3 = OH 2,3,24,25-tetra H l l . R , = OH,R2 = R3 = H, 2,3-diH 12. R, = R3 = OH,R2 = H 13. R, = OH,R2=R3=H, 17a-OH,2,3-di H
14. Ri =OH,R2=R3=H, 14a-0H 15 R, = OAc,R2=R3=H, 17a-0H 16 R, = OH, R2 = R3 = H,18-OH 17 R, = OH, R2 = H, R, = OH, 18. R, = R2 = H,R3 = OH, 17a-0H 19. R, = R2 = OH,R3 = H 20. R, = R2 = OH,R3 = H 24,25-di H 21 R, = R2 = R3 = H, 7a-0H, 17a-0H 22. R, = R3 = O H , R 2 = H 2p,3p - epoxy 23. Ri = R2 = OH, R3 =H, 2,3 - di H 24. R, = R3 = OH, R2 - H
146 Fig. l a . 5p,6p- Epoxides with 17p- side chain
25 26
R, = Rz = OH, R3 = H, 24,25 - epoxy Ri — R2 ~ R3 ~ H, 17a-0H, 1 9 a - O H , 2 , 3 - d i H
26a. R, =R2 = R3 = H, 17a-0H, 1 9 a - O H , 2 , 3 - d i H 26b. R,=R2 = R 3 = H , 19-OH, 2 8 - O H , 2 , 3 - d i H 27 R, =OH,R2=R3=H, 16a-0Ac 28 Ri = R2 = R3 = H, 14a-0H,15a-0AC 29 . R, = R2 = R3 = OH 30 R, = R2 = OH, R3 - H 14a-0H 31 R, = R2 = OH, R3 = H, 17a-0H 32 Ri = R2 = OH, R3 = H, 33 R, = R2 = OH,R3 = H, 7P-0AC
34 R, = R3 = H, R2 = OH 14a-0H 35 .R, = OH, 1 5 a - 0 A C , R2 = R3 = H, H 26,
TABLE lb 56,6B-EYOXIiIES WITH 17- SIDE CHAIN Compound
Hydroxyls Epoxide Ene
Other groups m.p. ("C)
[a],
Source
Ref.
Monohydroxy Compounds :
*
*
J. magellanica
38
--
--
--
J. bergii haves
37
2
--
--
_-
17
58,68
--
12-OX0
(44) 148,178
58,68, 24a,25a 58,68 24a,25a
--
Jaboromagellsne (43) Dthydroxy Compounds :
Jaborosalactone M
2,3-Dehydrojabcrcsalactone M (45).
148,178
-do-
37
Rihydroxy Compounds :
Withanolide E (46)
14a,178, 20 8
58,68
2,24
--
Withaperuvin E (47)
14a,175, 20 6
56,68
24
4-ox0
48,178,208 56,68
24
--
14a,178,
56,66
24
--
Jaborosalactol M (50)
148,176, 26a
58,68 i 4 ~25u ,
--
2,3-dehydrojabcrcsalactol M (51)
148,178, 26a
56,68 24a,25"
2
Withaperuvin G
(48)
2,3-dihydrowithanolide E (49)
20
167-68 (Acetone)
+
103.5
P. peruviana
85a,b
248-50 (Acetone)
-
72.5
P. peruviana roots
34
163 (CHC13)
_-
273-75 (Acetone)
--
P. peruviana
22,26-lactol
234-36 (EtOAc)
--
J. bergii
22,26-laccol
--
_-
-do-
leaves -do-
26b 26a
37 37
147
148
TABLE
l b ( Contd.
% , 6 6-EPOXIDES W I l l I 17a - S D E CHAIN
bID
Compound
Hydroxyls
Epoxi.de
Ene
Other g r o u p s
Physagulin C (52)
48,14a, 15a-OAc
56,68 168,176
2,24
--
242.5-243
+
105.8
P. a n g u l a t a ( L e a v e s & Stems)
86
48,14a 178,208
56,166
2,24
--
197-98 (EtOAc)
+
95.8
P . peruviana
26a 87
Visconolide (54)
48,14a, 178,208, 28
58,66
2,24
--
P. v i s c o s a
88
Physalactone (54a)
36-OMe, 46 -OH, 14a-OH, 178 -OH, 206-OH
58,68
24
--
P . alkekengi
58
Tetrahydro-
m.p.
("C)
Source
Ref.
Compounds:
4 -Hydroxywl.thanoll-de E (53)
Pentahydroxy compounds:
*
Not a v a i l a b l e
149 Fig. l b . 5 p ,6 p - Epoxides with 17a - side chain
43. R, = R3 = H,R2-CH, 12.0XO,2,3-diH
49 R, = R3 = H, Rz - OH Ma^OH ,2,3-di H
44. R , - R3-H,R2=OH, 14p-OH,2,3-diH
50. Ri = R3 = H,R2^0H, 14p -OH, 22-26, lactd, 24a,25a-epoxy, 2,3-di H
45 R, -R3-H,R2-OIi 24a, 25a - epoxy
51 R, =R3 = H,R2-OH, 14P-0H, 22-26 lactol, 24a,25a-epoxy
46. R, =H,R2 - R3 - OH, 14a-0H
52 R, =0H,R3 = H, 15a-OAc,R2=16p, 17p-q)oxy 53. R, = R2 - R3 = OH, 14a - OH
47. Ri =OXO,R2=R3= OH, 14a-OH,2,3-diH 48. R, = R2 = R3 = OH, 2P, 3p - epoxy
54. R,-R2=R3=OH, 14a - OH, 28-OH 54a. R, - R2 = R3 = OH, 14a - OH, 3p - OMe, 2,3-diH
150
TABLE l c 5B,6 6-EPOXIDES WITH MODIFIED SIDE CHALN ~
Compound
Hydroxyls Epoxide Ene
PI,
Other groups m.p. ("C)
Source
Ref.
Monohydroxy Compounds :
NS 1
Dihydroxy Compounds
vi th
Y-lactone side chain : (+)
Jabnrnsalactnne M (55)128,178
58,66
2,24
Trechonolfde B (56)
178,228
Trechonnlfde B (57)
176,22,2
56,65 2,24 12,22hemiacetal 58,66 2,24
Acnistin A ( 5 8 )
175,25
58,66
Jabcrosalactone U (55a) 128.176 Trihydroxy Compounds with Y-lactone in the side
12,22-~xidc 22,2641 de 22,26-olide 12 -Me0
---
* 264 (CH2C12:hex)
--
--
-
J. mageiianica
a9
Trechonates l a c i n i a t a
45
-do-
45
A . ramifluorum
Meirs
Leaves
56 66 2 248 ,258
42 215
J. sativa
chain :
Ixocarpalactnne B (59)
4 6,200,
56,65
2
Acnistin E
4 6,178
56 ,66
2
(60)
22
~
25
P . ixocarpa Brnt
20,24-cyclo methylene
--
--
A. ramifluorum
Meirs
25 42
Tetrahydroxy Compounds in the side chain:
idth I -lactone
Ixocarpalactnne A (61)
46,166, 205,22a
56 ,613
2
Withajardin E
36,48,
58 ,66
-
(61a)
1 7 ,24a ~
-21,25-cycln
294-95 (Et0Ac:MeOH)
+
a4
P . ixocarpa
Brot
Depreaorinocensis
25 25a
151 Fig, k .
3p,6P- Epoxides with Modified side chain O
OH
55 .
55a . 24P,25P - epoxy
5 6 . R = H , R, = OH 5 7 . R = OIVIe,Ri=OH
OH OH
Acnistin A (58) Acnistin £ (60)4P - OH OH
HO Ixocarpolactone B (59) HO O
OHE
OH 6 1 . Ixocarpolactone
OH
61 ( a )
Id
152
TABLE
6a ,7=-EPOXIDES W I T H 178- SIDE CHAIN ~
~
Compound
Other groups m.p.
Hydroxyls Epoxide Ene
[a ID
("C)
~~
Source
Ref.
Monohydroxy Cmpounds :
Lycium substance B (62)
f3,7a
2,24
--
260-65
+ 107
Lycium chinenseleaves 35
Withanicandrin (63)
6a,7Q
2,24
12-0x0
267-69
+ 105
Nicandra physaloides
90
Daturalactone A (64)
6w ,7a 24a,25a
2
12-OX0
303-05
+
Datura guerolfolia 8 D stromoniurn
91 31
Daturalactcne D (65)
6a ,7a
2
--
Nicalbin B (66)
6a ,7a
2
5-Dehydroxywithanolide R (67)
6a ,7a
2,24
--
Withancne (68)
w,ia
2,24
--
5-27-dihydrcxy-1-0x06a,7a-epoxy-22R-witha2,24-dienclide (693
@,7a
2,24
--
Withanolide R (70)
6a ,7a
2,24
-_
6a,7a
2
'
16,26-rxidc
--
282 275-76 (EtOAc)
63
+
--
24.2
--
.
D . queroifolia
92
Nicandra physaloides var. albiflora
93
W. somnifera (Pak variety)
94
Gi. somnifera Dun
66
Dihydroxy Compounds :
Nic-3 (71)
24 a,25a
275-76 (CHC13:EtOAc) 230-32 (EtOAc) (27-acetate)
f
+
81 73
- 64 182-83 (23-Acetate) -22,26-lactcl 248
(Indian chemctype) -do-
66
W. somnifera 95 (Chemctype I V s . 111)
Nicandra pysaloides
96a,b
TABLE
Id ( Ccntd.
6a,7a-EWXIDES WITH 178- SIDE CHAIN Compound
Hydroxyls Epoxide Ene
Other groups m.p. ("C)
Nic-7 ( 7 2 )
5a,26a
12-cxc; 22, 26-lactcl
5 a, 20aF-dihydrcxy6 a,7 wepoxy-l-cxc-witha2,24-dienclide (73)
5a,206
Daturalactone B (74)
5a,12a
Daturalactcne C (75)
5a,12B
Nicandrin B (76)*
5a,12a
m,7a 24a,25a W,7a
@
,7a
@,7~ 24a,2Sa 6a,7a
2
263 (Benz :CHC13) 282-4
I a ID _-
+
Source Nicandra physaloides
96a,b
w.
coagulans
16a
91
34
2,24
--
2
--
260-61
0
2
--
285-86
-I-73
N. Physaloides 8 D. quercifolia D. quercifolia
2,24
--
246-48
+
N. physaloides var.
88
110.7
Ref.
97
albiflora
Withaferoxolide (76)*
5a,12a
6a,7a
2,24
--
Vamcnolide (77)
5a,14a
6 ,7
2
--
*
*
P. angulata leaves
98
Ixccarpanclide (78)*
5a,206
6a,7a
2
--
*
*
P. ixocarpa aerial parts
99
W,20 6
6 ,7
2
-
281-83
-123.59
W. somnifera r m t s
217
256-58 (EtOAc) (3-Acetate)
+
71.5
W. somnifera (Indian chemctype)
66
257
+
60.5
W. somnifera (Chemotype I11 Vs. Ind. I)
100
Withasomnifercl B (29
>
278 (mci3)
116.4
D. ferox aerial parts 31
Trihydroxy Compounds :
1 a,3 6 , 5 &trihydrcxy6 a, 7 wepcxy-1-cxc-22Rwitha-24-enclide (80)
1~,36,5a ~ , 7 a 24
Withanolide T (81)
5",14", 20%
6",7a
2,24
-
--
153
154
TABLE Id ( Ccntd. 6a,7oEPOXIDES WITH 178- SIDE CHAIN ~~
~
~~~~
Compound
~
Hydroxyls Epoxlde Ene
Vitastramonolide (82)
5 SlP, 27
Nicalbin A (83)
5";1@, 26
i elD
Other groups m . p . ("C) 269-70 ( MeOH
6a,7'3 2 24a,25a
+ 37
W ,7a
2,24.
--
250 (CHC13:MeOH)
i29.8
140 -hydroxywithancne (85) 5 a, 148, 17
W,7"
2,24
--
280 (EtOAc)
+
148 -hydrexyixccarpanelide 5 a, 146, (86) 20 a
6a,7a
2
5 a, 120,
Withascmniferol A (86b)
5 a,208, 27
(86a)
N . physaloides
albifl ora
14"-hydrcxywithancne (84) 5 a, 14a, i7a
158 -hydroxynicandrin B
*
do-
36.7
*
*
Nct available
$'*
--
+
271-73
: May be identical
+
74.8
var.
93
s o m n i f e r a (Ind. VS. 102 Chemotype i11)
P. a n g u l a t a D. ferox
2,24
101
w.
150
6a,7a
Ref.
D . strarnonium
22,26-lactol 241-43 (EtOAc)
24,25-dihydr@
Source
leaves
W. somnifera rcots
Identity nct established
102 103
318 21T
155 Fig.Id. 6 a,7 a - Epoxides with 17 P - side chain
OH 62. Lycium substance B
72. 1 2 - 0 X 0 , 26 < , 24a,25a-epoxy OH
63. 1 2 - 0 X 0 , 64. 12 - 0X0 , 24a,25a - epoxy, 65. 24,25-diH
73. 20P-OH 74. 12a -OH , 24a,25a - epoxy
66. 16,26-oxido,24,25-diH
75. 12P-OH, 24a,25a-epoxy
67. 5 - deoxy, 23 a - OH ,
76. 12a-OH
68. 17a -OH
77. 14a - OH , 24,25 - di H
69. 27 - OH
* 78. 20p - OH , 24,25 -di H
70. 23a-OH
• 79. 20p OH, 24,25-diH
71. 24a , 25 a - epoxy H 26 < OH * identity not established , appear different by physical constants.
156 iMg. Id. 6a,7a- Epoxides with 17 (]-side chain
80. l a - 0 H , 3 p - 0 H , 2,3 - di H 81. 14a - OH, 20p - OH 82. I2a-OH,27-OH
83. 16a-OH, 26 < 24a,25a - epoxy OH 84. 14a - OH, 17a - OH 85. 14p-OH,17a.OH
86 . 14a-OH,20p-OH, 24,25a - di H 86a. 12a-OH,15p-OH 86b . 20p - OH, 27 - OH
Fig. le. 6 a,7a-Epoxides with 17 a-side chain
87. Withasomniferin A, 4en , 17p - OH H 88. 5a - OH , 17p - OH , 26 < ,24a ,25 a - epoxy, 2 en OH OH 89. 5a - OH, 25 a - OH, 26 < , 17p , 24 p - Oxido , 24,25 - di H H
TABLE
le
6a,7crEPOXIDES WITH 17
Ccmpound
Hydroxyls Epoxtde Ene
-
SIDE CHAIN
Other grcups m.p. <"C)
[a],
Source
Ref.
Mcnohydrcxy Compounds
Withascmniferin
ZL
--
W. scmnifera (Pak. variety)
224-45
--
N. physaloidesleaves 104
277
_-
(87)
94
Dihydrcxy Compounds
Nil Trihydrcxy Compounds :
5a,17B,
Nic-2 ( 8 8 )
6 a , 7a 24a,25a 2
--
26a
5a,25a, 26 B
Nic-11 (89)
6a,7o
2
17i.245 cxidc
m L E
-do-
96b
If
6a,7a-EPOXIDES WITH AROMATIC R I N G D (ME0 COHPOUNDS)
Compound
Hydrcxyls Epoxide Ene
Nic-1 ( 9 0 )
5a,26a
Nic-1-lactcne (91)
50
5 a,26a 24a,25a 5u, 6 a 24a , 2 P
Other groups m.p. I ' C )
2
--
138
2
--
230-32
[%ID
--
+
Source
N. physaloides
Ref
105
34.6
-do-
106
-dc-
107
5 a, 22
6Q
la
2
24-rxo
86
Nic-12 (93)
5a
6a
la
2,22
24-cxo
174-75
_-
-do-
107
Nic-10 ( 9 4 )
5a
6a
la
2
20-ow
107 (EtOH)
_-
-do-
1 U7
157
Nic-17 ( 9 2 )
--
158 Fig. If. 6 a,7 a - Epoxides with aromatic ring D
Nic - 10 ( 94 ),
Nic-17(92),
R=
Nic- 1 - lactone ( 9 1 ) , R =
Nic-1 (90),
R=
OH H
TABLE lg 5-ENES WITH 1 7 a SIDE C"
Compound
Hydroxyls Epox-Lde Ene
Other groups m.p. ( " C )
Source
[a],
Ref.
Mcnchydrcxy Compunds:
-
*
57
i7.5
*
57
2,5,8(14) 24
tic name ( 9 6 )
Withaphysalin A (97)
2,5,14, -184-85 24 -* 5,24 2,5,24 18-20 lactcne 222-23
Withaphysalin D (98)
3,5,24 18-20 lactcne
Seccwithametelin ( 9 9 )
2,5,24 27-Me0
190
i28.53
Jaturametelin C (100)
5,24
27-Me0
199-202 (CHC13:MeOH)
i68.7
-do-
110
Daturametelin E (101)
5,24
3 -OS03H
An amcrphcus pcwder
i25.8
-dc-
110
Ccagulin (101a)
3,5,24 14 ,20 -cxidc
coagdens
126a
Withascmifercl
14,155-epoxywithanclide I 20 (101b)
14,155
2,5,24
--
210-11
i56.5
No najle ( 9 5 )
*
* i43.6
*
W. somnifera
5 7.3
P. minima
64
(Indian variety) P . minima var. I n d i c a
108
D . metel
109
w.
Withania c o a g u l e o s
16c
159
lg ( Ccntd.
160
TABLE
5 - W S WITH 178- SIDE CHALN
Compound
Hydroxyls Epoxide
Ene
Other groups m.p.
("C)
[a
ID
Source
R2f.
Dihydrcxy Ccmpcunds :
17Q, 27-dihydr~xy-1-cxc 22a-witha-2,5,24trienclide (102)
17a,27
7,27-dihydrcxy-l-cxc witha-2,5,24-trienclide
78,27
--
2,5,24
--
205
+
74
(27-acetate) (acetcne:hex)
--
66
2,5,24
--
208-09 (7,27diacetate)
-
119
-do-
66
2,5,8(14), 24
--
224-25
+
48
*
57
Withanelide 0 (105)
2,5,8(14), 24
--
201-02 (CHC13:EtOAc)
+
112.5
Withanclide N (106)
2,5,8(14) 24
--
Amcrphous + 31 (27-acetate)
Withanclide G (107)
2,5,24
--
194-95 (EtOAc)
+
52.5
Withanclide J (108)
2,5,24
--
215-16 ( CHCl :EtOAc
+
32.5
-do-
111
Withanclide L (109)
2,5,14,24
--
213 (EtOAc)
+
9.6
-do-
111
(103)
Nc name
(104)
Withanclide M (110)
17a,205
14 ,15
2,5,24
--
240 (EtOAc)
+ 44.6
Withanclide I (111)
17a,20E
--
3,5,24
--
184 (EtOAc)
+
118
W. somnifera (Chemctype I) -dc-
W. somnifera (Chemctype 111)
w. somnifera (Chemctype 111) -do-
78 78 111
111 111
TABLE
lg ( Ccntd.
5-ENES WITH 176- SIDE CHAIN
Compound
Hydroxyls Epoxi.de
Ene
Other groups m.p.
[ QID
("C)
Scurce
*
Ref.
4 6,208
--
2,5,8(14) 24
--
230 (4-acetate)
+
110.6
la -hydrcxywithanclide (113)
la,14a
--
5,24
--
152-55
+
48
W. aristata Pauq (aerial parts)
112
Withaphysalin C (114)
14 8
+
33.4
P. minima (Indian chemctype)
113
114
J6-Withanclide
13,14 2,5,24 epoxy (13,14-secc)
8-20 lactcl 202-03
14a,208
--
2,5,16,24
--
212-13 (EtOAc)
+
44
W. sornnifera (Chemctype 111)
5,6-desoxywithaferin A (116)
4 8,27
-
2,5,24
--
218-20 (MeOH)
+
42.5
A.
2,3-dihydrc-5,6-desrxywithaferin A (117) (20S,20R)-la-acetcxy-3 hydroxyitha-5,24dienclide
46,27
--
5,24
27.4
-
5,24
212-13 (EtOAc) Amcrphcus
+
la-OAc,36
---
--
2,5,24
--
--
--
2,5,24
--
200-02 (EtOAc)
(115)
18-acetoxy-4-decxy208,18-OAc 5,6-decxy-5-withanclide D (11W
+ 58.8
--
breviflorus Gresib -dr-
57
70 70
Dunalia australis
115
Iochroma fuchsioides
46a
W. somnifera (Indian chemvtype)
95
rrcts
Trihydroxy Compeunds :
Withanclide Q
(119)
17a,236,27
-
6.6
161
lg ( Ccntd. 1
162
T&LE
5-ENES WIITH 17 - SIDE CHAIN ~
~~
Compound
Hydroxyls Epcxide Ene
L QID
Other groups Q . P . ("C)
Uithanolide H (120)
140,20~, 27
2,5,24
141-42 (EtOAc) (27-acetate)
Withanelide K (121)
140,170, 20
2,5,24
218-19 (CHC13:EtOAc)
17bhydrexywithanclide K (121a)
140,178,
2,5,24
45,76,20cctrihydrexy-1rxc-witha-2,5,24trienolide (122)
46,7B ,208
2,5,24
lB-acetoxy-5,6-deoxy5-withenclide D (118b)
45,208,18CH20Ac
2,5,24
Withanclide U (123)
45,140,
2,5,24
140,206,27
3,5,24
3 8,2C 0 -trihydrexyF 20R,22R-witha-5,24dienrlide (125)
10,35 ,208
5,24
Pubescenolide (126)
lQ,36,27
5,24
Physalclactcne B (127)
la-OAc, 38,206
5.24
(
124)
i0
~
+
35.5
9.2
Ref.
Y. somnifera
111
-do-
111
W. coagulens
16c
205
206
27-hydroxywithanrlide I
+
Source
234
+ 9.8
Dunalia australis (Griseb) Sleum
116
Iochroma fuchsioides 46a 230 (4-acetate)
+
* 273 (EtOAc)
110.6
* +
19.8
W. somifera Chemotype 111 Vs. Ind. I)
* W. somnifera
100
58 117
(Chemctype 111)
* *
* *
P. pubescens
118
P. peruviana
119
TaBLe lg
5-ms WIm Compound
Hydrexyls Epoxide Ene
( Ccntd.
1
178- SIDE CHAIN
Other groups m.p. ("C)
[.I,
Ref.
14a-20a,27-trihydrexy20R-22R-1-cxc-witha3,5,24-trienclide (128)
14a,20J, 27
--
3,5,24
--
Scminene (129)
la,36,27
-
5,24
-
Withajardin (130)
46,14Q, 17Q,25
--
2,5
3a-hydrcxy-2,3-dihydrcwithanelide H (131)
36,14a, 20aF,27
--
5,24
--
190-92 (EtOAc:MeOH)
i
64.7
W. coagulaos fruits
121
(ZOR,22R)-3 Eacetcxy-1a, lZB,ZO-trihydrcxy-l-cxewiiha-2,5,24-trienclide (132)
h ,36-OAC, 126,205
--
5,24
--
135-37
-
16.7
Dunalia a u s t r a t i s
115
184 (EtOAc)
i
98.7
W. somnifera (Chemctype 111)
117
*
*
W . somnifera
120
*
*
Deprea procumbens
51
Tetrahydrcry Ccmpouuds :
*
Nct
21,24-cycle
leaves
available
163
164
Fig.lg . 5 Eiics with 17 p- side chain
95 96 97 98 99
. . . . .
14a-OH, A^A«^''^ 20P - OH, A^ , A^^
14a - OH, A^ 18,20-lactone 14a-OH, A\18,20-lactone 21-OH,A^27-OMe 100 . 21-OH,27-OMe 101 . 21-OH,3p-0-S03H
101a. 101b. 101c. 102 . 103 . 104 . 105 . 106 . 107 . 108 . 109 .
27-OH,A\l4a,20a-oxido 20P-OH, 14,15 p-epoxy,A^ 3p - OH, 14a, 15a - epoxy 17a-OH, 27-OH, A^ 7p - OH, 27 - OH, ^ 17a-OH,27-OH,A^A^^''*^ 4P-0H, 17a-0H,A',A''^'^^ 7a - OH,27 -OH, A^A'^'^^
4a - OH,20p - OH, A' 17a- OH,20p-OH,A^ 17a -OH, 20p - 0 H , A ' ^
110 . 17a - OH,20P-OH, 14a ,15a - epoxy, A^ 111 . 17a- OH;20p-OH,A' 112 . 4p - OH,20p - OH, A^A'8(14) H 113 . 1< , 14a-OH OH
114 . 14P-OH, 13,14, seco - 13,14 - epoxy, A^ 115 . 14a-OH,20p-OH,A%A'^ 116 . 4p - OH, 27 - OH, A' 117. 4p-OH,27-OH, H 118 . 1< , 3P-0H OAc 118a. 20P-OH, 18-OAc, A^ 118b. 4p - OH, 20p - 0H,18 - OAc, A^ 119 . 17a - OH,20p - OH,27 - OH, A^ 120 . 14a - OH, 20p - OH,27 - 0H,A' 121 . 14a - OH, 17a - OH, 20p - OH, A' 122 . 20p-OH,A^ 123 . 4P-0H, 14a-OH,20p-H,A' 124 . 14a - OH, 20p - OH, 27 - OH,A^ 125 . la - OH, 3P - OH,20p - OH 126 . la - OH, 3P - OH, 27 - OH H 127 . 1>< , 3p - OH, 20p - OH OAc 128 . 14a - OH, 20a - OH,27-OH, A^ 129 . la - 0H,3p - OH, 27 - OH 130 . 4P-0H, 14a-OH,17a-OH,25-OH, A-,21 - 24 - cyclo, 24,25 - di H 131 . 3P-0H, 14a-OH,27-OH,2,3-diH, 20p - OH H 132. 1>< ,3p-OAc,12p-OH,20p-OH OH
TABLE
lh
5-ms WITH 17aCompound
Hydroxyls Epoxi.de Ene
__
Withanclide withnchydrcxyl k%ydroxy Compounds : Neb? nithznclide (13%) 17 B
SIDE CHAIN
Other groups m.p. ("C)
[ 0ID
Source
Ref.
- -.
3,5,24
14-20 Oxy
W . somnifera
85b
--
2,5,24
14-20 Oxy
W. somnifera
05c
__
2,5,24
--
216-17 (EtOAc)
W. somnifera
85b
2,5,24
-dc-
85c
_-
2,5,24
--
192-93
--
W . somnifera
85a
*
*
P. alkekengi (Turkmenisrhan)
122
*
*
P . viscosa
123
Dihydroxj Compounds :
Withanclide P (133b) New withanclide
140,176 173,200
+
51
Trihydroxy Compounds :
Withanclide F
(134)
1 4 ,176, 205
5.24
Physanclide (135)
4-CXO
(Chernctype 111)
Tetrahydroxy Compounds :
Nil Pentahydroxy Compounds :
28-hydrcxywithaphysanclide (136)
Nct available
--
5,24
--
165
*
46,14a, 1)B ,206,28
166
Compound
Hydroxyls Epoxlde Ene
--
Daturametelin D (137)
21,24epoxy
2,5
Other groups m.p.
("C)
[al,
Source
Ref.
199.5-201.5
- 90.6
D . metel aerial p a r t s
110
--
210
-
64.4
D . metel leaves
12 6
--
280
-
77.7
Amorphous pcwder
i5.0
27-Me0
CYCl3-MeOH
Wlthametelin (138)
--
21,24
2,5, 25(27)
Isowlthametelin (139)
--
21,24
335, 25(27)
Daturametelin F (140)
--
21,24 epoxy
5, 25(27)
126,176,
--
2,5,24 12,23-cyclo; 23,26-olide
--
2,5
26,28-olide
217-18 (EtOAc)
i56.8
P. peruviana leaves (Varanasi variety)
127
--
5
26,28-olIde
239-40 (MeOH) 244-45 (EtOH)
-
P. peruviana (Varanasf. variety)
128
Jaborosalactone P (a splranic withanolide) (141)
22
Perulactone B ( 1 4 2 )
14a,176, 206,22a
Perulactone (143) (176-oriented side chaln)
la-OAc, 36,206, 22a
3 -OS03H
*
*
3.2
-doD. metel aerial parts J . odenelliana
126 110 40
167 Fig. Ih , § - Enes with 17a - side chain
I33b R =H,A^ 133c. R = OH, 14-deoxy,A^ 134 . R=OH 135 . R = 0 H , 4 - 0 X 0 136 . R = OH,28-OH,4p-OH
3,4-diH,A^
Fig.li. 5 Enes with Modifled side chain
137 . A%27-CH20Me 138 . A''"<">
139 .A''25^27)
140 . A ' " ^ ' ' \ 3 p - 0 - S 0 3 H
168
OH
141 Jaborosalactone P.
142 Perulactone B OH 0H =
143 Perulactone
(145)
OH 144 With aphysaJian £
TABLE lj INTEXMDIATE COMPOUNDS WITH 178- SIDE CHAIN
Compound
Hydroxyls Epoxide Ene
Ocher gxups m.p. ("C)
[a],
Source
Ref.
Hcnchydrcxy Ccmpcunds : 68
Withascmidiencne (145)
27
W. s o m n i f e r a
126a
Jaborosalactone B (146)
68,27
Jaborosa i n t e g r e f o l i a Lam
67
Jabcrcsalactone C (147)
58,27
--
2,24
6 -Cl
218-20 (CHC13:EtOH)
-
-dc-
130
Jabcrcsalactcne E (148)
6 8 , 27
--
2,24
5 -C1
225-28
--
-dc-
130
Withacoagulin (149)
5u 208
*
*
Withania coagiilans
131 66
-
2,4,24 18-20 lactcne 311-12
+
Withaphysalin E (144)
61.4
var.
P . minima Indica
129
Dihydrcxy Ccmpcunds :
I
2,6,24
-
2,6,24
-
238-39 deccmpcses ( CHC13 :EtOAc )
+
75.5
W. SOmnifera Dunal
5a,17a-dihydrcxy-l-cxc22R-witha-2,6,24trienolide (150)
5a,17a
-
2,4,6-trien-l-cne (151)
14u,206
-
2,4,6,24
-
220-22 (EtOAc)
+
12.2
W. s o m n i f e r a L (Chemctype I1 Vs. Ind. I)
132
Pubescencl (152)
4u.7a
24 ,25
-
--
180-81
+
11.4
P . pubescens
24a
Scminclide (153)
48,27
14 ,15
-
*
*
W. s o m n i f e r a
120
2,24
(Indian chemctype)
(Panistan variety)
169
170
TABLE lj INTEWJDUl"E
( Ccntd. )
COIPOUNDS WITH 176- SIDE CHAIN ~
Compound
Hydrcxyls Epaxi.de Ene
Other graups m.p. ("C)
Source
[QID
Ref.
5a-methcxy-4,5-dihydrcJabcrcsalactcne B (154)
6 427
--
2,24
5 a-Me0
200-01
--
5*ethoxy-4,5-dihydrcJabcrcsalactcne B (155)
68,27
--
2,24
5a-ethcxy
203-04
--
GO-chlcrc, 5 Ehydrcxywithaferin A (156)
4Bt5B,27
-
2,24
6Q-Cl
281-84
+
68
4B,5 B,20 F -trihydrcxy-
48,5B,16Q
-
2,24
6a-Cl
247-49
+
76
Dunal i a tubul osa
5a
Acnistcferin**(158)
5Q,6B ,27
285-88
+
99.6
Acnistus b r e v i f l o r u s
41
Jaborosa i n t e g r e f o l i a
130
Acnistus b r e v i f l o r u s
-do-
69 69
Trihydrcxy Ccmpeunds :
Q
Withania f r u t e s c e n s
133
Pauq
6-chlcrc-1-cxc-witha2,24-dienclide (157)
227-29 (EtOH)
Jabcrcsalactcne D** (159) 5a,68,27
-
Withametelin C (160)
5a,68,21
--
24
Physagulin B
6B114Q 15a-OAc
--
2,16,24 5Q-Cl
(161)
**
* A white powder
May be identical
--
* 159.5
Lam D. metel
135
P. angulata L
77
Compound
Hydroxyls
Epoxide
Ene
Other groups
m.p. ( " C )
294-95
--
2,7,24
-_
Jaborosalactone F (163) 5a,65,12a, 27
-
2,24
--
Withamf.nCmin (164)
5a,66,14a. 15a-OAc
--
2,16,24
--
48, 5a,66,
19,27
WCthasomnCferol C (162) 5a,14@,205
[a],
+
67.78
Source
U. somnifera
Ref.
217
Tetrahydroxy Compounds:
268-70 (Acetone: Pet. ether)
-
208 (Amorphous powder)
-.-
Jaborosa i n t e g r e f o l i a 136 Lam P . minima
21b
Jaborosa l e u c o t r i c h a
3~~
Pentahydroxy Compounds: Jaborosalactone X (165)
24
204-05
171
172 Fig. IJ , Intermediate Compounds with 17(3- side chain
R,A^'<=
146 . A \ 6p . OH, R, = H, R2 = OH 157. 4P - OH, 5p - OH, R, = OH, R2 =H,6a-Cl 147. 5p - OH, 6a - CI, R, = H, R2 =0H 158. 4p-OH,5p-OH,16a-OH,6a-Cl, 148. 5a - CI, 6p - OH, R, = H, R2 =0H R, = R2 = H 149. 5a - OH, R, = OH, R2 = OH, A' 159. 5a - 0H,6p - OH,R, = H,R2 = OH 150. 5a - OH, 17a - OH, R, = R2 = H,A^ 160. 5a - 0H,6p - 0H,21 - OH,R, = R2 =H, 151. 14a - OH, R, = 0H,R2 = H , A \ A^ 2,3 -di H 152. 4a - 0H,7a - OH,24a ,25a - epoxy, 161. 5a-CI,6p-OH,14a-OH,15a-oAc, R, = R2 =H R, = R2 = H 153. 4p - OH, R2 = OH, R, = H, 162. 5a - OH, 14a - OH, R, = R2 =H 14a, 15a -epoxy 163. 5a - 0H,6p - OH, 12a - OH,R, =H,R2=0H 154. 5a - 0Me,6p-0H,R2 =OH,R, = H 164. 5a.OH,6P-OH,15a-OAc,R, = R2=H 155. 5a - OEt, 6p - OH, R2 = OH,R, = H 165. 4p - OH, 5a - 0H,6P - OH, 19 -OH, 156. 4p - OH, 5p - 0H,R2 = OH, 6a - CI, R2 = 0H,2 ,3 - di H R,=H
lk
TABLE
INTERMEDIATE COwpouNDS WITH 17a SIDE CHAIN ~~~
~~
Compound
Hydroxyls Epoxide Ene
~ ~ _ _ _ _ _ _ ~
~
Other groups m.p. ("C)
I QID
Source
Ref.
Monohydroxy Compounds : Ni1
Dihydroxy Compounds N o Name (166)
:
56.178
12.22oxi.do
-Jaborosalactone T (166a) 58,178 Trihydroxy Compounds : Jaborosalactone R (166b) 66,128,178 -Tetrahydroxy Compounds :
--
Wi thaperuvi.n C (167)
66,14a 178,206
Wtthaperuvin D (168)
48,56, 14a, 2a,6a178 ,206 oxido
Physalolactone C (169) 46,58, 176,20 8
--
Withaperuvin F (170)
46,56, 176,206
3a,6aoxido
4-Deoxyphysalolactone (171)
56,14a, 176,208
--
Jaborosalactol N (172) 68,148, 178,26a Withanolide C (173)
--
2
6a-C1: 12 -Me0 * 23,26101Cde Q-C1; 12-0Me 234-35
2,4
--
2,4,24
--
*
24
.-
209-11
2,14,24 6a-Cl 2,14,24 2,24 2,4
2,24
-6a-Cl
-5 -C1
*
J. magelianica
138
*
J.
sativa
219
sativa
219
*
263-64
+
*
*
P . peruviana
139
12
-do-
140
*
P . peruviana
141
174-75 (CHC13)
+
207-208 (Et0Ac)
i103
183-85
--
J.
39.70
-doP . peruviana
(Varanasi variety)
--
Jaborosa bergii
--
Y. somnifera
26b 142 37 137 173
68,14a, 178,206
24a,25a
2.24
174
TABLE lk (Contd.) IMZRWDIAlZ COMPOUNDS WITH 17'-
SIDE CHAIN ~~~
Compound
Hydroxyls EpoxCde Ene
Other groups m.p. ("C) 5a-Cl
*
--
265-66
68,14a,178, 206 Jaborosalactone S (166~)5a ,613,128,178 Pentahydroxy Compounds:
---
2,24
WCthanoltde S (174)
50,66,14a, 7 6,206
--
2,24
--
Physalolactone (175)
48,56,14a, 176,206
--
2,24
6a-c1
Wtthaperuvtn B (176)
48,58,6a, 176,206
--
2,14,24
Wtthaperuvtn H (177)
48,58,14a, 178,208
-
2,24
28-Hydroxywithaperuvtn C (178)
66,14a,i76, 208,28
--
2,4,24
--
*
--
2,24
--
*
--
2,14,24 6GCl.
Wtthanolide C (17%)
Wtthaphysanoltde (179) 46,5",14a, 178,208
2
--
[a],
Ref.
Source
* *
3. sativa
219
137
W. somnifera
272
+
97.5
P. peruviana
143
227-28
-k
29.4
-do-
144
*
*
4,6-mercapto 213-14 acetaldehyde adduct
+
84.3
P. peruviana
roots 139
-do-
P.peruviana -do-
145
leaves
88
146
Hexahydroxy Compounds:
23-Hydroxy physalolactone C (180)
48,58,17B, 20 8,23a
202-04
-k
60
P. peruviana
leaves 147
lk (Contd.) UITB 170- SIDE CIIBLN
TAE4IZ
INTERMEDIATE Epoxtde
Wtthaperuvh (181)
4 8,5 8,6 Q, 14~,178,208
--
2,24
--
28-Hydroxywithaphysanoltde (182)
48,5~,14~, 178,206,28
--
2,24
-
*
Physagultn F (183)
58,68,148,
2,24
--
A white powder
*
15Q-OAc
16?,178
Other groups
m.p. ("C)
Hydroxyls
Compound
Ene
COMPOUNDS
225-27
(MeOH)
Ref.
Source
+
156.8
*
+
70.7
P. peruviana (Varanast vartety)
142
P. viscosa leaves
123
P. angulata
148
L
Not available
175
176
lAoA^
OH
(166)
OH
OH ( 177) With aperuvinU
166a . 5P - OH , 6a - CI, R = OMe 1 6 6 b . 6 P - O H , R = OH,A4 166c . 5a - OH , 6p - OH, R = OH , 24,25 - di H
177 Fig. 1 k. Intermediate Compounds with 17a - side chain
167 . 6p - OH, 14a - OH, Ri = R2 =0H, A^ 168 . 4p - 0H,5P - OH, 14a - OH, R, = R2 = OH,2,3 - di H,3a -,6a -Oxido 169 . 4p - OH, 5p - OH, Ri = R2 =0H, A^\ 6a - CI 170. 4p - OH, 5p - OH, Ri = Rz = OH, A'\ 2 ,3 - di H,3a , 6a - Oxido 171. 5P - OH, 14a - 0H,6a - C1,R, = Rz =0H 172. 6P - OH, 14P - OH,R, = 0H,R2 =H, H 26 -C < , 24a ,25a - epoxy OH 173. 6p - OH, 14a - OH, R, = R2 ^ OH, 5a - CI.
174. 5a-OH,6p-OH,14a-OH,R, = R2=OH 175 4p-OH,5p-OH,14a-OH,R, = R2 = OH, 6a-CI 176. 4p - OH, 5p - OH, 6a - OH,R, = R2 =0H, 178. 6p - 0H,14a - OH,R, = R2 =OH,28-OH, A^ 179. 4p - 0H,5a -OH, I4a -OH,Ri =R2 K)H 180. 4p - 0H,5P - OH,R, =R2 =0H 23a - 0H,6a - CI 181. 4p -0H,5p-0H, 6a - 0H,14a-0H, R, = R2 = OH 182. 4p - 0H,5a - 0H,14a - 0H,R,=R2 =0H, 28-OH 183. 5p-OH,6p-OH,14p-OH,15a-OAc, 16p,17p-epoxy
Compound
Hydroxyls Epoxide Ene
Wi thanolide Y (184)
7Q17Q,205
5ah
2,24
Salpl.chrolide A (Ring D-arornatlc) (185)
26
5a,6a
2,13,15,17 22-26 (i3-18) lactol abeo
Somniferin (184a)
58 ,27
5a,6a
24
178
TABLE 1L 5 a,6 -Epoxu)ES
Other groups m.p. (“C)
--
4 -0Me
[a1 ,
270-73
--
179-80
--
--
--
Source Y. somuifera (Chemotype 111 vs. Ind. I)
Ref. 149
S. o r i g i n i f o l l a
52
W. somoifera
57a
QI,
Source
Ref.
-47.6
W. somnifera
132
I “I”
Source
Ref.
J. magelienica
150a,d
J. leucotricha
151
TABU l m 6 478-EpoXDES
Compound
Hydroxyls
66,7B-Epoxywithanone ( 186)
5a,14% 17a
Epoxide Ene
Other Groups m.p. (“C)
--
6 6,75 2 9 24
TABU
242-44 (CHC13)
[
In
pI1woLIc UI-LUIES Compound Jaborol (187) Jaborosalactone Q (188)
Hydroxyls
-1~,65,27
Epcxide Ene
---
Other groups m.p. (“C)
-1,3,5(10) 24
--
135 (MeOH)
--
176-77
---
179 Fig. 1.1. 5a,6a - Epoxides
(186)
^"'H
Fig, l.n. Phenolic Withanoiides O
(187)
OH
(188 )
180 71 withaferin A place
73 (12), withanolide D
at primary, secondary
(19). Hydroxylation
as well as tertiary
takes
positions.
A
primary alcoholic group is generally observed at C-27 in these 44 compounds while that at C-18 as in withacnistin (16) and lochroma withanolides ^ and at C-28 as in visconolide (54) is rare. Even hydroxylation at C-19 has been recently noticed ' Hydroxylation at C-14, C-17, C-20 is very common in withanolides eq. wi thanolide E "''"'^ (46). A close observation of the withanolides containing 6 a, 7 of-epoxides suggests the absence of C-4 hydroxyl in them unlike in 5 3,6 3-epoxides. Hydroxylation or an oxof unction at C-12 are 97 noticed in some of the compounds eg. daturalactone C (75). 14 3-hydroxy compounds have been isolated from Physalis pubescens 24b eg. physapubenolide (37) and from Withania somnifera eg. 102 (85) and even recently from Jaborosa 143-hydroxywithanone bergii Hydroxylation at C-15 was observed only in five compounds either
free
or
in
the
form
of
Physapubescein (35) and physapubenolide 95 95 Q (119) and R (70) possess 23-hydroxyl. noticed in nicalbin A93(83).
acetoxy
groups
eg.
(37). Withanolides C-16 hydroxylation is
Hydroxylation at C-1 and C-3 is mostly noticed in 5-enes. Epoxidation at the C-5 and C-6 positions with Epoxidation 5 0 , 6 3-conf iguration and at 6,7 position with G «, 7 «-conf i gura l.icjn is most common in withanolides. The isolation of withanolide Y149 (184), a 5a ,6a-epoxide 132 and 6 3,73-epoxywithanone (186) with 63,7B-configuration provides rare examples. Similarly epoxidation at C--2 and C-3 as in viscosa23 (22) (2 3,3 3-epoxy compound) and at C-14 and C-15, as in lactone A withanolide
M
(110) are also
rare.
In the side
chain,
epoxidation takes place prominently at C-24 and C-25 positions as , m . „. ^ . . . 104-107,96b , pubescenol , ,24a, datura, ^ ^ in Nicandra NiCi found steroids c' ,91,97 lactones^ 86 (52) has been ^^ig^ ~^i 7^ " Very recently physagulin C epoxide) isolated by Shingu et al. from Physalis angulata L. The
oxirane
bridge
is noticed
between
C-12 and C-22
181 positions, eg. Jaborosalactone M (44), trechonolide A (56), datumetelin"^^^ (137) and daturilin"*"^^ (138). The 3o',6a-oxiao (171), the 163,23-oxido bridge in bridge in withaperuvin F 25 ixocarpalactone B (59) and the 16,26-oxirane bridge in nicalbin B 93 (66) are a few other rare examples, Two new withnolides of Got, 7 a-epoxide series94 have been recently isolated, one without 5ot-hydroxyl 4 A -ene having 2,3-dihydro system.
and
the
other
with
Unsaturation Unsaturation at C-2 and C-24 positions is common in withanolides, while it is present at C-5 in twenty-five compounds. Unsaturation at C-14 and C-16 is rare. The /r compound ' was supposed to be the intermediate in the formation of compounds with 25(27) 17°^-oriented side chain. Unsaturation at ^ has been noticed 125 7 in daturilin (138). Withasomniferol (61) with A unsaturation has been reported very recently along with two more new withanolides, withasomniferols A & B from the roots of W. .^ 217 somnifera Dihydro systems A number of 2,3-dihydro derivatives were isolated with saturation of the 2,3-double bond eg. 2,3-dihydrowithaferin A 71 (13). The side chain may also possess saturated lactonic system as in 24,25-dihydro compounds. Incidentally, some tetrahydro derivatives have also been isolated as found in 2,3,24,25-tetra hydro-27-deoxywithaferin A (10). A dihydrosystem at C-5 and C-6 was also noticed in pubescenol (152) which was isolated by Row 4- al. 1 24a et Aromatisation Aromatisation in expanded ring D is common in steroids 07,96b^ ^^^ nicandrenone (90). Even
Nicandra phenolic
withanolides with B-secosystem were also isolated, eg. (+)-jaborol ' (187). It is observed that aromatisation takes place in ring D in 6 a, 7 o-epoxides and in 5 a, 6 a-epoxides. Nicandra
Steroids Nicandra
steroids possess a 5^-hydroxy-6 «, 7 o-epoxy pattern.
182 Additionally, thoy can bo classified into two types, (a) ring-D aromatic compounds and (b) So^-0H-6a , ?« ; 24 a, 25 a-diepoxy lactols. Furthermore, the side chain has been extensively modified to yield such complex structures as in Nic-11 (89) and even with cleaved side chains as in Nic-10''"^^ (94) or Nic-l?-^^^ (92). Several Nicandra steroids are closely related to withanolides (Chart I ) . Among them withanicandrin 90 (63) is the simplest. Their structures were established by X-ray crystallography and by chemical and spectroscopic data. The most important structural modification is the aromatisation of the ring-D in Nic-1 , 10, 12, and 17 . The side chain is also variously modified. The biogenetic relation 107 among these compounds was suggested by Begley et al. (Chart II). The aromatisation of ring-D involves the participation of 18-Me and especially 17 and 14 hydroxyls.
Crombie
presumed that
the aromatisation involves the 16-hydroxyl which is not commonly found in this group of steroids. A simple and convenient scheme (Chart III) with commonly occurring 17,14-dihydroxy compounds was suggested by L.R. Row for these compounds . The removal of 17-OH gives rise to C-17 carbocation which sets forth a series of rearrangements involving the intermediate 17-18 cyclosteroids giving rise to expansion of ring-D into a benzenoid ring. It is, of course, possible to visualise other schemes, but the scheme suggested has the merit and involves common reactions well known to occur biogenetically. Withanolides - relation with physalins Physalin A^° (89), B"'-^^ (190) and C"^^^ (191) were first reported by Matsuura et al. from Physalis alkekengi in 1969 and they estblished their structures beyond any ambiguity by X-ray analysis and also by chemical and spectroscopic study. Chemically, they are also related to ergostanes and bear resemblance to withanolides. The physalins are 13,14-secowithanolides with a bicyclolactone system in the side chain. (Table 1.0) T • ^ al. - 154-156, 22 have ^ - 1 4 . ^ severaln new physalins u Row et isolated from P' angulata and P- lancifolia . They are physalins D 154 (192), E 1 5 5 (193), F 1 5 6 (194), G^^ (195), H^^^ ^^^^^ ^ ^22 ^^^^^^ 156
(3^93) ^nd
K^^
(199).
The
structures
of
the
above
were
183 CilART - i BIOGENETIC RELATION OF NICANDRA STEROIDS TO WITHANOLIDES
6H
OH
^
Nic -3 (71)
H Nic-17(92)
{
O Nic -10 (94)
Nic -1 (90)
O Nic -12 (93)
184 Chart -11 Biogenetic Scheme ( Begley ct al) 1^7 ( for aromatisation in ring - D involving C - 18 methyl ) R
185 Chart - HI Biogenetic Scheme (L.R. Row ) 1^1 ( Ring - D aromatisation )
(O)
186
TABLE la PHYSALINS AND THEIR PHYSICAL CONSTANTS
Compound
m.p.
[a
1,
P h y s a l i n A (189)
266OC ( A c e t o n e ) 262°C (MeOH)
-
126
P h y s a l i n B (190)
25OOC ( A c e t o n e ) 271°C (MeOH)
-
150
Source
P.alkekeng1
var
.
franchelli
152
-do-
153
191)
274-277'C
EtOAc)
-160
Physalin D
192)
262-263OC
EtOAc)
-
68
P. minima
Physalin E
193)
305-307OC
MeOH )
-
83
P. angulata a n d P. (Leaves & Stems)
Physalin F
194)
295-296OC
-
20
Physalin G
19s 1
295-296°C
+
17
238-240°C
P h y s a l i n I (197)
305-306
(MeOH)
(MeOH)
+
12
20
-do-
Physalin C
P h y s a l i n H (196)
Ref
154
-doP.
lancifolia
P.
angula(Stems1 -do-
anc fo
I
155 156 22 155
22
TABLE lo ( Contd.)
PHYSALINS AND THEIR PHYSICAL CONSTANTS ~
Compound
[“I,
m.p.
-
Physalin J (198)
268-270°C
Physalin K (199)
280-282°C
Physalin L ( 2 0 0 )
248-249OC
- 118
Physalin N (201)
252-54’C
-
Physalin 0 ( 2 0 2 )
272-73°C
-
Physalin P (203
* *
Epidihydrophysalin C ( 2 0 4 ) Physalin (205)
270-274°C
60
Source
P.
--
angulata 8 P. l a o c i f o l i a
P . a n g u l a t a leaves
Re€
156 22
P. alkekengivar. franchelli
157
124
-do-
158
115
-do-
158
*
-do-
159
*
Wit h a r i n g i a c o c c u l o l i d e s
--
P . minima
47 160
187
188 O Phvsalins
O^ /P
Physalin A ( 1 8 9 ) ; R = OH PhysaliiiC(191);R = H EpidihYdrophYsalin C ( 2 0 4 ) ;
-24,25-diVdro
PhysaliiiO(202)R = OH, 25 pn - dihydro Physaiin L (200 ) AJ. 2,3-dihydro
Physalin B ( 190 ) , K> PhvsalinD(192); 5 a - O H , 6 p - O H Phvsalin E (193 ) ; 5 a - O H , 7 a - O H PhysaUn F ( 1 9 4 ) ; 5 p , 6 (5 - cpoxy Physalin G ( 1 9 5 ) ; A*. 6 p - OH PhysalinH( 1 9 6 ) ; 7 P - O H Physalin I (197 ) ; 5 a - OMe , 6 P- OH Physalin J (198 ) ; 5 a , 6 a - epox> Physalin K ( 199 ) ; 4 a» 5 a - epoxy - 6 a - OH PhysaUn (205 ) ; A4,6-OH
CH2 Physalin IS ( 2 0 1 )
physalin P ( 2 0 3 )
189 established
on the basis of chemical and spectroscopic evidence.
These are all derivatives of physalin B (190). 47 C (204) from Witharingia cocculolides
Epidihydrophysalin 4 , and a A ,
1fi0
(205) from P- minima
6-hydroxyphysalin
have also been reported
later. (200) was isolated from P. alkekengi
Physalin L
by Kawai
et al. and was shown to be 25-epi~4-dehydro-2,3^25,27-tetrahydro1 co
physalin A. Physalin O (202) (25S) 25,27-dihydrophysalin A and Physalin N (201a) were isolated from P. alkekengi var. franchetti. 159 (203) has been recently isolated from the same Physalin P species. There are several characteristic features of the physalins, A, B and C, in particular. a)
The lactone between C-18 and C-2 0.
b)
The oxido bridge between C-14 and C-17 with a 14 6-hydroxyl and oxido bridge between C-14 and C-27 giving seven membered oxygen heterocyclic system across the ring-C, D to the Y-lactone in physalin B.
c)
13,14-Seco ring system (C,D rings) with a 13a-hydroxyl.
d)
A ketone at C-15. The
biogenesis
of this
complex
and highly
oxygenated
steroids (8 rings) containing a minimum of nine oxygen atoms calls for
an elaborate
system
mainly formed in Physalis plants.
on the part of the plant. species
These
, not in the other
were
Solanaceous
A hypothetical biogenetic scheme, (Chart IV) was proposed
by Crombie et al. An insight into the biogenetic pathway can be gained from a study
of the structures
Physalis
species.
suggesting
that
of several
withanolides
cooccurring in
They were appropriately named as withaphysalins they
share
the general
characteristics of both 64 64 physalins and withanolides especially withaphysalins A (97), B (114) from P. minima ; 24b pubescens^ physapubenolide (37) from P. {2),
C
physapubescin
(35),
The withaphysallins A^"^ (97), B^^ (2) and C"^^"^ (114) share in common with physalins, the lactone (or lactol) between C-18 and C-20
and withaphysalin
C is a 13-14 secosteroid
with
an oxide
bridge between C-13 and C-14. It is noteworthy that withaphysalin A 64 (97) carries a 14 oe-hydroxyl while withaphysalin C (114) has
190 Chart - IV
OH OH Withaferin A (12 )
Withanicandrin ( 6 3 )
OH "OH Physlain A ( 189)
191 Q1
143-hydroxyl. Physapubescin (35) has the 24b function whorcas physapubenolide possesses along
with
14P-hydroxyl.
It
has
already
rare 15a-acetoxy 15^-acotoxy group
been
remarked
that
hydroxyl function is frequently noticed at C-17 and C-20 in several c o
withanolides.
A
corresponding
new
withanolide,
to withanolide
Turkhmenistan.
(54a)
physalactone in P. alkekengi
E occurs
found
in
This particular withanolide was shown to possess a
double bond between C-8 and C-14 which might be in fact an artifact from the parent 14a-hydroxywithanolide
(later A
structure was
corrected to 14a-hydroxy compound). CO
Thus
(54a)
physalactone
precursor
withanolide
essential
prerequisite
with
formation
of physalins.
to
can
be
regarded
as
14a,17a,20B~trihydroxy
start
the
biogenetic
the
ideal
system,
process
an
for
the
to
the
CO
Thus
physalcatone
is
the
key
biogenetic process, which is now represented in Chart V. step
is the oxidative
cleavage
of
C-13
and
C-14
bond
The key with
the
formation of 13-methylene, 14-ketone which sets the process to the course as shown in the Chart V Hypothetic biogenetic scheme to withaphysalin C physalin
(191)
C
by
17 o^OH-15-Oxophysalin scheme.
Odidative
transient
A
Glotter
14 a,i7 a-hemiketal
is
may
be
the
cleavage
of
13,14
13a,17a-dihydroxy-14-one
carbocyclic activates
E.
formation
frame work
from
16-methylene
which
precursor bond
(d)
(e).
in
(114) to
Chart
according
should
which
Thus
(d) due by
shown
is
to
result
the in
stabilised
rearrangement
to the presence
Michael-type
VI.
in of
addition
a by
the
15-one
at
24-25
olefinic bond affords the final product. Withanolide Glycosides Twenty withanolide glycosides have been isolated so far. Adam et al.49 isolated dunawithanine A (206) and dunawithanine B (207), m.p. 213° from the leaves of Dunalis
australis.
identified
evidence
on
the
basis
chemical degradation. (208)
was
isolated
(Varanasi variety). al.
from P- pubescens
of
spectroscopic
They were as
well
as
Physalolactone B-3-0-3- (D)-glucopyranoside by
A.B.
Ray
et
al.
from P-
peruviana
Pubescenin (209) was isolated by M. Sahai et 24b (Waltair variety) and it was shown as
la -acetoxy-2 0a -.hydroxy-24 a,25 a-epoxywitha-5-ene-22,26olide-33-0-glucopyranoside.
192 Chart - V Hypothetic biogenetic path of physalins ( L.R. Row ) ^^^
HO^ 5 .R
OH
OAc
OH
O HOL?^R
OH
OAc
H^
OAc
193 Chart -VI Biogenetic Scheme to 114 & 191 ( E . Glotter^3
Withaphysalin (114)
Physalin C ( 191)
194 Four new withanolide glycosides were isolated australis
by
Adam
et
al.
very
recently.
Dunalia
from
Among
the
four
glycosides, three contain physalolactone B as aglycone. Two
glycosides
were
isolated
Datura
from
tatura
L
29a
they were named as daturataturin A (210) and daturataturin B Very
recently
28-0-withanolide
glycosides
and G (223) have been isolated from Physalis Withanolide
glycosides
isolated
(211).
eg. physagulins E 1 48
angulata
so
far
and
(222)
L
are
listed
with
their physical constants (Table - Ip) Spectroscopic Studies of Withanolides U.V. Spectra Withanolides containing
5B,63-epoxides
/Nw^ 210-218 nm whereas 5 a-OH-6 a,7 a-epoxides /N^219-228 nm.
show absorption at
exhibit absorption at
Withanolides containing 5-enes also absorb similar
to 5a-OH-6ot,7a-epoxides in their U.V. spectra (See Table - 2 ) . I.R. Spectra Withaferin A^ (12), 2,3-dihydrowithaferin A^ (13) and 73 -1 -1 withanolide D (19) exhibit peaks at v 1692 cm , 1695 cm , -1 max 1700 cm respectively due to overlapping of the peaks of two chromophores.
Generally
«:3-unsaturated six membered ketone in -1 25 ring A is observed at/^'1685 cm . Ixocarpalactones A (61) and oc
19R
1?7
B (59), Perulactone (143), Perulactone B (142) contain a saturated-Y-lactone in the side chain which is recorded generally -1 24a at^^-'1770 cm
whereas pubescenol
epoxy- <s-lactone at 1728 cm
(152) exhibits its saturated
and its saturated six membered ketone
at 1710 cm""'". (See Table - 3 ) . "*"H NMR Spectra The
H NMR
spectra
(Tables
4a-d) of
the
polyoxygenated
steroids have been diagnostic to derive some basic functionalities present in these molecules.
For example an a:3-unsaturated ketone
is commonly present in ring A, the others being an a:3-unsaturated<5- lactone comprising the side chain, 5 3,6 3-epoxide; 6a ,7a-epoxide etc.
The chemical shifts of the 18 & 19-methyls give some specific
information regarding the prsence of 63,73-epoxide or 143-hydroxyl. The C-2
and C-3 protons of the a : 3-unsaturated
carbonyl
system
TABLE l p WITHANOLIDE GLYCOSIDES
Compound
r a1,
m.p.
Source
Ref.
Dunawithanine A (206)
208-213'C (Decomposed)
-+ o
Dunawithanine B (207)
192-195°C (Decomposed)
+
12.5
Physalolactone B -3 B - 0 D-c,lucopyranoside (208)
Amorphous solid
+
3.7
P . peruviana
Pubescenin (209)
188-189OC
-
38.6
P . pubescens
24b
Duturataturin A (210)
Amorphous
-
38.1
Datura t a t u r a L
29 a
Daturataturin B (211)
Amorphous
-
17.7
Dunawithanine C (212)
Amorphous
+
15.2
Dunawithanine D (213)
Amorphous
+
5.7
-do-
163
Dunawithanine E (214)
Amorphous
+ 12.3
-do-
163
Dunawithanine F (215)
Amorphous
-
-do-
163
18
Dunalia a u s t r a l i s
49
(dried sprouts) -do-
49
leaves
-doDunalia a u s t r a l i s
162
29 a 163
195
TABLE
196
I p ( Contd.
WITHANOLIDE GLYCOSIDES
r Ol0
Compound
S.ource
Ref.
Datura metelin A (216)
Amorphous
-
22.4
Datura metelin B (217)
Amorphous
+
1.4
-do-
110
Datura metelin G-AC ( 2 1 8 )
Amorphous
-
48.4
-do-
llOb
Sito indoside IX (219 ) Sito indoside X (220) Physagulin D
221)
*
*
*
*
A white powder
+
21.0
Physagulin E
222)
A white powder
+
56.7
Physagulin G
223)
A white powder
+
31.3
TA
-
*
Not available
TA
a (224) b (225)
.(
*
*
*
L
Datura m e t e l
Y. s o m n i f e r a
164
-do&
164
77
P. a o g u l a t a
leaves
llOa
stems
P. a n g u l a t a
berries
-doT . ano.valum
berries
-do-
148 148 48 48
197 Fig. Ip. Withanolide glycosides
OGIc
•OH Dunawithanine A ( 206 ) ; Ri=Glc-Glc, R2 = OAc
I
Glc Ri = OH , R4 = H Dunawithanine B ( 2 0 7 ) R, = Glc - Glc , R2 = OAc, R3 = 0H, R4 = H Physalolactone - 3p - 0 Glucopyranoside (208 ) R, = Glc , R2 = OAc, R3 = OH , R4 = H Pubescinin { 20P) R, = Glc , Rz - OH , R3 = R4 = H ,
24a , 25a - epoxy Duturataturin A ( 2 1 1 ) R, = Glc , R2 - OH , R3 = R4 = H , 7a - OH
Daturaturin A (210)
198 Fig. Ip. withanoiide glycosides
R'O Dunawithanine C ( 212)
XYI
o-
HO O
XYIO OH Dunawithanine D (213 )
HO GIcO O
XYIO OH Dunawithanine £ ( 214 )
GIcO
HO
Glc OH Dunawithanine F (215 )
GIcO
HO O
GIcO OH 12-OH
199 Fig. Ip. Withanolide glycosides
OH
Daturametelin A ( 216 )
Daturamctclin B ( 217 ) r-0-6'
DaturameteUn G - Ac ( 218 ) Physaguiin D ( 221)
OHoH Physaguiin E(222) Physaguiin G ( 223 ) 16P,17p-epoxy
Sitoindoside IX (219)
Sitoindoside X (220)
200 TABLE
2
U.V. SPECTRAL VALUES OF SOME WITHANOLIDES Compound
Bands observed at (x
)
Ref.
max Withaferin A (12)
214 nm (e, 17,500) over-lapping of tv70 chromophores
71
Withanolide D (19)
217 n^ (e, 19,500) over-lapping of two chromophores (» :^ unsaturated ketone in ring A, a :3 -unsaturated- o-lactone in side chain)
73
2,3-Dihydrowithaferin A (13)
210 nm (e, 10,000)
27-Deoxywithaferin A (3)
215 nm (^, 17,500)
2,3-Dihydro v/ithanolide D (224) acetate
225 nm (e, 9,600)
27-Deoxy-14-ot-OHwithaferin A (14)
216 nm (e, 16,000) over-lapping of two chromophores
72
24,25-dihydrowithanolide D (20)
214 nm (e, 9,500)
65
43~Hydroxy-l-oxo-56,63 epoxywitha-2-enolide
214 nm ( e ,
65
9,500)
71 65 73
(5) 25
A (61)
218 nm (^ , 8,200)
Ixocarpalactone B (59) Pubescenol (152)
218 nm (e , 8,300) 212 nm
24a
Lycium substa,nce B ( 62)
224 nm (log ^4.19)
35
5a,20a^(R)-dihydroxy-
223 nm {^,
16a
Ixocarpalactone
r
14,000)
25
l-oxowitha-2,24dienolide (73) 219 nm (log e ,
4.28)
101
27-Acetoxy-5 a-hydroxy221.5 nm (^ , 16,400) l-oxo-6a,7a-epoxy-22Rwitha-2,24-dienolide (69)
66
Withastramonolide (82)
Nicalbin A (83)
225 nm {^,
9,900)
93
201 TABLE
2 ( Contd. )
U.V. SPECTRAL VALUES OF SOME WITHANOLIDES
Compound
Bands observed at (x
)
Ref.
max Nicabin B (66)
225 nm (e,9,750)
Withanolide G (107)
223 nm (e,19,400)
111
Withanolide H (120)
220 nm (G,17,200)
111
Withanolide T (81)
224 nm (e:/18,000)
100
233, 227 Sh (£.13,000)
126
Withametelin (138)
222 nm (e,7,000)
126
Perulactone B (142)
225 nm (e,8,500)
127
Nicandrin B (76)
226 nm
Daturilin (138)
218
Jabarol (Unusual Phenolic withanolide (187)
(MeOH) 224, 281, 291 nm (log €A,29, 3.51, 3.34)
Isowithametelin
(139)
nm
93
34 (G/16,318)
(MeOH + OH ) 224, 282, 301 nm (log E' 4.3, 3.51, 3.41)
125 150a,b
202 TABLE
3
I.R. SPECTRAL VALUES OF SOME WITHANOLIDES
Compound
Peaks observed at (cm
Withaferin A (12)
1692
71
Withanolide D (19)
1695
73
2,a-Dihydrowithaferin A (13)
1700
71
27-Deoxywithaferin A (3)
1690
(a:B-unsaturated six membered ketone)
65
2,3-Dihydrowithaferin D (224)-4-acetate
1738
(a:3-unsaturated-6-lactone)
73
24,25--Dihydrowithanolide D (20)
1730
(Saturated-6-lactone)
65
1681
(a:3-unsaturated six membered ketone)
65
1703
(Saturated-6-lactone)
65
^.0 -Hydroxy--1-OXO-5 B, 63 epoxywitha -2-enolide (5)
Ixocarpalactone
A (61)
Ixocarpalactone B
Perulactone (143)
Perulactone B (142)
(59)
)
Ref.
1681
(a:B-unsaturated six membered ketone)
65
1770
(Saturated-Y~lactone)
25
1675
(a:3-unsaturated ketone)
25
1685
25
1735
(acetate)
1775
(Saturated-Y-lactone)
1762
(Saturated-Y-lactone)
1732
(acetate)
1770
(Saturated-Y-lactone)
1680
(fit:3-unsaturated six membered ketone)
Nicalbin A (83)
1685
(a:3-unsaturated six membered ketone
Nicalbin B (66)
1685
-do-
128
127
93 93
203 TABLE
3 ( Contd. )
I.R. SPECTRAL VALUES OF SOME WITHANOLIDES Compound
Peaks observed at (cm
)
2,3-dihYdro-27-deoxy withaferin A (11)
3400, 1715, 1697
65
2,3,24,25-Tetrahydro-27deoxywithaferin A (10)
3420, 1730, 1705
70
Lycium substanceB (62)
3450
35
Withaphysalin C (114)
1712, 1685
Acnistin E (60)
1675
(°' :P-unsaturated ketone)
1730
(lactone carbonyl)
(OH), 1705 (unsaturated-6lactone, 1690 (0:3-unsaturated six membered ketone)
Ref,
113 42
Daturalactone A (64)
3590-3500 (-0H), 1730 (Saturated-«S -lactone); 1690 (a:3unsaturated six membered ketone)
91
Acnistin A (58)
1655
(a :3-unsaturated ketone)
42
1730
(lactone carbonyl)
3460
(-0H); 1745 (Y-lactone)
1690
(ot : 3-unsaturated-Y-lactone)
1655
(a :3-unsaturated ketone)
Withaphysalin E (144)
129
Daturilin (138)
1650, 1680, 1720, 1125
125
(+) Jaborol (Phenolic withanolide) (187)
3400
(-0H); 1700 (12-ketone, six membered saturated ketone)
150a,b
1690
(Lactonic carbonyl)
1655
(2,5-di-en-l-one)
1718
(Carbonyl)
Withametelin (138)
126
204 with a 1-keto group are characteristically
noticed
at/xJ6 6.18
as
doublet and at r-^ 6 6.79 as d/d in compounds having 4-hydroxyl as in withaferin
A
(12) .
In a compound
with
proton appears a little upfield at around withanolide E
no 4-hydroxyl
the
C-3
6.6-6.9 as d/d/d as in
(46).
Of the 5,6-epoxy derivatives, except for two, the rest are 5B,63-epoxides.
The
6a-H
generally
appears
as
a broad
peak
at
around 6 3,20 and the 63-H slightly at lower field at/^'6 3.3 as a doublet. epoxy
The chemical shift difference of this proton in isomeric
compounds
is
too
small
stereochemistry of 5,6-epoxide.
to
distinguish
the
exact
However, using high resolution 500
MHz NMR spectra to observe the coupling constants of 6H ( a or 3 ) with
the
methylene
coupling
protons
constants
stereochemistry,
at
C-7
calculated
of
and
from
5,6-epoxide
was
comparing Altona
them
with
equation
decided.
A
larger
,
the the
coupling
constant 4.5 Hz (calcd. 4.9 Hz) has been noticed for 5a,6a-epoxide for 6 3-H and 7 3-H while a smaller coupling constant 2.7 Hz has been noticed for 5 3,6 3-epoxides for C-6a-H^ and C-7o-H^ coupling. In
the
case
of
6,7-epoxides,
except
example, all the rest are 6a, 7o'-epoxides. have two protons the 6-H
for
an
isolated
The epoxides in general
and 7-H, around/N/ <5 3.0, the former as a
doublet and the latter as d/d.
Of these the 7-H, appears at lower
field. The
chemical
shift
of
the
influence of 5,6- or 6,7-epoxides
19-methyl
is
subject
to
the
as well as the presence of the
4 3-hydroxyl and the presence of a:3-unsaturated system or saturated -1-keto
system
in
ring
A.
In
the
case
of
6ot , 7a-epoxides
the
19-methyl generally comes around 6 1.20 while the same comes around 6 1.30 in 53,63-epoxides because of the deshielding influences of the 63-epoxy oxygen on the 19-methyl in the latter. with
this
In agreement
19-methyl moved downfield to 132 63,73-epoxywithanone (186) with 6 3,7 3-epoxy system. The
the
configurational
assignments
of
6 1.32
in
53,63-epoxides
and
5a,6a-epoxides are decided by solvent induced chemical shifts C-6H.
Addition
of
causes a negative
benzene
to
CDC1-. solution
shift on the 19-methyl
(-5
of
of
5 3,6 3-epoxides
Hz) and a positive
shift (+11 Hz) on the same in the case of isomeric 5a,6a-epoxides. The shift of 19-methyl is more pronounced in pyridine where it
moves
from
6 1.32
to
1.69
with
53 ,6 3-epoxide
as
in
205 o -|
physapubescin pyridine for from
(35). Similar strong deshielding was noticed in 132 6 3/70-epoxywithanone where the 19-methyl moved
1.32 to 1.69 but in its 6a,7a-epoxy isomer the shift is just
marginal 0.07 ppm. in
Thus the solvent induced shifts, in particular,
pyridine form diagnostic evidence for the stereochemistry
of
the 5,6 and 6,7-epoxy systems. The chemical shift of 18-methyl is also affected to some extent by the presence or absence of hydroxy groups at C-17 and C-14.
In
the
absence
of
both
it
appears
at
6 0.75;
with
17a-hydroxyl it comesr^'^O .85 and with 17- and 14 a-dihydroxy system at
6 0.95.
The presence
of
a 143-hydroxyl
lowers
its chemical 1 no
shift very much to <5 1.16 as in 14B-hydroxyl withanone (85). The pyridine induced shift noticed on 18-methyl is much more (-2.4) with 14«-hydroxy system. The
21-methyl
usually
comes
around
1.0
without
much
deviation even with a hydroxyl at 14 or 17 but the same is very much subjected to solvent induced shifts. The
pyridine
induced
shifts
in
14a-0H-withanone
102
(84)
(14a,17a) indicate a significant deshielding effect of 17 a-OH on the signal of 21-methyl but not on that of 18-methyl. been
found
18-methyl
to
be
with
in
respect 102
143-hydroxywithanone
agreement to
with
17a-0H
(85)
the
relative
(dihedral
angle
(143 ,17a-hydroxyls)
the
This has
position
of
150°).
In
geometry
of
the molecule is changed to a cis C/D junction and the effect of the hydroxy groups is clearly felt on both the 18 & 21-methyls with a downfield shift of 0.3 6 ppm and 0.37 ppm respectively in pyridine. The
appearance
singlets between groups of the
of
two
methyls
on
double
bond
as
two
6 1.85 and 2.0 account for the 27 and 28-methyl
a : 3-unsaturated-<5-lactone
system.
In the presence
of an epoxide (24,25) these methyl groups move upfield and appear around <5i,45.
These two methyls, however, appear upfield
around
^ 1.2 in the example of having saturated five membered-'^-lactone or a spiro system 25 . In a fair number of examples either of these methyls may be missing to be found as hydroxymethyl which can be diagnosed easily. Another
characteristic
proton
generally as d/t is that of C-22 H.
that
appears
around
6 4.60
It varies from 6 3.9 to 4.6,
In the case of 5,6-enes, the 6-11 can easily be located at 6 5.6 as a multiplet.
2-n
Cn-puru
3-ii
4-H
6-ii
3.20~ 4.40dt (Wlw4)
22-.2
1u-ri3
19-r13
206
TABLE 4a H' NMR SPEC'IRBI. DATA OF 5,6-EPOXIDES
21-H3
26-113
27-33
Other chsr,ps
58,66-Cpcxides
i;itrefcrin A
6.16~ 6.97c.d (10) (1O.i)
3.75d (6)
Withanclide
tj.21d (1U)
6.97dd (lU,6)
6.206 (10)
7.08dd (10,6)
--
0.68s
1.38s
0.97d (7)
4.35Lrs 2.03 (!.lethjrlene)
3.77u 3.25 4.25dd (6; (;Jiy4)
0.85s
1.41s
1.27s
3.76d (6)
0.68s
1.39s 0.98d (6)
0.70s
1.32s 1.01d 2.09 (6.8)
4.41
(27-C€&
1.16s 0.97d (6)
4.37
(27-CF12 OH)
2
27-&c:;ywitha-
ieric A (3165
3-23 4.37dt (Wj-94) (12,3.5)
1.91 Trrc
aethjrls
--
1.91
Twc methyls
2,3-dihydrc71 withaferin A (13)
--
--
2,3-dihydrc-Jabcrcsalactcne A (9169
--
--
--
Jab? csalactcl M (50157
--
--
--
3.22d 0.04d (3) (12,4)
1.10s
1.21s 0.97d
--
3.20
4.88~1
1.10s
1.25s 1.42s
1.93s
1. 88s
--
3.20m 4.56dd (Wr6) (12,4)
0.98s
1.25s 1.29s
1.92s
1.88s
-_
Withanclide E (46Iasa
6.03dq 6.87dq
3.55t 3.18br 4.40dt (3.5)
4.42dt 0.67s (J22,23'3Hz, (J22,20=12Hz)
2.03s
1.40
3.56d(11),26-OH; 4.99d(11),26-2
(10)
E 6.03dd 6.86dq -(10,2.7) (10,6, 2.5)
*
--
OH)
Ccupling ccnstants in parenthesis.
TdBLE
4a ( Ccntd. 1
H' NMR SPECTRAL DATA OF 5,6EPOXLDES
Ccmpcund
2-H
3-H
4-H
6-H
22-H
18-H3 19-H3 21-H3 27-H3
28-H3
Physagulin C (in Bgridine)
6.4d (9.8)
7.26dd (9.8,6.2)
3.96d
--
4.43m
1.26s
1.78s
0.99d (7)
1.68s
1.87s
2.09~,15-CHCO 5.21s,15-15~ 3.72~,16-E
6.19d
6.92dd
6.73d 3.24
3.96s
1.15s
1.43s
1.38s
1.23s
1.17s
4.50,16-H; 4.47d,23=&
Ixcc palactcne B (59)
6.28
7.05
4.66
4.14
1.06
1.41
1.47
1.18d
1.21d
4.48,16-&
Phys3gibenclide (37)
6.18d (10)
6.95dd (10,5.5)
3.79d 3.36m 4.32dt (5.5) (W; 4)
1.11s
1.40s
1.02s
1.87s
1.94s
4.97d(4.4), 1% -g; 1.99s ,CH,CO
6.95dt (10,6)
3.75d (6)
4.18dd (12,4)
0.88s
1.40s 1.27
1.92
2.12
2.10 (acetate) 4.82dd( 9,2), 7a -g
4.51dd (13.5,3.5)
0.83s
1.33s
1.27s
1.87s
1.94s
3.9lddd( 11,5,5), 7-g 1.98ddd (12,12,5), 8-E axial
3.84ddd (11.3,5.6, 2.6)
--
1.38s
1.24d (7)
1.37s
1.35s
6.99d(8),15a -E; 7.12dd(8,1),16-2; 6.90d(1),17-3; 4.99d(9.5),26-Z; 3.40d(9.5),26-%
(6.2)
(52)
Ixcc2fpalactcne A (61)
If
6.20d 78 - Acetoxy- 45, 20B-dihydrcxy-56, (10) 63 -epcxy-1-cxcwitha2,24-dienclicie (33)79
3.23
3.33d (2)
Other charges
5 a, 6a-Epcxides
Wi thanrlide Y (184)
Salpichrclide A (19515'
5.98dd 6.72ddd 1.93dd 3.36d (10,3) (10,5,2.5) (20,5) (5) (4.&H), 3 103t (?0,2.5) ( 4 8-g) 6.0ddd 6.77ddd 3.14ddd 3.24d (10.1, (10.1.5, (19.4, (4.9) 2.8,l) 2.5) 2.5,Z.B) (46-g)
207
Compound
2-H
7-H
22-H
Lyciun substance B 5.86dd 6.60ddd 3.05d (10.1,2.2) (10.1,5.0, (3.7) (62)35 2.2)
3.32brs
4.39dt 0.77s (13.2,3.4)
1.19s (6.7)
1.03d
5a,2CilF(R)5.86d d (10,3,1) Dihyarcxv-Fa,70epoxy-i-o::rvi tha2,24-dienclide(73)16a
6.61dd 3.05d (10,4.5,3)
3.33dd (4,l)
4.26dd (1234)
1.18s
1.31s
Withastramonclide (82)lo1
5.84dd (10,Z.l)
6.61ddd (10,4.9, 2.1)
3.04d (4)
3.32dd 4.44dt 0.78s (3.7,1.8) (13.4,3.3)
1.18s
1.10d (6.1)
12-Oxowithanclide
5.85d
6.6Ad !-d,4.5, 5.2.2.4)
3.08d (4)
3.42d (4.1)
4.551~
1.1s
1.26
0.9d (7)
3.05d (4)
3.28dd (4,l)
4.21dd (12,5)
0.95s
1.20
1.31
(10)
2,3-Dihydrc-5Q, 20aF(R)-dihydrcxy 6 a,7o-epcxy-l-cxcritha-2,24-dienclide (234)16a
3-H
6-B
18-H3 19-H3 21-H3
0.95s
208
TABLE 4b H' NMR SPECTRAL DATA OF 5u-HYDRoxY-6,7-EwxU)Es 27-H3 28-H3 Other g r w p s 1.95s
1.89s
1.93
---
Two methyls
-1.52s
2.05s 4.04brs(WtN6), 12-H; 4.38d(5.6),27-CH2 1.58s
1.91 Two methyls
---
Withancne (68)66
5.81dd (10,2.3)
3.06d 6.60ddd (10,5,2.3) (4.1)
3.34dd 4.64ddd 0.86 (3.8,1.6) (12.3,4.6, 4.0)
1.18
1.03d (6.3)
1.88
1.93
2.69brd(18.7),4-xaxial; 2.53dd(18.7, 5.3), 4-Heq; 2.41111, 20-g
14a-hydrcxy- 102 withancne (84)
5.85dd (10,2.3)
2.98d 6.64ddd (10,5,2,3) (4.1)
3.32dd 4.70ddd 0.97 (3.8,1.6) (10,6.8, 2.6)
1.20
1.08d (6.3)
1.88
1.94
2.68brd(18.7),4-Haxial; Z.Xdd(18.7, 5.3),4-Heq;2.4n,ZO-H
TABLE 4b ( Ccntd. ) H' NMR SPECTRAL DATA OF 50-HYDROXY-6,7-EF'OXU)ES Ccmpcund
2-H
3-H
6-H
7-H
22-H
18-H3
146-hydrcxywithancne ( 85)lo2
5.86dd (10.6, 2.6)
6.61ddd (10.5,5.2 (2.4)
3.04d (3.8)
3.78dd 4.71ddd 1.16 (3.8,1.6) (12.9,4.4)
19-H3 21-H3 1.18
27-H3 28-H3 Other grcups
1.05d (6.3)
1.89
1.95
2.67brd(19.0).4-Haxial; 2.59dd' (19.2, 5), 4-11dd; 2.67~1, 20-11
1.09d (6)
1.94s
1.88s 4.02~,12-02
Nicandrin B (76)34 5.83dd (10,2.5)
6.61ddd 3.04d (10,5,2.3) (4)
3.37dd (4,1.7)
4.40~
Daturalactcne-3 (75197
5.86dd (10.1,Z)
3.06d (3.7)
3.33d (3.7)
1.18d (6.7)
1.95s
1.88s 3.55dd (10.4, 4.61, 12-
(5.82dd (10,2.5)
3.04d (3.5)
3.26dd (3.5,1)
4.49ddd 0.77s (13.1,3.4, 4.6) 3.97dt 0.76s
1.18s
Nicalbin A (83)93
6.61ddd (10.1,4.8, 2;4) 6.62ddd (10,5,2.5)
1.18s
0.93d (7)
1.42s
1.40s 4.18t, 16-11; 5.08s, 26-H 26-11
Nicalbin B (66lg3 5.83dd (10,2.5)
3.03d 6.59ddd (10,5,2.5) (3.5)
3.27dd (3.5,l)
3.57t (6.5)
0.82s
1.17s 1.03d (6.5)
1.43s
1.36s 3.98dd-(7.5, 4.5), 16-H; 5.02~,26-g; 1.81dd (10, 7.51, 17-11; 1.59~,20-g
Withanclide R 95 5.85dq (as acetate) ( 7 0 ) (10,5,1)
3.05d 6.56dd (10,4.5,3) (4)
4.73dd (3.5,2)
0.80s
1.17s 0.93d (7)
5.52 cctet 2.97d (4)
4.41dt
0.75s
0.85s
I a, 36,,50-trihydrcxy-6a ,7aepcxy-witha-24enclide (as acetate) (80)66
--
66,76-epcxy 132 5.83d withanone (186) (9.4)
6.61m
3.728
3.7910
(4)
4.64m
0.747s 1.17s
0.86
1.32
1.01d (7)
1.07d (6.3)
1.97
Twr methyls Twr
CH-CO-2.15;5.538 (Zj, 23-11
1.92 3.68,1--2;2.05, methyls acetate
1.86
1.96
209
3.19brd(19.5), 4-11 6-axial; 2.15dd (19.2, 5.0),4-gdq)
210
Ccmpcund
2-H
3-H
4-H
6.76dd -Withanelide G (107)11'5.83dq (10,391) (10,5,2.5)
6-H
18-H3
19-H3
21-H3
1.05s
1.25s
1.30s
4.65brs 0.71s (Wyd 8.8)
1.22s
3.95d(12.7)6.76brs 1.44s (12.7) 6.02brs 3.73dd (12.7,3.0) ( 2 l-CZ2)
5.86
4.48dt 0.73 (12, 3.5)
1.26s
1.05d (7)
1.41s
1.30s
5.60 4.21dd (Wtw 8) (10,6.5)
Wlthametelin (138)lZ6 5.88d 6.77dd 3.30dt 5.58t (9.8,2.5) (9.8,5.1, (20,2.5) (5.8) 2.5) 4Pi; 2.80dd (20,5.1), 40-1!
-
22-H
27-H3
28-H3
1.91
Two methyls
4.90s 2.07 (27-Cl&,)
Other grcups
---
2.07 (acetate)
7a,27-dihydrcxy-l5.99dq cxc-witha-2,5,24trienclide (as acetate) (103)66
6.83dq
Withanelide'U (as acetate) (123)
6.75dd (10,4.7)
5.78d (4.7)
6.15 (Wp4)
4.25dd (10,6.5)
1.08s
20K, 22R-4 B, 76, 5.92d 20-Trihydrexy-1-cxc- (10) 24-trienclide (122)"6
6.76 (10,5)
4.62d (5)
5.78d (1.5)
4.22dd (12.5,4)
0.91
1.44
1.28
1.87
1.93
3.85d(6),
48,17,27-trihydrcxy- 6.15 l-cxr-22R-witha-2,5, (10) 24-trienclide112
6.70 (10,6)
5.79 (6)
6.10t (2.0)
4.65
0.86
1.47
1.07
--
2.07
4.39, 27-CZ2;
6.05d (10)
1.91
Twc methyls
2.10 (acetate) 7-3
TABLE 4c ( Ccntd. ) ‘H N!lR SPECIRBI, DATA OF 5-=
Ccrnpcund
2-H
3-H
78 Withanclide N (as acetate) (106)
5.90dq
6.83dq
Withanclied I
--
(111)11’ Withanclide K (121)l” Iscwithametelin (139)lZ6
--
4-H
--
6-H
22-H
18-H3
19-H3
21-H3
27-H3
28-H3
Other grcups
5.62t
4.66dt
1.03
1.25
1.05d
--
5.71t
4.25dd
1.07s
1.40s
1.30s
1.87
1.94
--
1.88
1.95
--
2.07 4.93s, 27-CX2; 2.07, acetate; 5.25, 15-11
5.62dt
6.08dt
(10)
(10)
5.64dt (10)
6.08dt (10)
5.70
4.66dd (10,5)
1.07s
1.3%
1.32s
6.02dd (lo,,?.5)
5.62dd 4.63brs (5,2.5) (Wt@lO)
0.68s
1.33s
3.7dd 5.99s (13,2),1-H; 27-H; 3.89d, (13T, 6.73s. 1-I! 27-&
1.42s
--
0.89
1.29
1.25
1.89
1.95
-
0.87
1.03
1.25
1.8;
1.96 3.84 (Wd7.2), f 1-26
2.72dd 5.58dt (20,5), 2-H(10,5) 3.28d ( 2012-€J
(11.5,4.5)
--
3.87 (Wfrv19.5)
--
5.62
10,36,23trihydrcxy-l-cxrwitha-2,24-dienclide (125)”7
--
3.99 br.cctet
--
5.58 4.23dd (WfN9.9 ( 13,3.6
4.22
Twc methyls
Twc methyls
211
36 ,2G0 -dihydrcxyI-cxcwitha-2,24117 dienrlide
Ccnpcund
2-H
3-H
4-H
6-H
22-H
212
TABLE 4d H' NMR SPEC'IRAZ. DATA OF 1NTEKi.WJATE
DERIVATIVES
18-H3 19-H3
21-H3 27-H3
28-H3 ~
2,4,6-trien-l-cne (151)~~~
5.97d (9.3)
6.99dd (9.4,6.5)
5.97d 5.86dd 4.22dd 1.15s (5.3) (9.4,1.8) (13.2,3.8)
Withaphysalin E ( 144)lZ9
5.96d (9.7)
6.9dd (9.7,6)
6.14d 4.54t (6) (3)
Jabcrcsalactcl
4.60dd (13.4,3.6)
--
~
Other grcups ~~
1.30s
1.20s
1.89
1.95
6.30dd,(10,2.9),7-g 2.74brd(12), 8-g
1.48s
1.52s
1.88s
1.96
--
1.49s
0.96d (7)
5.0d(11),26-H; 3.56d(11),26-g
6.Oldd 6.92dd (9.5,l) (9.5,6)
6.14dd 6.42brs 4.07~ (6,l)
1.18s
Withaminimin (164)
5.87dd 6.58ddd (10,2.5)(10,5,2)
3.19dt 3.60brt 4.34ddd (20,2.5) ( 2 ) (12,7,4) 48-2
1.16s
1.21s (7)
1.12d
1.87brs
Physalclactcne C (169)141
5.9dd
5.00t 4.391~ 4.76dd (2.4) (12.6,4)
1.06s
1.22s
1.38
1.85s
1-97s
--
(10.2,
4.67d (8.5)
1.04s
1.22s
1.35s 1.85s
i.97~
4.34d (8.5), 230g;
5.72~1 4.63dt
0.85s
1.21s
1.04s (7)
Twc methyls
0.68s
0.91s
0.84d (6)
1.45s Twc methyls
S
6.55dd (10.2,2.5)
2.1) 23-Hydroxy-physalc- 5.90dd 6.55dd lactcne C (180)'47 (10.2,2)(10.2,2.5)
5a,17a-Dihydrcxy- 5.91 l-rxcwitha-2,6,24trienclide (151)66 Pubescencl (152)24a
--
6.66
--
4.99dt 4.3810 (10.3,
1.40s Twc methyls
1.98brs 5.33d(2.5),15-H; 5.60brd(2.5),16-g; 2.53m,20-g; 2.31dd ( 17,4), 23%; 2.01s, 15-O&
2.5)
4.2801
--
4.38m
1.90
--
3.64m,7-11;5.33d, 4a-OH; 4.31111,7a-OH
TABLE 4d
( Ccntd.
1
H ' NMR SPECTRAL DATA OF DEEiWEDIA'lT
DWIVATIVES
~
4-H
6-H
6.OOdd 6.47dd 200 -trihydrrxy-1- (10, (10,2.5) F cxr-22R-witha-2,24- 1.9) 134 dienclide ( 157)
5.08m
4.44dd (12.3, 5.3)
4.18dd (13.2,3.5)
0.81s
1.22s
1.25s
1.87s
1.94s
Withaperuvin (in pyridine) ( 181)14'
6.28dd 6.89dd
5.77t
4.53dd
5.16dd
1.31s
1.60s
1.78s
1.98s
1.82s
Withaperuvin D ( 168)140
2.37dd 4.46m (18,3*5), 1-11; 2.82d (181, 1-1!
5.2id (6.5)
4.27d (7.5)
4.48dd (10,4)
1.07s
1.14s
1.40s
1.87s
1.94s
Ccmpcund
2-H
3-H
6a-Chlcrc-4 0,5 6;
22-H
18-H3
19-H3 21-H3
27-H3
28-H3
Other grcups
--
Ccupling ccnstants in parenthesis
213
214 1 f. f.
The
solvent
induced
saturated-6-lactone
CDC 1
shifts
A
systems were used
3
on
25~methyl
to decide
the
in
conformations
of lactone system. A fairly chain.
large number
occur with
17a-side
In all these the presence of 14a-hydroxyl, 17B-hydroxyl and
20-hydroxyl
has
withnolide E groups
been
^'
held
noticed. on
the a -face
bonding,
thus
decreasing
and
17 3-hydroxyl
between
20-hydroxyl
reflected (strong
in
the
the
and
solvent
shifts
of
of
structure
21-methyl
and
22-H
structural
changes
are
'
(46)
to
1.37,
Similar
been
and
distance
E
5 1.10
-
also
hydrogen
the
withanolide
have
by
173 -hydroxy1
increasing
18-methyl
of
14a,20hydroxy
molecule
between
These
spectrum
the
and 22-H; 4.88 to 5 . 1 6 ) .
- 61.42 to 1.76
18-methyl,
the
22-H^ while
18-methyl.
to
analysis the
of
distances
and
pyridine
negative
21-methyl
According
(46) derived by X-ray
together
18-methyl
on
of withanolides
shifts
noticed
with
40-hydroxy withanolide E ^ ^ ^ ' ^^ (53) (See Tables 4a to 4 d ) .
"*-^C NMR Spectra A
detailed
study
of
withanolides
(Table
5) was
followed
Kirson
and
by
13
made
C
NMR
by
Gottlieb-*-^^
find useful applications
spectral
Pelletier in
data of various 1 fi8 al. in 1979
et
1981.
The
•^'^C NMR
in structural and conformational
data
analysis
of withanolides. The downfield unambigously and
the
6132.0 and The
the
lactone
two
singlets around
6202.0
carbonyl
groups of
at
respectively.
C-26
and 6167.0
«:3-unsaturated The
two
correspond
to
the
«: ^-unsaturated
shift
singlets
double
lactone
bond
system
around
carbons as
in
6149.0 C-24
(13).
The presence of a hydroxymethyl at C-25 the
C-24
withaferin A Next
carbon
shifts
to
at
lower
respectively. and
and
6 121.0
C-25
of
instead of a
field
to
A
the lfi8
simple
6 153.5
as
in
(12). in
carbons
connected
The
and
C-7
order, to
an
carbons
the
carbons
epoxy of
easily
oxygen,
a
recognisable
hydroxy1
5oi-hydroxy-6,7-epoxy
or
are
an
660.0 ppm for eg. lycium substance B
compounds (62)
the
acetate. can
easily recognised where both come as doublets with a chemical lower than
C-1
around
2,3-dihydrowithaferin
methyl
C-6
ketone doublets
6 142.0 ppm are of the C-2 and C-3 carbons chemical
recognise
be
shift
(56.2
and
215 1 ^ ( C NMR
57.3)
data
for
the
C-6
and
C-7
carbons
of
only
one
isolated example of 66,73-epoxy derivative (186) is not available). Similarly,
the
more
common
53,66-epoxy
recognised by the chemical shifts
system
can
also
be
664.0 as a singlet for C-5 and
662.0 as a doublet for C6 carbon as in withaferin A
(12).
The presence of 5a,6a-epoxide has marked shielding effect 52 on C-6 carbon<\^ 4 ppm as noticed in salpichrolide (185). In the case of Nic-2 lactone
(91)
v/ith an epoxide at
C-24/ C-25 in the side chain-6--lactone, the two carbons 24 and 25 apper at 659.1 and 63.1 as singlets. In the case of viscosalactone A
29a
(22) (having 2B,3 3-epoxy
system) the carbons appear at 6 54.9 and 55.8 as doublets. The C. carbon with 43-hydroxyl as in withaferin A
(12)
appears at <5 69.8 as a doublet which shifts to lower field to 672.I in its acetate.
The 2 7-carbon with a primary hydroxyl appears at
^ 57.0 as a triplet which deshields to "Sss.O on acetylation. C-10
and
C-13
carbons
come
as
singlets
at
648.O
and
The 6 42.5
respectively, of which the former is more affected by the presence of a functional group in ring A and B. Of the chemical shifts of methyl carbons C-18, C-19, C-21, C-27 and C-28 the chemical shifts of C-18, C-21 remain more or less constant ( 6 11.5 and 13.5). methyl
carbons
in
The chemical shifts of the remaining
particular
that
of
C-19
is
affected
by
the
functionalities as well as their stereochemistries present in rings A and B. The chemical shift of C-2 2 carbon with the 6-lactone oxygen is around 6 78.0 in all the compounds. The presence of 43-hydroxyl produces a deshielding effect on C-3 ir^l
ppm) and shielding effect on C-2 (^^'2-3 ppm) as well as
a shielding effect on C-19 hyf^2
ppm by 1,3-dixial
interaction
1 fift
The presence of 5 3,6 3-epoxy ring, saturation of 2,3 double bond of ring A
ketone
(f^3 ppm), and
has
a deshielding
C-4
by (r03
effect
ppm ). The
on C-5
presence
(r^ 3 ppm) of
Y -effect not only on C-10 but also on C-S^
produces
C-10
53 ,63-epoxide A similar
Y-effect has been noticed on C-9 by 6a,7a-epoxy systems. In the tives, C-5
commonly
appears
trans and 5-hydroxyl
occurring
around is
5a-hydroxy-6oi,7a-epoxy
73.0 where the ring
a-axial.
deriva-
junction A/B
With 53-hydroxyl
with A/B
is cis
5
216
TABLE
13C NMR DATA OF W I m O L I D E S Carbrn Nr.
1
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
2,3-dihydrr Witha- Witha17-1sc Withawithaferin A nclide D ~ ~ A nclide ~ E nclide ~ (12)168
(19)168
202.3 132.3 142.5 69.8 63.9 61.7 29.8 31.1 44.0 47.8 21.8 27.2 42.5 56.0 24.2 39.2 51.8 11.6 17.0 38.7 13.3 78.7 29.8 153.5 125.6 167.0 57.0 20.0
202.2 132.5 142.2 69.9 64.0 62.1 31.1 29.1 44.1 47.7 21.7 39.6 42.7 56.3 23.8 21.9 54.6 13.5 17.1 75.1 20.7 80.9 31.4 149.1 121.9 166.2 12.4 20.5
(11)168 211.5 31.6 26.2 72.8 66.7 58.5 29.6 31.4 43.1 50.4 21.3 27.2 42.6 56.2 24.2 39.0 51.9 11.5 15.2 38.8 13.4 78.3 29.4 149.1 121.9 167.0 12.4 20.5
(46)16’
(34)16’
203.2 129.8 143.9 32.9 62.2 64.2 26.2 34.1 36.9 48.6 22.9 34.3 54.5 82.3 30.1 37.7 87.8 20.6 14.6 80.0 19.5 80.3 32.5 151.1 121.4 166.6 12.3 20.6
129.7 144.0 33.0 62.1 64.1 25.8 33.3 37.1 48.6 21.9 26.5 50.7 85.3 33.3 32.7 90.9 19.2 14.8 76.2 21.6 81.4 31.6 150.9 120.9 164.8 12.3 20.7
-
Ixccarpa ~ lactcne A? (61)25 202.0 132.6 143.2 73.0 64.1 61.2 31.2 29.0 44.2 48.1 21.3 40.0 43.3 54.5 37.2 70.0 57.6 14.1 16.8 79.5 22.1 73.2 78.9 41.9 40.3 181.6 14.5 13.0
2,3,24,25Ixrcarpa Physapube- Physapube- Viscrsa Tetrahydrclactrne ~ ~ nnrlide lactcne A 27-derxy (acetate) withaferin A (59)25 (35I8l (37)24b (22)23 201.2 202.5 134.0 132.2 143.2 139.9 72.2 69.7 61.1 63.6 60.1 61.2 31.0 30.4 29.2 28.9 44.3 43.7 48.3 47.6 21.4 20.7 39.4 39.5 42.8 42.9 54.4 58.8 33.7 76.2 37.0 75.2 62.5 5C.2 12.7 14.9 17.0 15.6 74.9 38.4 12.6 27.0 71.9 65.1 107.6 29.5 64.1 49.3 42.4 63.6 177.6 91.7 13.9 16.6 12.2 18.8 AcO 20.7 AcO 21.4 170.1 171.1
202.6 131.1 143.5 69.6 63.4 62.7 26.1 40.3 36.1 47.9 21.8 41.4 46.1 84.1 80.8 33.6 52.3 15.6 17.2 37.5 17.2 78.5 31.2 149.5 121.9 166.8 12.4 20.5 AcO 21.5 169.8
206.9 54.9 55.8 74.6 64.0 59.6 29.6 31.0 42.7 48.6 20.0 27.3 42.7 56.1 24.3 40.7 51.9 11.5 14.5 38.9 13.3 78.7 29.8 153.8 125.8 167.4 57.2 20.1
211.6 31.6 26.2 72.8 66.7 58.5 29.4 31.4 43.0 50.4 21.2 27.5 42.6 56.1 24.2 38.9 51.9 11.5 15.2 38.2 12.7 80.0 29.2 27.2 38.9 176.2 12.0 18.1
TABLE 5
( Ccntd.
1
13C NMR DATA OF WITHANOLIDES Carbrn Nr.
Lycium Withanone substan B ( 6 ~ ) ~ ~(68)lo2
1
2 3 4 5 6 7 8 9 10 11 12 13. 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
203.0 129.1 139.5 36.8 73.3 56.2 57.3 35.8 35.6 51.5 21.9 39.9 43.6 52.0 23.6 27.3 51.0 12. i* 14.7 39.2 13.3* 78.3 29.7 149.0 122.1 167.0 12.5 20.4
203.4 128.1 140.9 36.9 72.9 55.1a 55.Za 35.7 34.5 50.4 21.1 32.4 48.2 45.1 22.5 36.3 83.1 14.2 14.7 42.9 9.4 78.5 32.0 150.R 120.1 166.0 12.0 20.1
14wOH 14b-OH Witha- Witha- DaturaNical- Nical- 5a-OH withancne witha- nican- fercxc- lactcne C bin A bin B -6-ene ncne drin lide
(84)"' 203.5 127.8 141.1
-
72.9 52.7a 56. - 6a 25.3 49.8 20.lb 33.5 50.6 84.4 28.1 86.0 18.8 13.8 43.4 9.7 78.7b 33.1 151.3 119.3 166.1 12.4 .19.8
(85)102 (63l3I (76)31
(75I3l
203.1 202.1 128.8 128.9 139.6 139.8 36.7 36.8 73.2 73.3 56.2 56.2 56.8 57.0 35.7 36.1 37.7 28.7 51.5 50.6 38.4 30.1 212.0 72.5 57.7 47.1 52.9 43.7 23.6 23.1 27.7 26.6 42.8 42.9 11.5* 12.C' 14.7 14.7 39.5 39.1 13.1* 12.4" 76.3 79.0 29.1 29.7 149.3 149.2 121.8 122.0 166.8 167.0 12.5 12.5 20.5 20.5
202.8 129.0 139.9 36.7 73.2 56.3 57.0 38.6 35.1 50.9 31.3 77.6 48.5 53.4 22.8 26.9 49.6 7.6 14.6 37.7 14.9 79.0 32.7 149.1 122.0 166.9 12.5 20.5
203.6 127.8 141.2 72.6 53.1a 53.7a 30.8 50.6 21.5 34.3 52.4 83.5 31.6 83.1 16.8 13.8 41.6 10.0 78.4 32.9 151.9 119.9 166.1 12.1 20.1
*
tnterchangeable
202.5 202.9 129.0 128.9 140.0 139.8 36.8 36.7 73.3 73.3 56.2 56.0 57.0 56.9 35.3 35.4 35.3 35.4 51.0 51.0 21.7 21.1 40.2 38.9 45.1 44.8 48.6 49.5 35.8 35.2 75.2 81.8 64.0 59.4 13.6 13.2 14.7 14.7 38.3 43.2 14.3 19.2 67.2 75.9 32.0b 32.6 65.0 60.3' 63.5b 59.1' 91.9 95.8 16.5 14.4 18.8 21.8
204.8 129.1 141.0 36.5 74.9 132.8 129.5 38.1 40.8 51.4 22.2 32.7 48.9 47.8 23.3 36.5 84.9 15.1 14.6 42.9 9.5 78.9 32.7 150.9 121.3 167.5 12.4 20.6
(
202.8 128.7 140.1 36.9 72.8 56.9 55.7 38.6 31.7 51.7 24.4 29.3 137.0 135.2 124.1 125.4 141.5 128.9 14.1 43.1 17.3 67.4 33.7b 64.7b 63.3 91.7 16.6a 18.7a 217
a,b &
(83Ig3 (66)93 (159)16'
Nicandrencne (Nic-1)
218
Carbcn WithaNc. nclide G (107)"~ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
204.3 128.0 145.3 33.5 135.2 125.0 25.3 35.2a 36.3a 50.8 22.2 32.5 47.5 85.0 32.1 20.6 49.4 17.4 18.9 75.3 21.2 18.4 31.7 149.2 121.9 166.7 12.4 20.5
WithaChlcrchydrin Chlcrchydrin 3S-hydrrxy2,3dihydrcwithacf withanclide cf withanrlide nclide-H acetate nclide D ( 1 2 0 ) ~ ~ (~ 1 2 1 ) ~ ~(~1 ~ ) ' ~ ~( 1 7 4 ) ~(~1~5 7 1 ~ ~ ~ (131)121
Withanclide H
204.2 128.0 145.5 33.5 135.2 125.0 25.3 35.2a 36.3' 50.9 22.2 32.5 47.4 85.1 31.9 20.7 49.4 17.5 19.0 75.3 21.1 81.7 31.9 153.7 125.6 166.4 57.1 20.1
Withanclide K
Perulactrne B
-
205.2 127.8 146.1 33.6 135.4 125.2 25.5
39.8 127.4 129.4 140.7 121.6 25.2 34.Za 34.ga 52.6 20.7 26.5 51.4 85.9 33.0 33.0 89.2 18.9 20.4b 76.gb 20.2 81.0 32.4 151.6 120.9
-
12.2 20.7
35.A
37.2 50.9 23.2 32.3 54.4 83.4 31.7 37.2 88.5 20.5 19.0 78.8 18.8 73.1 30.3 38.4 38.0 181.8 10.5 72.6
'-
204.3 128.6 141.4 35.0 76.3 76.0 25.9 33.5 34.6 52.0 22.8 34.6 54.9 83.5 30.9 37.3 88.2 21.5 15.4 79.0 19.6 81.1 32.6 151.4 121.1 167.2 12.3 20.6 OdC 21.5 170.3
a,b interchangeable
201.1 127.7 143.1 66.6 78.3 66.0 39.1
206.8 127.0 144.5 34.5 77.6 66.5 31.6
1~,38,20-trihydrcxy l-cxrwitha-5,24dienclide ( 125)117
212.2 52.9 68.7 41.0 134.9 126.0 25.6
72.9 38.3 66.3 41.4 137.6 125.2 31.7 3 1. .?
31.5
39.1
35.9
45.7 55.7 22.5 39.2 43.1 57.2 23.5 21.9 54.4 13.7 9.9 74.9 20.6 80.7 31.3 149.3 121.8 165.6 12.5 20.5
37.3 55.7 22.9 34.5 54.9 82.2 30.2 37.6 87.4 20.6 8.6 78.8 19.0 81.0 32.3 152.0 121.3 167.8 12.2 20.6
34.1 51.3 20.9 32.1 47.5 84.9 31.9 20.8 49.4 17.4 19.1 75.2 21.1 82.0 31.9 154.7 125.5 166.9 56.6 20.1
.
41.5 41.7 20.2 39.8 43.0 56.8 23.9 22.0 54.7 13.6 19.4 75.2 20.8 80.1 31.5 149.1 122.0 166.2 12.5 20.5
TABLE 5 ( Contd. ) 1 3 C NMR DATA OF WITHANOLIDES
Carbrn Nr
.
Daturilin (138)~’~
1 2 3 4 5 6 7 8 9 10 11
12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
23-hydrcxy Physalc- WithaWithaphysalclactrne peruvin peruvin D lactcne (164)’~~ (18~1)’~~ (175)’~~ ( 1 ~ 1 )( 168)140 ~ ~ ~
Withaminimin
204.06 204.15 128.0 128.71 145.11 141.33 33.524* 36.03 136.06 77.22 74.26 124.60 33.334* 26.47 33.297 35.43 39.963 35.43 50.544 52.20* 23.678 23.18 39.749 38.82 52.23* 42.662 56.051 82.28 24.124 83.36 26.556 120.37 47.699 161.30 12.751 16.80 18.976 15.10 42.939 36.11 60.574 17.21 75.629 78.47 30.795 32.35 150.25 69.355 139.2 121.44 165.26 167.44 129.74 12.37 25.627 20.64 -CH 3 CO 21.36 C H - C O 170.63
203.6 126.8 147.5 65.8 80.0 66.0 35.8 40.0 39.9 58.3 23.7 31.0 55.9 83.7 32.8 37.1 88.2 20.9 9.8 80.4 19.3 85.7 67.5 153.8 122.5 166.9 12.7 16.2
203.8 126.9 147.6 66.0 80.0 66.0 35.7 40.1 39.9 58.3 23.8 35.5 55.8 83.5 31.2 37.8 88.3 21.1 3.7 79.7 19.3 82.5 34.0 153.3 121.8 168.9 12.2 20.5
202.4 127.2 145.2 67.0 79.4 74.5 32.0 37.4 37.8 55.6 22.7 34.5 54.0 82.8 30.7 37.4 87.4 20.7 9.7 78.8 19.1 80.9 32.2 151.1 121.2 166.7 12.2 20.7
214.0 42.3 77.6 74.5 79.8 77.3 26.4 35.8 34.9 55.8 21.6 35.4 55.6 83.9 31.1 37.4 88.7 20.6 15.3 78.3 19.4 83.0 32.8 154.2 121.7 165.7 12.3 20.8
Withaphysalin E
150a,b
(+) Jabarrl (187)
(144)~” 206.1 117.5 140.4 126.0 160.0 72.8 37.1 37.8 44.7 53.8 22.7 36.3 60.0 83.1 34.8 25.7 57.7 177.3 20.0 83.9 26.3 78.4 31.9 148.7 121.9 165.4 12.5 20.7
a,b,c,d : : Interchangeable
219
-3-
149.76 114.04; 126.55 116.56a 140.62 76.14‘ 39.57, 43.50, 73.23 121.04b 58.90 212.81 45.5gd 46.96 24.52 34.44 83.35 16.09 11.01 40.85 13.04, 78.29 33.72 153.97 121.67 166.10 12.28 20.52
220 ring junction and the hydroxyl being equatorial as noticed in for 134 (171), the C-5 carbon appears
eg. chlorohydrin of withanolide E deshielded at
677.6.
The stereochemical effect of C/D ring junctions can also be noticed, though to a lesser extent, on crbons - 13, 14 and 18 for 102 eg. in 14o-hydroxywithanone (84) with C/D trans stereochemistry, the C-14 appears at 6 84.4 while it appears at 6 83.5 in 143-hydroxy 102 isomer with C/D cis stereochemistry. The 146-hydroxyl has a deshielding effect on C-13
(1.8 ppm) and a shielding effect (2.0
ppm) on C-18 in the isomers. Effect of 14a-0H The presence of 14 0'-axial hydroxyl compared to those with no hydroxyl produces a gauche shielding effect of 5-8 ppm on C-7, C-9 and C-12 in rings B and C.
A similar Y-interaction might have
also been expected on carbons-16 and 17 in the pentacyclic D ring but only C-17 has been found
shielded.
This has been explained
that in a five-membered ring no more than one carbon experiences a Y-effect.
The
17 B-side
chain
forces
position to receive the Y -effect.
the
17a-H
into
an
axial
However, if a 17^-hydroxyl is
present no change is observed in the shifts of either C-16 or C-17 since C-17 carbon is non-protonated. Effect of 17a-OH The oxygen atom at C,- shields C-12 and C-14 (but not C-15, also in the pentacyclic, vide supra).
In the side chain, C-21 is
shielded but not C-22; the former carbon is thus gauche 17-OH
but
not
the
latter.
results are explained by a 3 The J(HH) between H-20 and H-22
conformation such as structure I. was measured
from the 270 MHz
(12) acetate and withanone
to the
These
H NMR spectra of withaferin A (68) and found to be 3 and 3.5 Hz,
respectively, in agreement with I.
The gauche relationship between
the lactone ring oxygen and C-2 0, in this conformer explains the quite high field position of the resonance of this methyl group. The effects of 17 °'-hydroxylation
in the presence of 2 0-OH 169 to or 14 o'-20-(OH)^ functionalities respectively are very similar the case without the additional OH groups, for C-14 in the latter case, where this carbon is nonprotonated and, therefore, does not feel the
Y-effect, indicating
conformations
similar to 1 in the
221 vicinity of C - 1 7 . Effect of 20-OH The
presence
r^ 5 ppm on C-16 relationship
of
possess
group
is
causes
a
strong
group
17a-oriented
side-chains
which
a
causes
(6.1 ppm) (Structure I I I ) .
expected
is
Y-alcohol axial
containing
17^-hydroxyl
effect on C-21 carbon
20-hydroxyl
Y-effect
the carbon and the oxygen are in
gauche
(Structure II) whereas C-23 is unaffected.
Withanolides to
a
indicating
to
almost
shield
C-12.
unchanged.
replaces
the
oxy-substituent
one
may
from
a
C-20.
caused
where a hydrogen bond is possible
known
deshielding
The presence of a 14a-0H
Instead,
Probably
have
strong
are
the
Steric the
shift
Y-effect
of
from
hindrance
rotation
this
the
14
from
around
the
C,^-Cppj
(Structure I V ) .
The introduction of 2 0-hydroxyl
does not cause shielding
on
C-16 because of formation of a hydrogen bond between the 14 and
20
alcohols
by
(Structure
V).
The
deshielding
of
C-21
caused
20-hydroxylation is larger than usual. The C-17 epimeric compounds with conformations interesting. where
as
I and V
in
V
the
same
Y-effect
is
noticed
from
C-20.
interactions are absent in the case of compounds with an side chain such as withanolide E The presence
of
a
double 3.5
allyl bond
alcohol
2 7-hydroxyl
causing
causes
(ring
polarisation
shielding
These
«-oriented
E)
on
C-25
and
in
the
side
chain
Acetylation of
of
the
C-24
deshielding
and
on
this C-25
C-24
by
ppm. The axial 12o-OH in withaferoxolide
axial
hydrogens
at
C-9, C-14
through shielding by 6.9 in daturalactone C-17
C-16
(46).
causes deshielding on C-24 and C-25 by 4 ppm. primary
are
In I the 17^-011 experiences Y-effect on C-12 and
and
C
produces
and
to 8.3
C-17
and
(76) is gauche to the experiences
a
Y-effect
ppm, whereas the equatorial
123
OH
(75) produces minor shielding effects on C-9, a characteristic
high
field
C-18
methyl
signal
( 'S 7.6 ppm) . In
withanolides
containing
5-enes
eg.
withanolide
(107) the C-5 and C-6 carbons appear at<*^<5 135.2 and The C-22
{f^'5
presence
of
23-hydroxyl
ppm) and produces
3 and
produces
an
G
125.0 ppm.
upfield
shift
Y-effects on C-24 and C-25
on
as in
222
OH
HO
H
c^"P OH
20 ^ 2 1
«H
y
1 ,/
^
. ^ ^
1 OH
\
«\
/23 )^22
\y ^0
"^•-HO
H
^21
ri vi
223 23-hydroxyphysalolactone
(180).
Mass Spectra Mass
spectrometry
is
a
useful
characteristics of a withanolide.
tool
in
diagnosing
the
The molecular ion in electron
impact is either weakly present or totally absent in some cases. 65 Cleavage of the side chain at C-20 and C-22 in (3) and 31 91 (62) ' produces m/z 125 whereas in a saturated- <5-lactone it produces m/z 127 by same type of fission.
A fragment m/z 125 may
also be produced by a system containing 5 a--0H-6 a,7a-epoxide as in 31 91 ' (74) or 5,6-glycolic system as in Jaborosa-
daturalactone B
F""""^^ (163)
lactone
resonance.
(Chart
Vila).
This
will be stabilised by The presence of an epoxy- lactone 24a in the side chain,
revealed by a fragment m/z 141, further disintegrates to m/z 125 by the
loss
of
oxygen
1 fi7 .
The
same
27-hydroxymethyl disintegrates
ion m/z
further
141
which
by acquiring
comes
from
a hydrogen
a
and
losing water molecule to give m/z 124 (Chart V i l a ) .
Carbonyl group at C-12 in withanicandrin
90
(63) triggers a
fragmentation involving the cleavage of C Q - C, . bond on one side and a McLafferty rearrangement with the participation of 2 0-proton and the 12-ketone leading to a peak m/z 275 (Chart Vila). In 24,25-dihydrowithanolide D
(20) fragmentation between
C-20 and C-22 produces m/z 127 to confirm the dihydrosystem in the 127 side chain (Chart Vllb). In perulactone B (142) and 125 ixocarpalactone A (61) scission between C-20 and C-22 produces the ion m/z 143.
If the side chain contains a hydroxyl at C-20 or
glycol system at C-20 and C-17 scission occurs at C-17 and bond
producing
m/z
169,
as
in
eg.
4
C-20
-hydroxywithanolide
E^^^'^"^(Chart Vllb). In the compounds with 5a-0H-6a ,7 a-epoxide
in
ring
a 12 a- or 3-OH
A/B
the
scission
system at
C-17
containing and
C-20
produces m/z 299 (M-side chain-H^O)
as in withaferoxolide (77). 142 In chlorowithanolides, eg. 4-deoxyphysalolactone the molecular + + ion M could not be located. Under electron impact (M -HCl) is the peak with highest intensity (m/z 486). In B
the
spectra
of
5a-methoxy-4,5-dihydrojaborosalactone
(154) and 5a-ethoxy-4,5-dihydrojabarosalactone
B
(155);
the
224 Chart - Vila
m/zHl
m/zl42
m/zl24
m/z275
225 Chart - VII b
Perulactonc B ( 142 )
Ixocarpalactonc A ( 6 1 )
/
\ OH
O m / z 143
OH e
V o
o^ o m/z 113
m / z 143
226
m / z 185
227
CHART-Vlld MASS SPECTRAL FRAGMENTATION OF METHANOL ADDUCTOF ISOWITHAMETELIN126 (139)
(139) m /z 468
in/z436
m/zl34 -28
CH2
-«r ^^'^
OMe -OMe
m / z 155
in/zl24
-CO "O^ ^O
+
iii/zl23
in/zl06
' Q^ m/z95
228 TABLE 6a C D . VALUES OF SOME WITHANOLIDES
Compound
CD values observed at
Ref.
43-Hydroxy withanolide E (53)
400(0) ;340 (+1.42) cis ring junction of A/B; 304(0), 294 (-0.32), 282(0), 22R, 217.5(4-13.91), 252(+4.25), strongly negative at shorter wave-lengths.
26a
Withaperuvin (181)
370(-0.25), 354(-0.53), 322 (-0.60) due to strong compression. Due to the interaction of substituent and carbons 4,5 and 6.
142
Withanolide S (174)
336(-1.32)
143
Withaperuvin E (47)
345(-0.71), 245(+7.24)
Physalolactone (175)
363(+0.7), 353(+0.1), 348(+0.14), 338(+0.11) cis fusion of A/R, 306(-0.33); 239(+12.35), (22R), 205(-3.53) .
144
Withaperuvin D (168)
288(-4.55) (cis A / B ) , 251(+5.31)
140
4-DeoxyF>hysalolactone (171)
342(+0.89), 334(+0.85)
142
Withanolide O (105)
336(-0.29), 302 (-0.09), 256(+3.R6)
78
Withanolide U (123)
337(-0.28), 302 (-0.09), 256(+3.86)
100
Withanolide T (81)
339(-2.17), 253(+5.10)
100
Nicandrin B (76)
338(-1.95), 250(+3.83), (22R)
34
Withanone (68)
338.5(-2.16), 252.3(+5.02), 195(+29.5)
66
Withanicandrin (63)
336.5(-1.96), 287 (+0.8), 252(+5.01) 195(+31.0)
90
2,3-Dihydroderiv., of 5 a,2 Oa (R)-dihydroxy-
302 inflection (+0.35), 253(+4.32), 198(+16)
16a
r
6a,7a-epoxy-l-oxowitha-2,24-dienolide (234) Nic-1 (90) (Nicandrenone)
338(-1.7), 224(+6.22)
34
105
229 TABLE
6a ( Contd. )
C D . VALUES OF SOME WITHANOLIDES Compound
CD values observed at
Ref.
Withanolide Q (acaetate)(119)
340(-3.14), 260.5(+3.85)
95
Withaphysalin C (114)
346(-3.64), 251(+5.80)
113
Oxidative product at C-20 of perulactone (234)
286.8(+3.5), indicative of 17aoriented side chain
128
18-20 Lactone of withaphysalin B (2)
345(+1.30) cis A/B, 256(+3.8) (22R)
64
Oxidation product of physapubescin (233)
348,294, 254.5. A positive band 294 nm (e+2.76) is characteristic of 14aH-15-one.
81
Physapubescin & Nic-2-lactone (232)
230 nm (Ae_2.9) 22R, 24S, 258, configurations
81
230 TABLE 6b 2 111 COTTON EFFECTS OF A -EN~l-ONE AND 1-ONE CHROMOPHORES
Compund
X
max
nm
Ae
226
345
+ 0.96
227
335
- 0.76
228
294
- 3.32
229
291
+ 0.67 (shoulder)
TABLE
6c
111 COTTON EFFECTS OF 20-ONE CHROMOPHORE
CD
Compound X
max 36-Hydroxy pregn-5-ene-20-one
(230)
Compound (230a) 3B,17a-Dihydroxy-pregn-5-en-2-one Compound ( 2 3 1 a )
(231)
287.5
+ 3.00
294.0
+ 3.59
285.8
+4.03
298.2 303.0
+2.83 + 2.29
296.6
+3.89
231 Table 6a. A positive Cotton effect at r^ 250 nm suggests 22R configuration in ring E ( a: e-unsaturated-6~lactone) (See Table 6a). Even the stereochemistry of 17~0H ( a or B ) can be decided. A comparison of the CD spectrum of 36 -hydroxypregn-5-ene-20~one (230) with that of 36,17a-dihydroxypregn-5-ene-20-one (231) is shown in Table 6b. 1 oo
An oxidation product of perulactone was confirmed to possess 17a-oriented side chain Ae, 286.8 (+ 3.50). A negatice Cotton effect atro 230 nm ( Ae, - 2.9) in lactone 81 of physapubescin similarly indicates 22R, 24S, 25S configuration as in Nic-2-lactone-'-^^ (232). A positive Cotton effect at 287 (+ 0.80) is indicative of 90 the presence of 12-ketone in withanicandrin (63) as in 5«-pregnane-12-one and other ketosteroids. A positive band at 294 nm ( AG, -f 2.76) is characteristic of 81 14a-Ii-15-one as in the derivative of physapubescin (233). A very weak triplet of bands at 275.5, 268 and 263 nm are observed for the aromatic ring absorption in Nic-1 (90) due to the dissymmetric environment and 224 nm for side chain epoxy lactone. Even the stereochemistry of ring E (27- and 28-methyls) 1fifi were confirmed from the CD data and from molecular rotation differences (See Table 7 ) . Microbial Transformations and Cell Free Cultures There are several investigations on microbiological transformations of withanolides. Withaferin A (12) is hydroxylated by CuDiiinghamella elegans to give two metabolites , one of them originally identified as 14a-hydroxywithaferin A (236). In a 171 subsequent paper , it was shown that the previous assignment was wrong and that the structure of the above compound is 15 3 -hydroxywithaferin A (237), whereas that of the second compound is 12B-hydroxywithaferin A (238). However, in a patent 172 of 1986, it was claimed that fermenttion of withaferin A with the same microorganism afforded 14a-hydroxywithaferin A (236). 33-Methoxy2,3-dihydrowithaferin A (239) was also transformed by C. elegans
232 TABLE - 7 MOLECULAR ROTATION DIFFERENCES ( A M D ) IN CERTAIN WITHANOLIDES65 Saturated Lactones
Unsaturated Lactones
AMD
- 425.3
155.3
R MD -412.5
t OH
Ci ^oK
R MD - 546.0
-342.8
-do-
OH,
I R
H
-351.6 1
^ o \
r]^
O
-^S^
- 195.3
^
AcO
^
233 into
its 12 3-hydroxy
derivative
173
(240).
Biotransformations of 1 74 simplex . Of the
withaferin A were also induced by Anthrobacter several
derivatives
thus
obtained,
only
5 a,63-epoxy-2 7-hydroxy-
was identified. Anthrobacter l ,4-dioxowitha--2,24-dienolide citreus 175 deacetylated withaferin A (12) 4,27-diacetate t o the free withaferin A"^^^ ( 1 2 ) . From
tissue
of W, somnifera
cultures
several
sterols such as 24-methylene and 24-ethylidenechlesterol as well
a s sitosterol 177
(242),
stigmasterol
(244) were isolated
. No withanolides
extract
tissue
of
investigation
these
isolated
24-methylenecholesterol.
in the
Concomitantly, in an 1 7fi plants , 24-methylcholesterol,
24-methylcholesta-5,24-dien-33-ol, were
(243) and campesterol
could be detected
cultures.
of W. somnifera
28-isofucosterol
simple
(247, 241)
sitosterol, along
with
stigmasterol and small
amounts
of
This was the starting point for a study
on the biosynthesis of withanolides, to be discussed. By using labeled physalin B (190) and physalin F (194) in 179 that both were
cell free extracts of P. minima , it was observed rapidly
converted
(192)).
However, callus
sysnthesized callus
into
only
derived
the corresponding 5a,6 0-diol (physalin D 180 derived from diploid P. minima plants
small
from
amounts
triploid
of physalin P. minima
D, in contrast to which
synthesized
physalins B (190), D (192) and F (194). Biosynthesis Goodwin and co-workers
178
isolated radioactive
withaferin 3 A(12) and withanolide D (19), by administering [28-^ H]-24-methylene cholesterol to young leaves of Withania somnifera 3 Similar experiments with [28- H]-24(R,S)-24-methylcholesterol gave negative results, whereas [28H]-24-methylcholesta-5,24-dien-3 -ol gave ambiguous results. Later 184 Whiting et al. found that it was incorporated in Nic-1 (90). r. 4-u w ,24(28) . 24 . ^^ ^ From the above A and A isomers are the precursors of withanolides. 1ftR — 1ft7
Investigations of Gros and co-workers by 14 administration of [2- C]-mevalonolactone to seeds and seedlings of 1 QC
A, breviflorus resulted in the isolation of withaferin A (12) and jaborosalactone A (6). The results of the incorporation 185 confirmed the suggestion that jaborosalactone A (6) must be the
234
( 226 ) 5P , 6P. ( 227 ) 5a ,6a (228) 2,3.dihydro-5p,6p. (229) 2,3-dihydro-5a,6a-
OH
(230a)
MeO (232)
(233)
(90)
235
OH (236); (237): (238); (239); (240); (248);
( 241 ) R = CHCH3 (242) R = CH2CH3 (243) R = CH2CH3,A22 I4a -OH (244) R = C H 3 , A 7 , 5,6-diH ISp -OH ( 244a) R = C2H3 , A25. 24 4oH 12p -OH (247) R= =CH2 3p - McO, 2,3 - di H 3P-lVIeO, I2p - OH, 2,3. diH 3 - (1 - aziridinyl) ,2,3 - di H
OH HO HO
HO
a - ecdysone ( 245 ) ; 22a - OH P - ecdysone ( 246 ) ; 22p - OH
Physalindicanol A,
:x^
OH
(246a) and ( 246b) OH
Phsalindicanol B, R = (247a)
236
(249)
(250)
HO H O Ajugalactone ( 252 )
237 plausible precursor of withaferin a (12) and biosynthesized prior to withaferin A. Whiting
and
co-workers
18 4 18 8 '
published
two
papers
concerning with the biosynthesis of Nic~l (90) in N.physaloides; 18 8 the first , with the origin of the aromatic D-ring and the 184 second with the elaboration of the epoxylatol side chain (Chart VIII).
From the biosynthetic experiments performed by Mulchandani 189 14 et al. with Physalis minima radioactive acetate (1- C and 14 14 2-
C)
and
mevalonic
acid
(2-
C ) , were
incorporate into physalin D (192). A
found
to
efficiently
Similarly tritiated withanolide
(12) was found to incorporate into physalin D (192). From the
above
the authors
concluded
that
withanolides
are
the
possible
precursors of physalins. Ergosta-5,25-diene-3 3 ,24 e-diol (24Aci) isolated from the fruits of W. coagulans and two isomers (246a,b) named 1 90 physalindicanols isolated from P. minima var. indica (whole plant) along with other withanolides, were proposed as potential biogenic precursors. Physalindicanol whereas
(246a,b)
A
physalindicanol
(247a)
B
is
the
is
24-epimer
of
(244a),
25-hydroxy-24-methylene-
cholesterol. Biogenesis of Withanolides (247) is the biogenetic precursor
24-Methylenecholesterol
of withanolides. The formation of 24-methylenecholesterol from 1 78 cholesterol was explained by Lockley et al. . They synthesised it and also isolated from Withania somnifera cultures. Hydroxylation followed
by
at
oxidation
C-1
from
produces
the
1-oxo
rear
side
compound.
i.e.,
« -side
Dehydration
of
3-hydroxyl produces a: &-unsaturation in ring A. Among withanolides the 4P-hydroxyl is generally noticed in 5-enes and
53 ,6 3-epoxides.
4 3-Hydroxylation
is easy
as C-4
is
allylic to A^'^ system. It is presumed that formation of 4-hydroxyl takes place first and epoxidation at C-5 and C-6 follows later. This explains the formation of more 53,63-epoxides with 43-hydroxywithanolides 7-hydroxyl (Chart IX).
and
might
then be
with
formed
4d-hydroxyl by
the
containing
allylic
5-enes.
oxidation
of
The
5-enes
238 CHART - Vlll Possible pathways for Ring D > Aromatisation O
II
1,7
{Xn^{
R
HQ
(O)
SAM = S - adenosyl methionine
itf^-^ixy R
M
SAM
T
Possible pathways to the biosynthesis of the epoxvlactol side chain
OH
(O)
(0)
= H
239 CHART-IX BIOGENETIC SCHEME IN RINGS A&B OH
OH
OH
OH
0H£
a
a OH
240 The hydroxylcction at the tertiary positions i.e., 14, 17, 20
is
common
in
both
the
173-
and
17a-side
chain
derivatives
although this system is more dominant in the 17a-oriented system. Lavie et al. isolated a A
-withanolide
it is the precursor of 17a-oriented
(115) and suggested that side chain.
It might
have
originated due to the dehydration of 17a-hydroxyl and the highly crowded side chain will rearrange to the a-side. Hydroxylation at C-27 is frequent whereas at C-28 is rare. ^-lactone are produced by allylic 95 95 oxidation eg. withanolides Q (119) and R (70) whereas ^-lactone 128 (145). ring is noticed in a few compounds eg. perulactone 25 Ixocarpalactones form C-23 and C-26-olides with 22-free 23-hydroxy
compounds
with
hydroxy1 as in ecdysones
(245,246).
'
r ,-a.u u 1- 64,108,129,133 are obtained u^ • ^ w 4- • *. • Withaphysalms by i lactonisation of 18-methyl and 20-hydroxvl. Hydroxylation at C-18, C-19, C-21 is rare. C-21-hydroxyl
and their related derivatives
C-19-hydroxyl
'
and C-18-hydroxyl have been recently reported.
Aromatisation of ring D produces Nicandra Formation
of
saturated
dominent in w. somnifera
lactones,
formation
of
A
steroids
24,25-dihydrolactones
South African variety.
hydrolactones were isolated from The
Compounds with , compounds with
breveflorous
5a-hydroxy-6a
,7a -epoxides
explained, from 53 ,6 3-epoxides as given in the scheme. explained
from the following
less in number.
is
2,3,24,25-Tetra-
reason.
can
be
This was
4-Deoxy-53,63-epoxides
are
Transdiaxial opening of epoxide forms glycol at
C-5 and C-6 position.
Dehydration at C-6 followed by epoxidation
from the rear side produces 5a-hydroxy-6a,7a-epoxides. 5a,63 and 53,6a-dihydroxy systems arise from the scission of
53,6 3-epoxides
opening
by
the trans
respectively.
diequatorial
opening
Formation of
diaxial of
and trans
diequatorial
chlorowithanolide
by
the
53,63-epoxide
bulky nature of chloro group.
ring might be due to the 181 Sarma et al. proved this point by
performing the reaction of NaCl on 53,63-epoxides indicating the presence of NaCl in the plant itself. Hydroxylation at 12, 15, 16 positions is rare. Hydroxyla91 97 tion at C-12 was noticed in daturalactones B (74) and C (75)
241 (164) whereas a 12-oxo group was found
and Jaborosalactone F
in
Qfl 91 31 withanicandrin^^ (63) and daturalactone A ' (64). Even 12-methoxy group is noticed in (23R)-6a-chloro-5B,17a-dihydroxy-12B 138 ~methoxy-l-oxo-12,22--epoxy-ergosta-2,24-diene-23,26-olide (167). 81 15a-Acetoxy group is noticed in physapubescin (35) and in 24b 152-4 physapubenolide (37) whereas physalins contain 15-oxo group in common. But 15-hydroxy compound as such has been recently , . -,31a isolated q •] 93 25 Nicalbins A'* (83) and B (66), ixocarpalactones A (61) 25 and B (59) possess 16-hydroxyl. Formation of 14B-hydroxyl in 102 146-hydroxywithanone (85) was explained through the formation of carbocation, which produces either 14 3~OH or 14a-OH by
hydration
(Chart X I ) . Dehydration of 14-hydroxyl gives A by
subsequent
epoxidation
withanolide M (110).
producing
14
a
-withanolide followed
14,15-epoxide
as
in
These compounds are naturally occurring.
The
frequency of epoxidation is found to be higher at C-5 and C~6 than at C-14 and C-15. ^
-withanolide
formation
of
Similarly, elimination of 17-hydroxyl produces (115) which
17a-oriented
is
side
the
key
chain
intermediate
compounds,
for
the
followed
by
oc
epoxidation gives C-16 and C-17 epoxides, eg. physagulin C
(52).
Hydroxylation at C-22 and C-27 takes place in 24-methylene cholesterol.
The oxidation is carried up to the aldehyde stage to
form a 6-lactol, which yields a 6-lactone by oxidation. will
give
nicalbins
epoxy ,
pubescenol
lactol
as
physapubescin (153),
Nicandra
in .
Epoxylactone
nic-1-lactone
The above
steroids
(91).
is The
'
,
noticed
in
formation
of
lactonic ring is found to be stereospecific. Modifications of
side chain during
withanolide
formation
are shown in Chart X. The formation of the novel side chain of withametelin is considered acnistins
to
follow
a mechanism
similar
to
that
proposed
for
(Chart X I ) .
Pharmocological Activity Withanolides
are
polyoxysteroids
and
several
of
them
possess significant pharmacological acitivity, eg. Withaferin A(12)
242 Chart-X MODIFICATIONS IN THE SIDE CHAIN
,
OH H -:
^ CH20H !
24 - Methylene cholesterol
243
Chart-XI
\ /
r^ OH
OH 0 O''^—OH
OH R=*-OH X ^ leaving group
Acnistins
Withametelins
244 exhibits
tumor inhibitory
activity
in
activity, bactereostatic
experimental
tumors
immunosuppressive properties. activity
mainly microorganisms 57
flavus,
against and
Epidermophyton
in
mice
and as
cytotoxic well
as
Withaferin A possesses antibacterial
acid-fast
antifungal
floccosum
bacilli
activity
and
grampositive jergj Aspergillus
against
.191
and Cladosporium
herbarum
and invivo growth inhibitory and radiosensitizing effect on mouse 2 14 ascites carcinoma ' . It showed significant activity in
Ehrlich
vitro against cells derived from human carcinoma of the nasopharynx (KB) and in vivo against sarcoma 180 (SA) in mice. shown to produce tumour
significant
systems in mice.
growth
retardation
Withaferin A
(lymphocytes)
strongly
versus
inhibited.
It
host
seems
reaction that
It was also a number
(12) suppressed
lesions in adjuvant induced arthritis in rats. graft
in
of
secondary
The locally induced in
chicks
besides
was
also
antiproliferative
activity, withaferin A (12) has a complex influence on inflammation 57 and immune response . Withaferin A (12) and its microbial transformation products, 123-hydroxy and 153-hydroxy derivatives, were found to inhibit the growth and biochemical functions of in 171 . The adduct of vitro grown P-388 lymphocytic leukemia cells aziridine
to
2,3
double
bond
i.e.,
2,3-dihydro-3(l-aziridinyl)
A (248) possesses antitumor activity against P-388 192 lymphocytic luekemia 27-Deoxywithaferin A is found to be more 193 active than other compounds
withaferin
Withanolide P-388
luekemia
E
(46)
exhibits
cytotoxic
activity
against
system, activity against B-16 mouse 57 melanoma and Lewis lung carcinoma , antifeedant property against Shodoptera
and
L-1210
littorolides
,
suppressive properties.
antineoplastic
activity
4 3-Hydroxywithanolide
and
immune
E (53) possesses a o n
considerable lifespan increasing activity against L-1210 leukemia and showed less antifeedant property against larvae of 195 Spodoptera littaralis . Even the model compound having resemblance in ring A/B, i.e., (249) , prepared
53,63-epoxy-l-oxocholest-2-en-43-ol
synthetically
has inhibitory
activity
against
the growth of sarcoma 180 ascites tumor. Withanolide
S
(174)
and
53,63-epoxy-la,14a,173,20-tetra-
hydroxy-witha-24-enolide (250) possess antifeedant activity against 195 the larvae of 5. littoralis 5 a,20a (R)-DihYdroxy-6 a, 7 a-epoxy-l-oxo-5 oi-witha-2 ,24-dieno-
245 lide (73) exhibits immuno modulating properties
197
33-Hydroxy-2,3-dihydrowithanolide F (251) has a protective effect in the cases of CCl. induced hepatoxicity rats.
in adult albino
It also produces a moderate fall of blood pressure in dogs
and has a significant anti-inflammatory . 198 inflammations produced by formalin
effect
in
subacute
24,25-Et>oxywithanolide D (25) and physangulide (42) have 199 effects when administered mtra-peritioneally
antiinflammatory
to mice and rats (10 mg/kg) in exudative and proliferative types of experimentally
induced inflammation.
The activity was comparable
to that of hydrocortisone. Topoisomerase
Withangulatin A (39) acts in vitro on
II
to
induce topo isomerase II mediated DNA damage Several daturalactones show, to some extent, antifertility 201 . Daturalactone B (74) is more
effects on albino female rats active
than daturalactone A
23~hydroxyphysalolactone
(64) and 2,3-dihydrodaturalactone
(180) exhibited
cytotoxic activity
B.
(ICcp
value 40 ug/ml) against L-5178 Y cell in vitro"''^^. The epoxide and quinoid like moiety in AB ring as well as the unsaturated lactone in the side chain have been shown to have tumor-inhibitory
activity
as
found
in
several
classes
of
•J 202 terpenoids
Withaferin A (12) and withacinstin
(16) showed cytotoxity
invitro, against KB cell cultures derived human carcinoma of the nasopharynx and invitro against sarcoma 180 in mice and walker 25 6 , . 44,203 intramuscular carcinoma Physalolactone was
inactive
against
175
, a chlorohydrin
P-388
lymphycytic
of
4P-0H withanolide
leukemia,
indicates
E
the
5,6-epoxide is a requisite for the activity 17P-Hydroxy
group
along
with
5P,63-epoxy
system
is
essential for the antitumor activity, eg. withanolide E (46), 4P-0H withanolide E (53). Thus 17-isowithanolide (34) possessing 17°'-0H is found to be inactive
.
17 3-Hydroxywithanolide K was found to
be active against a number of potentially pathogenic fungii 16c
Dunal
204
Even the crude extracts of the leaves of Withania
somnifera
have been reported in Ayurveda and Unani Medicine (India)
used for the treatment of tumor and tubercular glands and besides
246 being sedative and hypnotic. W. somnifera
The glycowithanolides from effective
on
Swiss
mice
in
alleviating
were shown to be
the
adverse effects of 215 . The same were
morphine and attendant immunosuppression action also found
to act on an animal model of Alzheimers disease and
perturbed central cholinergic markers of cognition in rats. findings
were
"medharasayan"
taken
to
support
(Promoter
of
the
of ^'
effect
learning
and
These
somnifera
memory)
as
^s
used
in
Ayurvedic medicines A. arborescens and tubercular glands Physalins
is also used
44
which
resemble
for the treatment of tumors
closely
in
their
withanolides occur mainly in the plants of Physalis
structure species.
to The
plants as such as well as the isolated physalins have been reported to exhibit varied pharmacological activity. P. alkegengi
was
diuretic, anthelmintic
reported
in
Chinese
medicine
and anticancer activities
P.angulata^^^
andP. peruviana^^^
P. angulata
and P. peruviana
are
diuretic.
are
.P.
The
anthelmintic
and
to
have
minima
leaves P-
of
pubescens
(Puerto Rico) has been used in indigestion. Physalin B (190) and epidihydrophysalin from
Witbaringia
cocculolides
were
shown
to
C
(204) isolated
possess
promising
antitumor activity Physalin B (190) was found to be moderately active in PS. The
favourable
intensification
influence of
of
antitumor
a
5a,6ot-epoxy
activity
was
grouping
discolsed
in
the
from
the
observation that 5a,6a-epoxyphysalin B is more cytotoxic in 9 KB than physalin B
'
Antitumor activities of physalins A, B, E, F and L were determined
by
using
He
La
cells
moderate in vitro cytotoxicity Physalin
B
cytotoxic
(190) and
physalin
against mouse
tumor
physalin
(IDCQ F
A
(18)
exhibited
yg/ml) against He La cells.
(194), which were known
cells
show
higher
activity
to be (IDc^
0.32 -0.35 yg/ml) than physalin A, while physalins E (193) and L (200) were found to be inactive. Physalin X, a compound of unknown modifying physalins of Pbysalis ^ ^.^ . ^54,211 abortifacient
minima
structure, obtained by
has been reported to be an
247 Nicandra physalolides
104
a South American plant is noticed
for its fly repellent activity. Ecdysones which are yet another closely related group of polyoxy steroids and Nicandra
steroids are knwon for their powerful
antifeedant properties. These are regarded as insect moulting 212 213 hormones , eg. « - and 3 -ecdysones (245,246), ajugalactone (252). Synthesis The methods
efforts
on synthesis
for the synthesis
substitution
patterns
of withanolides
of model
of rings
A
compounds and B
comprise (a)
with
the required
(b) methods
synthesis of the unsaturated 6-lactone side chain
for
starting
the from
androstane skeleton and (c) attempts involving rings A and B and the side chain finally leading to several natural withanolides, as withaferin A, withanolide D etc. reviewed by E. Glotter
These details have been recently
and hence no description has been included
in this article on the synthetic aspects. ACKNOWLEDGEMENTS One of the authors
(A.S.R. Anjaneyulu) wishes to express
his gratitude to the authorities of Andhra University for granting sabbatical leave from January to June, 1996 and the authorities of Northeastern visiting
University,
Professor during
update and finalise
Boston
for extending
him facilities as
this period which made it possible to
this review.
The assistance
rendered
inthe
preparation of manuscript by Messers D.V. Jagannadha Rao (typing), V.V.S. Prasada
Rao (drawings) and M.V.R.
reading) is gratefully acknowledged.
Krishna
Murthy
(proof
248 REFERENCES
1.
George H.M. Lawrence "Taxonomy of Vascular Plants", published by Publishing Co., Ninth Edition, 1964, p. 693. "The useful plants of India", Publication Directorate, CSIR, New Delhi, 1986, p. 583.
3.
Ibid ' p. 581.
4.
Ibid ' P- 251.
5.
Ibid ' P- 342.
6.
Ibid
P- 398.
7.
Ibid
P- 62
8.
Ibid
p. 163
9.
Ibid
P- 280
10.
Ibid
P- 579
11.
Ibid
p. 580
12.
Ibid
P- 234
13.
Ibid, P- 690
14.
Ibid
15.
D. Lcivie r E .
Oxford and
and
IBH
Information
P- 452
16a. S.S. Subramanian, P.D. Sethi, E. Glotter, I. Kirson and Lavie Phytochemistry,10 (1971) 685.
D.
b. V.V. Velde, D. Lavie, R.D. Budhi Raja, S. Sudhir and K.N. Garg Phytochemistry,22 (1983) 2253-57. c. M. Iqbal Chowdhary, DureShahwar, Parveen Zeba, Jabbal Abdul, AliArshad and Atta-ur-Rahman Phytochemistry, 40 (1995) 1243-6. 17.
A.G. Gonzalez, J.L. Breton and J.M. Trujillo An. Qum,, 68 (1972) 107-108.
18.
I. Kirson and E, Glotter J. Nat, Prod.,44 (1981) 633-47.
19.
B.L. Modawi, G.M. Iskander, M.A. Karim, C.K. Fair and Schlemper J. Pract. Cbem., 328 (1986) 291-294.
20.
T. Matsuura, M. Kawai, R. Nakashima and Y. Butsugan Tetrahedron Lett. (1969) 1083-1086.
E.O.
249 21a. E. Glotter, I. Kirson, Subramanian J. C/iem. Soc, Perkin Trans 1,
A.
Abraham,
P.D.
Sethi
and
S.s.
(1975) 1370-1374.
b. H.E. Gottlieb, M. Cojacaru, S.C. Sinha, M. Sahai, A. Bagchi, A. Ali and A.B. Ray Phytochemistry, 26 (1987) 1801-1804. 22.
L.R. Row, K.G. Reddy, N.S. Sarma, T. Matsuura and R. Nakashima Phytochemistry, 19 (1980) 1175-1181.
23.
S.W. Pelletier, G. Gebeychu, J. Nowacki, N.V. Mody Heterocycles, 15 (1981) 317-320.
24a. L.R. Row, K.S. Reddy, K. Dhaveji and T. Matsuura Phytochemistry, 23, (1984) 427-430. b. E. Glotter, M. Sahai, I. Krison and H.E. Gottlieb J. Chem. Soc. Perkin Trans 1, (1985) 2241-2245. 25.
I. Kirson, A. Cohen, M. Greenberg, H.e. Gottleib, P. Verenne and A. Abraham J. Chem. Res,(s), (1979) 103 J. Chem. Res.(M), (1979) 1178-1195
25a. F. Echeverri, W. Quinones, F. Torres, G. Cardona, R. Archbold, J.G. Lewis and G.A. Gonzalez, Phytochemistry, 40 (1995) 923-25. 26a. I. Kirson, A. Abraham, P.D. Sethi, S.S. Subramanian Glotter Phytochemistry, 15, (1976) 340-42.
and E.
b. P. Neogi, M. Sahai and A.B. Ray Phytochemistry, 26 (1986) 243-7. 27.
L.R. Row, K.S. Reddy, N.S. Sarma, Nakashima, Phytochemistry, 19, (1980) 1175-81.
T.
Matsuura
28.
I. Kirson, H.e. Gottlieb and E. Glotter, J. Chem, Res (M), (1980) 2134-56. J. Chem, Res,(5), (1980) 125.
29.
S.C. Sinha, A.B. Ray, Y. Oshima, A. Bagchi and H. Hikino, Phytochemistry, 26 (1987) 2115-7.
29a. K. Shingu, S. Yahara and T. Nohara, Chem, Pharm, Bull,, 38 (1990) 3485-7. 30.
R.N. Tursunova, V.A. Masiennikova and N.K. Abubakirov Khim, Prir, Soedin., (1978) 91-95.
31.
W.C. Evans, R.J. Grout and M.L.K. Mensah Phytochemistry, 23 (1984) 1717-20.
31a. C. Adriana, V. Adriana, J.C. Oberti and G. Burton, Phytochemistry, 40 (1995) 611-13.
and
R.
250 32.
Y. Oshima, A. Bagchi, H. Hikino, S.C. Sinha, M. Sahai and A.B. Ray, Tetrahedron Lett., (1987) 2025-28.
33.
M.A. Qurishi, Ashok K. Kalla, K.L. Dhar, Phytochemistry, 18, (1979) 1756-7.
34.
A. Bagchi, P. Neogi, M. Sahai, A.B. Ray, Y. Oshima and H. Hikino, Phytocbemistry, 23, (1984) 853-55.
35.
R. Hansel, J.T. Huang and R. rosenberg Arch, Pharm., 308 (1975) 653-54.
36.
R. Tschesche, H. Schwang, H.W. Fehlhaber and G. Snatzke Tetrahedron, 22 (1966) 1129-38.
37.
Edith S. Monteagudo, G. Burton, Claudia M. Gonzalez, Juan C. Oberti, Eduardo G. Gros, Phytocbemistry, 27, (1988) 3925-8.
38.
M. Parvez, Victor Fajardo and Maurice Sharma, Sec. C, Cryst. Struct. Commun.,4S Acta Crystallogr, 1850-3.
39.
(1990),
D. Lavie, H.E. Gottlieb, M.J. Pestchanker and O.S. Giordano, Phytocbemistry, 2